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Abstract
For a drug to be effective it must be in solution so that it can be absorbed by the body at
the site of action. Therefore, it must be soluble in an aqueous environment. For practical
reasons many drugs are formulated in the solid state; an understanding of how the drug
transitions from solid to solution is hence critical. The two key factors to be considered
are the drug’s solubility and dissolution rate.
In this work a novel method for the analysis of phase transitions in pharmaceutical
materials was developed by combining high energy synchrotron X-ray diffraction with
differential scanning calorimetry (DSC-XRD). This was used to collect in situ structural
and calorimetric data on temperature driven phase transitions. Initial work was carried
out to prove the utility of the technique by examining two enantiotropically polymorphic
systems, and subsequently it was used to examine phase transitions in materials
exhibiting multiple polymorphs. Building on this, the effect of sugar based excipients on
the crystallisation behaviour of paracetamol glasses upon heating was examined, with
particular emphasis on the stabilisation of metastable polymorphs II and III.
DSC-XRD was further employed in the production of new co-crystals between
isonicotinamide and three antioxidant compounds. The ability of four different techniques
(solvent evaporation, thermal inkjet printing, heating, and milling) to prepare these co-
crystals was investigated in detail.
Finally, physical vapour deposition, a novel technique in the field of pharmaceuticals,
was investigated for the preparation of amorphous materials, with particular emphasis
on drugs considered to be poor glass formers.
DSC-XRD has been demonstrated to be an incredibly powerful tool for the analysis of
phase transitions and co-crystallisation in pharmaceutical materials, and physical vapour
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Impact Statement
For a drug to be effective it must be absorbed by the body at the site of action. In order
for this to happen the drug must be in solution and so, regardless of the pathway it is to
take, it must be soluble, to some extent, in an aqueous environment. One of the most
significant barriers to the success of new chemical entities is their solubility, with up to
70 % of candidates being reported as having poor aqueous solubility in the past decade.
The formulation of drugs in the amorphous or metastable forms and co-crystallisation all
have the potential to overcome this problem. However, current methods of vitrification
are incapable of producing amorphous matrices of adequate stability and methods of
screening possible co-crystals are slow and expensive. Methods of stabilising
metastable polymorphs using molecular additives are well known, but detailed
knowledge of the mechanism and rate of conversion between the polymorphs of drugs
is lacking. More significantly, knowledge of the interactions occurring between additives
and active pharmaceutical ingredients, and consequently which additives to use for any
given scenario, is lacking.
The research contained within this thesis goes some way to addressing the problems
outlined above and in particular presents a novel and powerful technique for the
simultaneous structural and thermal analysis of phase transitions in pharmaceutical
materials. It further reports a number of new co-crystals with potential pharmaceutical
applications.
Finally, a novel deposition technique for the preparation of amorphous materials is
presented. The method’s ability to produce amorphous materials where this cannot be
achieved using traditional methods may make this new approach an invaluable tool for
future pharmaceutical research. Armed with these tools, future researchers will be able
to design more intelligent medicines.
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1 Introduction
1.1 Solubility and Dissolution
For a drug to be effective it must be absorbed by the body at the site of action. In order
for this to happen the drug must be in solution and so, regardless of the pathway it is to
take, it must be soluble, to some extent, in an aqueous environment.1 However, for
practical reasons such as stability, ease of manufacture, transportation and
administration, many drugs are formulated in the solid state; an understanding of how
the drug transitions from solid to solution is therefore critical.2 The two key factors to be
considered are the solubility: the extent to which a solute (i.e. a drug) will disperse as
molecules throughout the solvent, and dissolution: the process by which the molecules
of the solid transfer into solution.1 The rate at which dissolution occurs is particularly
important as fast dissolution is often linked to high bioavailability. As dissolution is
defined by a rate it is a kinetic process, whereas solubility, an equilibrium state, is
thermodynamic.3
One of the most significant barriers to the success of new chemical entities is their
solubility, with up to 70% of candidates being reported as having poor aqueous solubility
in the past decade.4–6 The solubility of a substance is directly related to its physical form.
Materials may exist as solids, liquids and gases and the form they take is dependent on
the conditions (pressure and temperature) of the environment that surrounds them.
Unlike liquids and gases solids are rigid forms of matter, and their shape is independent
of the container in which they are held. A crystal’s external shape is known as the habit
and is determined by the underlying structure.7 Molecular crystalline solids consist of a
repeating array of molecules termed the crystal lattice. The smallest unit of the lattice is
known as the unit cell and may consist of one or more molecules. The molecules in a
molecular crystal are held together to form the lattice by intermolecular bonds: hydrogen
bonds (H-bonds), and van der Waals forces. The energy required to break these bonds
and separate the molecules, for example during dissolution, is called the lattice enthalpy.
Different crystal structures are held together by a different combination of intermolecular
bonds and so have a unique lattice enthalpy.8 Materials may exist in a number of crystal
forms, which are summarised in Figure 1-1 and Table 1-1.
14
Figure 1-1. Overview of crystalline forms. Reproduced with permission from ref 9.
Table 1-1. Summary of the crystalline forms and their definitions.
Crystal Form Definition
Polymorph Any one of the individual crystalline forms of a single substance.
Monotropic
Polymorphic system in which the order of stability is independent of
the pressure and temperature. Phase transitions observed upon
heating are irreversible.
Enantiotropic
Polymorphic system in which the order of stability changes at a
critical temperature. Transitions between enantiotropic polymorphs
are reversible.
Pseudopolymorph Different crystal structures arising from the addition of one or morechemical entities to the unit cell.
Co-crystal
Solid that is a crystalline single phase material composed of two or
more different molecular and/or ionic compounds, generally in a
stoichiometric ratio which is neither a solvate nor a simple salt.10
Hydrate/solvate
Solid that is a crystalline single phase material in which the unit cell
comprises a drug and water or another solvent in a stoichiometric
ratio.
 Reversible
A hydrate/solvate in which dehydration/desolvation results in a stable
dehydrate/desolvate that may be rehydrated/resolvated to give the
original hydrate/solvate.
 Nonreversible
A hydrate/solvate that when dehydrated/desolvated becomes
unstable and converts to an anhydrous form. Addition of further
solvent will not result in formation the original hydrate/solvate.
In ambient conditions the majority of drugs exist as crystalline solids11 in their most stable
state. This is ideal for long term storage but their high stability presents a problem for
solubility and dissolution. There has been a great deal of research into ways of improving
the apparent solubility and dissolution rate of poorly soluble active pharmaceutical
ingredients (APIs) in an attempt to improve their bioavailability.4–6 These include; particle
size reduction, modification of the crystal habit, polymorph formation, amorphous phase
preparation, co-crystallisation, solid dispersion and chemical modification among others,
15




Full characterisation of the crystalline solid state (and to a lesser extent the amorphous)
requires determination of the positions of the atoms and molecules, in the unit cell, and
its dimensions. Single crystal X-ray diffraction is the only tool capable of collecting this
information. However, often single crystals are not easily obtainable, but powders
consisting of many small crystallites (too small for single crystal diffraction) are, and
limited information on the structure of a material can be collected by powder X-ray
diffraction (PXRD). The technique relies on the repeating nature of the crystal lattice to
build an image of the internal structure of the crystal.9,15
When X-rays are focused onto a substance they are scattered by electrons within that
material, and the pattern of the diffracted light can be collected using an X-ray detector.
If the subject is crystalline then the ordered arrangement of atoms, and so electrons,
results in a diffraction pattern of regularly spaced spots. The intensity and position of
these spots can be used to calculate the positions of the atoms in the crystal lattice.8
The crystal lattice can be described by sets of parallel planes that extend infinitely
throughout the lattice (Figure 1-2 (a)). The relationship between the distance separating
adjacent planes and the angle at which X-rays must hit the crystal for constructive
interference (intense reflections resulting from X-rays diffracting in phase) is known as
Bragg’s Law:
݊ߣ= 2݀݅ݏ݊ߠ (1)
Where ߣ is the wavelength of the incident beam, ݀ is the interplanar spacing, and ߠ is
the incident angle (Figure 1-2 (b)) of the beam. For constructive interference to occur ݊
must be an integer (i.e. the difference in path length between planes must equal an
integer number of wavelengths so that the diffracted waves remain in phase).8
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Figure 1-2. A schematic representation of (a) planes in a crystal lattice, and (b) X-rays diffracting
constructively off of lattice planes in a crystal.
From the diffraction pattern collected it is a simple process to calculate the d-spacing of
the lattice planes using the Bragg equation (1), and this information can be used to find
the unit cell parameters and crystal system/structure. Electron rich atoms scatter X-rays
more strongly than lighter atoms and so the intensity of the reflections can be used to
calculate the position of the atoms. This is not a simple process.8
As previously mentioned often single crystal XRD is not possible and so PXRD must be
employed. Rather than the spots produced by single crystal XRD, as the crystallites in a
powder are arranged in all possible orientations in relation to the beam, and so the X-
rays diffract in 360° resulting in a pattern of rings. A consequence of this is that all
symmetry equivalent reflections have the same d-spacing and so individual intensities
cannot be measured,16 making full structure elucidation from powder samples very
difficult. However, if structure solution is not an issue then PXRD is a powerful tool for
identifying polymorphs, monitoring structural changes within a polymorphic system (see
Section 1.1.3) and phase quantification in multiphase materials.
1.1.2. Differential scanning calorimetry
Differential scanning calorimetry (DSC) is used to measure the flow of energy into or out
of a material as it undergoes temperature related phase changes such as melting and
crystallisation. Each phase change will be either endothermic or exothermic and will have
an enthalpy associated with it. The DSC measures this enthalpy and the temperature at
which it occurs. However it gives no specific structural information related to these
changes, and so often the technique is used in conjunction with PXRD.8,17
DSC measures the power required to maintain the sample at a temperature equal to that
of an inert reference in accordance with a prescribed temperature programme. The
reference is an empty sample pan identical to the one in which the sample is held. Thus,
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the difference in power can be ascribed to the sample alone. The theory of DSC will be
discussed in more detail in Chapter 2.
1.3 Excipients and metastable polymorphs
1.1.3. Polymorphism
For the majority of drugs, the most stable form under ambient conditions is a crystalline
solid.18 However, a drug can exist in more than one crystalline state.19 Polymorphism
describes the existence of multiple crystal systems defined by different unit cells but
having the same molecular composition (Figure 1-3).20 With monotropic materials, the
polymorph with the highest melting point is considered to be the stable polymorph at all
temperatures, and all others are metastable. Enantiotropic materials exhibit polymorphs
with a different order of stability either side of a critical temperature.9
Figure 1-3. A schematic representation of two polymorphs of the same drug. The unit cell in
each case is marked by a red outline.
Each polymorph of a material possesses different physicochemical properties such as
density,9,21,22 solubility,12,21,22 dissolution rate,12,22 flow properties,15,22 compressibility, and
crystal habit.15 By definition, metastable forms are less stable than the stable form and
so will have a higher dissolution rate and solubility, and, often a higher bioavailability.
However, as the stable polymorph is the only form that is in thermodynamic equilibrium
all metastable forms will eventually convert to it over time.18 That being said, kinetic
stability is often very high and polymorphs considered to be metastable can take years
to convert to the thermodynamically stable form.23 This causes an obvious problem for
pharmaceutical scientists as with this conversion comes an accompanying drop in
18
solubility and/or dissolution rate, as well as changes to many other physicochemical
properties. Therefore, in cases where the stable form of a drug has poor bioavailability
and conversion from the metastable form to the stable form occurs rapidly at ambient
temperatures,9,18 it is desirable to find some method of stabilising the metastable form of
choice.
1.1.4. Polymorph control
Methods of polymorph control currently employed include: introduction of additives (e.g.
seeding, templating, polymorph growth inhibition), solvent modification, physical
confinement of crystals during growth, and the use of radiation to stimulate nucleation.22
1.1.4.1. Seeding
As the name suggests, seeding involves growing the desired bulk crystalline product
from a seed-crystal of the same polymorph added to a supersaturated solution. The
obvious disadvantage of this method is the necessity for the presence of the initial seed-
crystal. It is also important to know the width of the metastable zone (Figure 1-4) as
seeding is most likely to be successful under these conditions. If a solution is cooled or
the solvent allowed to evaporate so that eventually it becomes supersaturated nucleation
will not occur immediately. Rather, there is a point to which the solution must cool or
concentrate past the line of solubility before spontaneous nucleation will occur. The line
of solubility and the nucleation border form the limits of the metastable zone. It is
important to note that the border of nucleation is not a clearly defined line and should be
determined by performing controlled crystallisations24,25 If seeding is attempted in too
dilute a solution then the seed-crystal will dissolve. Conversely, if the seed is added to a
supersaturated solution in which nucleation has already begun then growth from the
seed may be negated.22 Quench cooling (see Section 1.1.9.1) is a typical method of
obtaining seed-crystals, because nucleation from the quenched material should begin
with the least stable polymorph and progress through the other polymorphs via minimal
changes in free energy (Ostwald’s rule of stages).25,26 In theory, this allows access to,
and isolation of, all metastable polymorphs of a material. However, in practice this is not
always the case, for instance in the case of concomitant polymorphism: the
phenomenon of a particular set of crystallisation conditions yielding more than one
polymorph.27 Seed-crystals of paracetamol (PCM) form II have been grown by this
method and used to seed its growth from ethanolic solution.28
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Figure 1-4. A graphical representation of the metastable zone for crystallisation from solution.
1.1.4.2. Growth inhibition
By inclusion of soluble additives to a crystallisation solution it is possible to inhibit the
growth of some polymorphic forms whilst permitting the evolution of others (Figure 1-5).29
The additive must be able to mimic motifs (characteristic intermolecular bonding
patterns) of the target higher stability polymorph on one side, allowing it to attach, and
be sufficiently different from it on the other side that no more drug molecules can attach.27
In so doing it must inhibit, at the very least, the stable polymorph’s fastest growing face.
This results in relative stabilisation of the metastable form.22,30 Molecular modelling is of
particular use in this field of polymorph control, and has been utilised to design
experiments which successfully inhibited the growth of the stable β phase of L-glutamic
acid and in so doing stabilized the α form.31
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Figure 1-5. A schematic representation showing the selective inhibition of polymorph growth in
solution.
1.1.4.3. Templating
Templating relies on heterogeneous nucleation27 from the surface of a substrate. The
substrate is chosen so that it has either a similar lattice to the desired polymorph, or a
morphology that directs molecular ordering of the subject material to that of the desired
polymorph.32 Prior to crystal growth in solution the molecules must form an aggregate,
which must eventually form a nucleus with the structure of the ultimate crystal. This
process is enthalpically unfavourable due to the energy associated with the phase
boundary between the nucleus and the solution.33 The presence of the template serves
to lower the free energy barrier to nucleation, and consequently the process is more
favourable than homogeneous (spontaneous) nucleation.32–34 A number of examples of
pharmaceutical polymorphs that have been templated can be seen in Table 1-2.
21
Table 1-2. Examples of polymorph templating in pharmaceutical materials.























YN Pimelic acid Physical vapourdeposition
36
Carbamazepine









V Dihydrocarbamazepine II Physical vapourdeposition
39,40
Cyheptamide III Dihydrocarbamazepine II Physical vapourdeposition
36





L-glutamic acid α Phenylalanine SAMs Solution cooling 42




















Paracetamol is well known to exhibit three polymorphic forms, named I,47 II,48 and III49
(Figure 1-6). Form II is of particular importance due to its superior compression
properties50 (important for making tablets) compared to those of form I, resulting from its
layered structure. However, form II is difficult to prepare in large quantities51 as
polymorph I is the thermodynamically stable structure.52 Form III is the least stable of the
three, and its instability is evidenced by the fact it was known to exist for 27 years prior
to the elucidation of its crystal structure in 2009.49
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Figure 1-6. Graphical representations of the herringbone structure of PCM form I and the
layered structures of forms II and III.
Lang et al.38 templated the growth of pure PCM form II from solution using a number of
different polymers. Prior to their work, pure form II had only been grown from solution
once48 (although it had been isolated by crystallisation from the melt)53 and all
subsequent efforts resulted in a mixture of form II and the more thermodynamically stable
form I. Lang’s work appears to be the first example of such heteronucleation of crystal
growth. The method is referred to as polymer templating; it is particularly useful as it
requires no prior knowledge of the lattice or surface chemistry of the polymorph38 and
can produce single crystals.22,38 The process works in the same way as templating, with
the generality of the method resulting from the use of a library of polymers with diverse
functional groups and spacing of the groups, from which polymorphs are grown.
Characterisation of the products informs which polymorph is templated by each
polymer.38
In 1994 Femi-Oyewo and Spring54 grew PCM crystals from aqueous solutions containing
various concentrations of the additives agar, gelatin, polyvinylpyrrolidone (PVP), and
hydroxypropylmethyl cellulose (HPMC). They observed significant modification to the
PCM crystal habit for each of the excipients, with PVP and HPMC suppressing crystal
growth somewhat and resulting in low yields of microcrystalline material. Kachrimanis
and Malamataris55 also showed that crystallisation of PCM in the presence of polymers
resulted in alteration of the crystal shape and in some cases an improved yield. No
mention was made of the polymorphic form grown in either of these studies, although all
crystals grown in the presence of a polymer additive showed improved compressibility
over those grown without. This appears to suggest the presence of at least some form
II. A study by Garekani et al.56 in 2000 on the effect of crystallising PCM with PVP at
different molecular weights showed good agreement with these results. These authors
too make no mention of the polymorph grown but present DSC and powder X-ray
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diffraction data that is consistent with data recorded for crystals grown without polymer
additives, suggesting polymorph I. Furthermore, all DSC traces are described as
showing a sharp melting point at ca. 171 °C with a flat baseline, confirming the presence
of polymorph I.
The three studies discussed in the previous paragraph all involved crystallisation of PCM
from solution. In 1997 Di Martino et al.53 attempted to develop a thermal method for the
preparation of larger quantities of PCM forms II and III than had previously been reported.
Initial experiments were carried out and analysed in situ prior to scaling up the synthesis
in a glass flask and using an oven as the heat source. In situ experiments showed form
II to be prepared by crystallisation from a PCM glass prepared by slowly cooling the melt
(whereas fast quenching resulted in recrystallisation to form I). The slowly cooled
material was shown to either melt or covert to form I upon heating, depending upon the
ramp rate. Preparation of polymorph II was successfully scaled up. However, the bulk
always converted to form I upon heating. Form III was prepared by melting crystals of
form I between a microscope slide and cover slip using a hot stage. The melt was then
held isothermally at 54 °C for 90 minutes, in which time the material crystallised to form
III. Crystallisation below 50 °C was found to be very slow and above 56 °C nearly
impossible, with 54 °C being the optimum temperature. Form III was stable between the
slide and cover slip for several months, but removal of either slide resulted in conversion
to form II. This crystallisation to polymorph III was reproduced by DSC in a closed pan
but by no other method, leading the authors to postulate the necessity of closed
conditions for its preparation.
In 2002 Giordano et al.52 examined the effect of recrystallising PCM from the melt in the
presence of polymeric excipients (microcrystalline cellulose, HPMC, and cross-linked
PVP). They melted and cooled binary mixtures ranging from 50 % w/w to 90 % w/w drug
and found that both form II and form III could be reproducibly crystallised (although phase
purity was not assessed, and in most cases mixtures were prepared). The degree of
crystallinity of the product was influenced by the polymer, the composition of the mixture,
and the thermal history. Microcrystalline cellulose was found to be particularly effective
at stabilising form II.
Further work by Rossi et al.51 showed that PCM forms II and III can be prepared from
binary mixtures of form I with 10 % w/w HPMC using thermal methods. Following an
identical melting step at 180 °C both samples were reheated, each to a specific
temperature, and held isothermally for 2 minutes to allow crystallisation. Material
prepared by DSC resulted in form II or form III depending upon the hold temperature.
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Upon reheating form II showed no phase changes except for its melt at 158 °C. Form III
prepared by DSC was shown to convert to form II when reheated following a melt at ca.
139 °C, whereas the same polymorph prepared in larger quantities using a Köfler hot
stage bypassed the conversion to form II and instead converted directly to form I.
Analyses were carried out separately using DSC, powder X-ray diffraction (PXRD) and
micro-Fourier transform infrared spectroscopy (MFTIR) and the transitions observed in
the sample of form III prepared by DSC were not reproducible by other methods.
Burley and co-workers26 investigated the method of Di Martino et al.53 for preparing PCM
form III between a microscope slide and cover slip, and discovered that holding the
material at 54 °C following the melt was not necessary. Gently warming the glass was
sufficient for crystallisation (Figure 1-7). Further heating caused the transformation to
form II above 120 °C, and this subsequently melted at 159 °C. Furthermore, the authors
prepared form III in a NMR rotor by melting form I at 190 °C and cooling to form a glass
which they then warmed to 50 °C, demonstrating that confinement between glass slides
is not essential. This constituted the preparation of a relatively large amount of pure
paracetamol form III, however neither it nor form II could be removed from the rotors
without dissolution.
Figure 1-7. Hot stage microscopy images recorded whilst heating a PCM glass formed by
cooling the melt. (a) the glass, (b) PCM form III, (c) PCM form II, and (d) PCM form II melting.
Reproduced with permission.26
Gaisford et al.57 prepared PCM form III by annealing a PCM glass at 113 °C for 2 minutes
and used rapid-heating DSC to supress the solid-solid III→II transition. In so doing they 
observed the melt of form III at 143 °C. However, they argue that due to differences in
the enthalpies of crystallisation and fusion relating to polymorph II it was not possible to
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crystallise pure polymorph III from the melt and propose that prior evidence in the
literature of its isolation is inconclusive. In DSC experiments, the data show an exotherm
following the melt of form III that is ascribed to the crystallisation of form II. This is
followed by form II melting. In all cases the enthalpy of crystallisation of form II is lower
in magnitude than its enthalpy of fusion. Thus, as the enthalpy of fusion for any
polymorph is equal and opposite to its enthalpy of crystallisation, form II must always
have been present. Gaisford and co-workers support this theory by annealing the
quenched samples at lower temperatures, so favouring the crystallisation of form III,
which results in a slight increase in the magnitude of the form II crystallisation exotherm
prior to its melt, but it never equals the enthalpy of the melt. In the same work, this team
assessed the effect of HPMC on the thermal recrystallisation behaviour of PCM from the
glass (Figure 1-8) and show that it favours the formation of form III. The authors suggest
that it does this by restricting molecular movements: since the movements required to
crystallise to polymorph III are smaller than those needed to generate polymorph II, the
former is favoured. Furthermore, they demonstrate that a higher molecular weight (hence
viscosity) HPMC results in stronger stabilising effects on form III. Increasing the
proportion of HPMC in the mixture was found to stabilise the amorphous phase, and at
a mass ratio of 1:1 the PCM remains amorphous when heated well past the melting
temperature of the stable polymorph.
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Figure 1-8. DSC data for mixtures of PCM and HPMC following crystallisation from the glass at
113 °C. (a) 9:1 PCM:HPMC grades E5, K4M, and K100M heated at 200 °C min−1. (b) 9:1
PCM:HPMC E5 at heating rates up to 1000 °C min−1. (c) 7:3 PCM:HPMC E5 at heating rates up
to 1000 °C min−1. (d) 5:5 PCM:HPMC E5 at heating rates up to 1000 °C min−1. Reproduced with
permission.57
1.4 Co-crystallisation
Co-crystallisation is another method by which the chemical and/or physical properties of
a molecule can be tuned without making or breaking any covalent bonds.58 It can be
used to improve a material’s solubility and/or rate of dissolution and, as a consequence
of the substance existing in a crystalline form, co-crystals are likely to be more stable,
reproducible and easier to purify than high energy solids such as glasses and therefore
more desirable.58,59 Examples of co-crystals that have been developed with APIs and the
properties that have been improved include: carbamazepine (CBZ) and nicotinamide
(NCT) to improve the physical stability of CBZ;60 CBZ and saccharin (SAC) to improve
both the dissolution rate and the oral bioavailability of CBZ;61 indomethacin (IMC) and
SAC to increase the physical stability and dissolution rate of the drug.62 Saccharin is a
sweetener, providing the additional benefit of taste masking, a useful property
considering the common problem of bitterness in pharmaceuticals.
A recent perspective,10 prior to which there was little consensus, has attempted to clarify
the definition of co-crystals, concluding that “co-crystals are solids that are crystalline
single phase materials composed of two or more different molecular and/or ionic
compounds, generally in a stoichiometric ratio, which are neither solvates nor simple
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salts.” It is important to ensure that a suitable non-toxic, pharmaceutically acceptable59,63
co-former is used that will not interact covalently with the drug and alter its chemical
structure.58 A graphical representation of a co-crystal can be seen in Figure 1-9.
Figure 1-9. A schematic of the composition of a co-crystal [adapted from Schultheiss and
Newmann, 200964].
Co-crystals rely on non-covalent intermolecular interactions (usually hydrogen bonds) to
make associations between the molecules of the different compounds involved, with the
necessity that the interactions between drug and co-former must be more favourable
than those between two molecules of the same species.65 Co-crystals can be designed
by selecting molecules59 where hydrogen bonds can form between specific functional
groups. These interactions have been termed supramolecular synthons (Figure 1-10)
and are defined as “structural units within supermolecules which can be formed and/or
assembled by known conceivable synthetic operations involving intermolecular
interaction”.66 Pharmaceuticals are ideally suited to this type of interaction as they very
frequently contain external hydrogen bonding moieties.67
Crystal engineering is a term which refers to using these synthons for the design and
manipulation of molecular solids with the aim of tailoring the entity’s physical and/or
chemical properties, often to improve solubility and dissolution.68 Synthons (Figure 1-10)
may comprise either homosynthons (both functional groups are the same, e.g. carboxylic
acid to carboxylic acid) or heterosynthons (two different functional groups, e.g. carboxylic
acid to amide).59,68 It is the competitive nature of the attraction between these functional
groups that allows for the formation of different supramolecular synthons and ultimately
the formation of co-crystals.59
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Figure 1-10. Examples of supramolecular homosynthons and heterosynthons.
A number of methods are currently employed in the screening/discovery of co-crystals,
including; solution crystallisation59,62,68,69 crystallisation from the melt,68,70 and grinding.69
Microfluidic and supercritical fluid tecnologies59 are also known to aid the formation of
co-crystals but are less common. Failure to form a co-crystal via one route does not
preclude its production by another, and so it is often necessary to carry out
comprehensive screening employing multiple techniques to obtain the material of
interest.59,71,72 Thus, it is desirable for these techniques to be fast, inexpensive and
environmentally friendly.
1.1.5. Solution methods
Solution crystallisation is of great importance as it is currently the most common method
for producing co-crystals of sufficient quality for single crystal XRD.69 The technique can
be divided into four categories depending on the treatment of the solution.
1.1.5.1. Evaporation
Evaporation from solution is the most common72–79 method of co-crystallisation. It
requires the API and co-former to be dissolved in a stoichiometric solution, the solvent
from which is then allowed to evaporate. The solution becomes saturated with respect
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to the co-crystal and further evaporation results in its precipitation. A disadvantage of this
method is that both components need to have similar solubility in a particular solvent,
and it is possible that they may crystallise individually.72 A recent novel approach to
evaporation crystallisation has seen the employment of thermal inkjet printing for the
preparation of pharmaceutical co-crystals. The rapid evaporation of solvent associated
with the technique promotes the growth of metastable polymorphs. Recent work by
Buanz and Gaisford80 has isolated the highly metastable β polymorph of glycine using
inkjet printing of aqueous solutions in small volumes (< 0.1 µL). The authors ascribe their
results to the confinement of the solution in small drops on a scale at which the β form is
thermodynamically stable. Upon printing larger drops (> 0.1 µL) a mixture of forms α and
β grew. The growth of the β form in this instance was thought to be due to the rapid
evaporation of water resulting from the small volume of the droplet. The method also
offers a much more rapid option for screening than traditional methods of solvent
evaporation.81
1.1.5.2. Reaction crystallisation
Similarly to solvent evaporation, reaction crystallisation involves dissolving the co-crystal
components in a stoichiometric ratio. However, here there is no need for evaporation of
the solvent. Instead, a saturated or near saturated solution of one component is prepared
and the second solid component is added until the solution becomes saturated with
respect to the co-crystal; subsequently, co-crystallisation proceeds. This method has the
advantage of being applicable to materials with different solubility in the chosen
solvent.69,72,82
1.1.5.3. Cooling crystallisation
The third method of solution crystallisation, known as cooling crystallisation, involves
mixing the solid co-crystal components and solvent in a vessel and heating the mixture
to ensure all solutes have dissolved. Co-crystallisation occurs as the solution is cooled
and becomes supersaturated with respect to the co-crystal.69,72
1.1.5.4. Ultrasound assisted solution co-crystallisation
Ultrasound assisted solution co-crystallisation is another method by which materials of
differing solubility in the solvent can be co-crystallised. It is similar to cooling
crystallisation but, following dissolution of the components and during cooling, the
solution it is subjected to high intensity ultrasound. The ultrasonic waves lower the
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Mixed fusion (Figure 1-11) uses hot stage microscopy to examine phase behaviour
between two components, and hence has been used as a strategy for co-crystal
screening.70 Initially the higher melting component is melted before allowing it to cool
and solidify, following which the second component is melted and brought into contact
with it. This results in the solubilisation of the first material, and upon cooling and re-
crystallisation of the mixture a zone of mixing can be examined. Each side of this zone
lie regions of pure crystalline material of each of the components, and across it is a
concentration gradient, similar to a binary phase diagram. Observing the material under
polarised light microscopy whilst heating reveals phase changes, in particular eutectic
melting points (the occurrence of a singular melting point for a mixture, provided the
components are present in the correct stoichiometric ratio), relating to co-crystals. It
therefore allows for the identification of the number of phases present and their melting
points. A disadvantage of this method is the necessity for both components to be stable
in the liquid phase.70,85
Figure 1-11. A schematic representation of the process of mixed fusion.
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1.1.6.2. Co-melting
Co-melting bypasses the problem of stability in the liquid phase, as the process does not
require either of the pure components to be melted prior to mixing. Instead it takes
advantage of the eutectic melt of a system, which effectively lowers the temperature at
which the components melt. The main benefit of co-melting is that it is a rapid method
that does not require organic solvents and is therefore cheap and environmentally
sound.86 A thorough investigation of the mechanism by which co-crystallisation occurs
when a mixture is heated is yet to be carried out, although interesting work has been
done based on binary phase diagrams.86,87 Fucke et al.88 showed that although piroxicam
could not be co-crystallised by the mixed fusion method due to its poor melt stability,
heating a physical mixture of it and a co-former on a microscope slide sufficiently lowered
the melting point, in most cases, to produce co-crystals. Lu et al.89 demonstrated the
utility of the method for rapid co-crystal screening in a study in which they heated 20
binary systems using a DSC and found that 16 formed co-crystals, nine of which were
previously unreported. A more recent study using the same methods, but with the
mixtures being ground together prior to heating, has shown similar results.86 Others have
also produced co-crystals by this method,71,90,91 with one group concluding screening via
DSC to be the most efficient method at early stages of research, stating that it makes it
possible to screen out systems in which co-crystal formation is most unlikely.92
1.1.7. Mechanochemical methods
The term mechanochemical co-crystallisation encompasses three techniques by which
the raw materials are ground together to form co-crystals:93,94 neat grinding,95,96 liquid
assisted grinding,88,97 and the relatively novel technique of polymer assisted grinding.93,94
These have advantages over the traditional technique of solvent evaporation in that they
are faster, cheaper, and “greener” as either no or very little solvent is required.98
Mechanochemical routes also avoid the possibility of unwanted solvate formation.93
Another benefit of the technique is that it can be used to co-crystallise heat-sensitive
materials that cannot be submitted to mixed fusion or, to a lesser extent, co-melting. Its
limitations lie in the fact that it produces very small crystals or fine powders, from which




Neat grinding is the simplest of the three mechanochemical co-crystallisation
techniques102 and involves grinding the two solid raw materials together, either in a pestle
and mortar or using a mill, in the correct stoichiometric ratio for co-crystals to form.69,71 It
has been used to study co-crystal polymorphism and variations in co-crystal
stoichiometry.103 Possibly the earliest example was reported in 1893 for the synthesis of
the quinhydrone co-crystal consisting of equimolar amounts of p-benzoquinone and
hydroquinone.104 Etter et al.105 stated that the driving force is the formation of stronger
hydrogen bonds in the co-crystal than in the crystals of the two components. Caira et
al.106 demonstrated that the method is able to produce co-crystals identical to those
produced by solution methods, crystallising sulfadimidine with several aromatic
carboxylic acids. First order kinetics were observed, suggesting the reaction proceeded
via a random nucleation mechanism.
Jayasankar et al.107 found that the co-crystallisation of an equimolar mixture of
carbamazepine and saccharin by neat grinding occurred via an amorphous intermediate.
Samples ground both at ambient temperature or under liquid nitrogen resulted in partial
vitrification, with the greatest disruption being observed in the cryogenically milled
sample. The material milled at ambient temperature partially co-crystallised during
grinding. Upon storage, co-crystallisation from the glass occurred for both and the rate
of crystallisation was found to increase with relative humidity, due to the plasticising
effect of water. The lack of co-crystallisation during cryogenic milling was attributed to
the material being at least 200 °C below the Tg of both of the components and the blend.
A study of an equimolar mixture of carbamazepine and indomethacin found similar
results, with the additional finding that grinding amorphous starter materials produced
the same co-crystal as grinding them in crystal form. However, simply mixing the
components in either form (crystalline or amorphous) did not cause any co-crystallisation
after storage under the same conditions.95
Friščić et al.104 published a review in 2009 and stated that, provided that the components
are low volatility and are held together by strong intermolecular interactions (hydrogen
bonds), criteria that many pharmaceutical compounds meet, an amorphous intermediate
is the most likely mechanism of co-crystallisation. These authors also discussed the
effect of grinding time on co-crystal/glass formation, concluding that there must be an
optimum time during which co-crystal formation is not overwhelmed by glass formation.
Grinding for longer causes the ratio of glass to co-crystal to increase.
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1.1.7.2. Liquid assisted grinding (LAG)
The LAG methodology (otherwise known as solvent-drop grinding) is similar to neat
grinding but with the addition of a catalytic amount of solvent to assist the co-
crystallisation process. The mechanism by which the liquid influences the
mechanochemical process is unknown. However, it has been shown that the addition of
a small amount of liquid to the grinding vessel can accelerate co-crystallisation and
enable the formation of co-crystals that cannot be formed by neat grinding.108 There
appears to be no correlation between reactant solubility in the liquid and reaction
efficiency. Instead the volume of liquid added appears to be the key parameter, with an
increase in volume resulting in an increase in rate of crystallisation.97 Recently Tan et
al.108 proposed an explanation for the independence of reaction rate and solubility,
suggesting that due to its small volume the liquid is in a state of constant saturation with
the reactants, thus negating any effects resulting from differences in solubility.
Furthermore, Tan suggested that the liquid facilitates a mobile layer on the surface of
the solid components which results in co-crystallisation irrespective of the solubility of
either material.
1.1.7.3. Polymer assisted grinding (POLAG)
POLAG utilizes the process of LAG but substitutes the solvent/liquid with a small amount
of polymer, in either the liquid or solid phase. Hasa et al.93 showed that POLAG with solid
or liquid polyethylene glycol (PEG) catalyses and assists co-crystal nucleation,
demonstrating the formation of caffeine and citric acid co-crystals that could not be
formed by neat grinding. They utilised PEG with six different molecular weights, three of
which were liquid and three crystalline solids. The authors proposed no explanation for
the role of the polymer, except that it may be similar or different to that of the liquid in
LAG. Further work by Hasa et al.94 has demonstrated the ability to control the
polymorphic form of the product by varying the polymer chain length. Lengthening the
polymer chain, and in so doing reducing the microenvironment polarity, favoured the
formation of the more stable polymorph of the caffeine–glutaric acid co-crystal (CAF-
GA). Hasa suggests the reason for this lies in the crystal structure of the two known
polymorphs (Figure 1-1), citing the explanation of Trask and co-workers109 that form I
consists of sheets stacked along the b axis to form what may be described as non-polar
cleavage planes, whereas form II sheets are stacked in a staggered arrangement. The
latter lack non-polar cleavage planes. Trask suggests that these cleavage planes are
stabilised by non-polar solvents and showed that CAF-GA form I could be prepared
selectively by LAG using a non-polar solvent, while form II could be prepared using a
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polar solvent. A significant and notable advantage of POLAG over LAG is the elimination
of the possibility of the formation of undesired solvates.
Figure 1-12. The crystal structures of (a) polymorph I, and (b) polymorph II of the CAF-GA co-
crystal.
1.5 The Amorphous Form
Often, the rate of dissolution is the rate determining step in the absorption process, and
so increasing the rate of dissolution will increase the bioavailability of the drug. For
crystalline solids to dissolve the solute-solvent system must overcome the lattice energy
of the crystal and replace solute-solute interactions with solute-solvent interactions.2
Amorphous materials have the structure of a liquid, and so no crystal lattice, but the
viscosity of a solid. More explicitly, they are high energy solids without the molecular
ordering of a crystal but with randomly oriented molecules. If the material has no crystal
lattice, there is no lattice energy to overcome and therefore the drug will likely have a
higher thermodynamic solubility and a higher rate of dissolution.110 Unfortunately, due to
the high energy nature of amorphous materials, they are thermodynamically unstable
and with time will relax, with the molecules reorienting towards the crystalline
configuration. Eventually they will crystallise and lose the aforementioned beneficial
properties.2
Amorphous solids have no long range (crystalline) order and little short range order. They
can be formed either by rapid cooling of the melt or a solution of the drug, in which the
molecules are not allowed sufficient time to reorient to the crystalline from the disordered
fluid state, or by disruption of the structure of a crystalline solid (by milling or grinding for
example). Molecules in a fully amorphous material will be arranged completely randomly
with no long or short range order. In practice, this is very difficult to achieve and each
different method employed will impart a different degree of amorphous character on the
sample. It is considered that any amorphous material is likely to consist of a number of
regions, each with a different degree of short range order.2
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As mentioned above, amorphous materials are high energy, and as such are
thermodynamically unstable.111 The molecules are not held securely in a crystal lattice
with the energy evenly spread throughout the structure and unlike a crystal, which may
only exhibit molecular vibration, the molecules can also undergo rotational and
translational movement. This will, over time, result in relaxation to a more stable
amorphous state prior to recrystallisation of the substance,2 and is the principal reason
the amorphous form is not more widely used in medication.110 The challenge is to
develop a method of inducing amorphous character onto drugs whilst also imparting a
level of stability.
Amorphous materials, also referred to as glasses, undergo a step change in their
physical properties and heat capacity at a temperature specific to the compound, known
as the glass transition temperature (Tg). They are formed as a result of cooling a
supercooled liquid below this temperature at a rate sufficiently fast to avoid
crystallisation. Above the Tg but below the melting point (Tm) amorphous materials are
said to be rubbery, whereas below the Tg they are more brittle and are termed glassy.
These two states are directly related to the molecular mobility within the sample.18
Molecular rotations in a liquid above the Tm will occur extremely rapidly, on the
picosecond or nanosecond scale. As the sample is cooled these molecular rotations
become slower and the viscosity increases until the temperature drops below the Tg and
the time scale for these rotations moves to minutes or hours.112 At this point the viscosity
is similar to that of the crystalline form of the same material.
A liquid that is cooled below its melting point but above the Tg is considered to be in
structural equilibrium with respect to enthalpy/volume. In this state, any change in
temperature is followed by a corresponding rearrangement of the molecules to maintain
the structural equilibrium. If this linear behaviour were to continue as the temperature
decreased, eventually the enthalpy or volume of this supercooled liquid would become
smaller than that of the stable crystal. The theoretical temperature at which this would
occur is named the Kauzmann temperature (TK) (Figure 1-13). However, this cannot
happen as the stable crystalline form is usually the form of a material with lowest enthalpy
and volume (with water being an exception).2 Instead, as the temperature drops below
the Tg the molecular movements become too slow for them to reorient into an equilibrium
state before the temperature drops further. At this point the system deviates from
equilibrium (Figure 1-13) and becomes a glass.112 As the molecules are randomly
oriented throughout the glass there are regions of differing energies: thus, whereas in a
crystal the energy around each molecule is balanced and equal, in an amorphous
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material the energy around each molecule is unbalanced, which causes their physical
instability.
Figure 1-13. A schematic representation of the cooling of a liquid to form a glass, displaying the
melting point, glass transition temperature, Kauzmann temperature, and the ageing and
recovery processes.
1.1.8. Annealing and Relaxation
As previously stated, due to their lack of crystal lattice, glasses are fundamentally
unstable materials and will undergo molecular movements and revert to crystallinity over
time. Annealing is the process of holding a glass isothermally for a period of time. During
annealing the material will undergo structural rearrangement towards a more stable
state. The line extrapolated from the supercooled liquid line in Figure 1-13 represents
the equilibrium glassy state. If the supercooled liquid continued to be cooled slowly
enough that the material remained in equilibrium, providing that it avoided crystallisation,
then this is the line it would follow. When annealing, the structure of a glass will alter so
that the enthalpy or volume will approach this state: this process is termed relaxation and
is represented by the ageing process in Figure 1-13. Relaxation will eventually end in
crystallisation and loss of the enhanced solubility of the amorphous state.2 There are two
types of relaxation that can occur in an amorphous matrix, structural α-relaxation and
Johari-Goldstein β-relaxation (Figure 1-14). Structural relaxation is slower but more
significant for pharmaceuticals and involves movements or rotation of entire
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molecules.2,112 The faster β-relaxation processes can be attributed to intramolecular
motions, such as rotation of a group around a bond within a molecule.2,112 Both processes
contribute to the overall relaxation of the glass.
Figure 1-14. A diagram to show structural α-relaxation and Johari-Goldstein β-relaxation.
When an aged amorphous material is heated, at the glass transition there will be enough
energy input that the molecules will respond to any change in temperature with
movement. As when cooling they become “frozen”, when heated they become free to
move again and will tend towards the equilibrium state. The energy associated with this
process is known as the enthalpy of recovery and is depicted in Figure 1-13. It is
considered to be equal and opposite to the enthalpy of relaxation, and can be measured
using modulated temperature differential scanning calorimetry (MDSC).2
1.1.9. Vitrification of Pharmaceuticals
There are a number of methods currently employed to vitrify pharmaceuticals, and they
fall into two mechanistic categories. The most effective with respect to disruption of
crystallinity involves converting the crystalline raw material to a thermodynamically
unstable, non-crystalline, intermediate (generally a melt or solution). The amorphous
product is prepared by quenching the melt, or by rapid precipitation from solution (e.g.
spray drying, freeze drying, quench cooling).113 This mechanism often results in almost
entirely amorphous matrices. The second mechanism employs the direct solid-state
conversion of the crystalline material to a glass (e.g. compaction or milling). These
methods usually result in partially amorphous products.2
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1.1.9.1. Transformation via a Non-Crystalline Intermediate
Quench cooling is the simplest method for vitrifying drugs and involves melting the
crystalline form and rapidly cooling it to below the Tg. Providing that the material does
not degrade upon melting and the cooling process occurs faster than the molecules in
the sample can rearrange into an ordered crystalline structure, a glass is formed.
Glasses formed by quench cooling are considered to be completely amorphous, having
no long range order.2 A drawback of this method is the tendency for quench cooled
glasses to form cracks upon cooling; these can then act as nucleation sites for
subsequent crystallisation. However, this can often be avoided by adjusting the rate at
which the melt is quenched.114
The spray-drying process (Figure 1-15) involves pumping a solution or suspension of the
material through an atomiser using heated air at a high pressure. The droplets produced
are subsequently dried by evaporation in a vortex of air. If successful, the result of this
rapid precipitation from solution is spherical amorphous particles.2 This technique may
be used to vitrify the drug alone or in combination with a polymer, and can result in a fully
or partially amorphous matrix, depending on the compound and experimental
parameters. A significant drawback to this method is the temperature at which materials
are processed. Often the temperature required to evaporate the solvent exceeds the Tg
of the drug. As a consequence, upon exiting the spray-drying chamber the particles may
be in the rubbery state, allowing sufficient molecular mobility for crystallisation to occur
before they cool below the Tg.113
39
Figure 1-15. A schematic of the spray drying process.
Freeze-drying may be used to vitrify materials that are heat-sensitive and so unable to
be converted to glasses by quench cooling or, to a lesser extent, spray drying. The
compound must first be in aqueous solution or suspension at ambient temperature and
pressure (Figure 1-16, point 1), which is then frozen (point 2). After freezing, the pressure
of the system is reduced to below 610 Pa (point 3), the triple point of water. The
temperature is then increased (point 4) and, provided the pressure remains below 610
Pa, the water will sublime. If the solute avoids crystallisation upon freezing then an
amorphous product will remain after the completion of sublimation.2,18 Upon freezing, the
water forms a matrix of ice crystals, between which are regions of drug. Consequently,
when dried the remaining material occupies the same volume as the initial
solution/suspension, and so is very low density and porous with a high surface area.
Freeze-dried materials therefore often have very rapid dissolution rates.2 Other
advantages of the technique stem from its gentle nature; the low temperature inhibits
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decomposition, and due to the vacuum conditions oxidation is minimised. Its main
drawbacks are the long timescale required for the drying process and the expense.18
Figure 1-16. A schematic phase diagram of water with the stages of freeze drying
superimposed.
1.1.9.2. Amorphous solid dispersions
Amorphous solid dispersions (ASDs), also termed glass solutions, consist of molecules
of an API dispersed amongst molecules of an amorphous excipient (usually a polymer).
The result is a single phase amorphous system with the drug dissolved or suspended in
a pharmaceutically acceptable excipient.115 The role of the excipient is to stabilise the
otherwise unstable glass form of the drug (see Section 1.5) whilst retaining its increased
dissolution rate and solubility relative to the crystalline form(s).115
The method involves vitrifying a solution or mixture of the API and carrier via a non-
crystalline intermediate (commonly by spray drying or hot melt extrusion). If spray drying
is employed then a solution of the drug and carrier in a common solvent or mixture of
solvents is dried as described in Section 1.1.9.1. Hot melt extrusion applies the theory of
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quench cooling to produce an ASD, and thus requires no solvent. The materials are
simply mixed before being fed into a heated barrel with a rotating screw which further
mixes them in the liquid state. The melt is then fed through a die and forms strands, films,
pellets or tablets. The heat applied at the screw, shear forces, and rate of cooling all
have an effect on the final structure of the ASD.115 The stabilising action of the polymer
gives ASDs the advantage over glasses formed from the pure drug. However, the
addition of a polymer has the effect of reducing the total w/w drug content in the dosage
form and brings added manufacturing costs and considerations, such as; polymer
solubility in water (important for the end product) and organic solvent (if spray drying), or
thermal stability and melt viscosity if extrusion is to be employed.
1.1.9.3. Transformation via solid-state mechanical disruption
Milling uses mechanical stress to induce transformation of the crystalline material to a
glass, and is more commonly regarded as a particle size reduction process.2,113,116 The
technique can be divided into three categories relating to the method by which energy is
applied to the material: ball mills, shear action mills, and shock action mills.113 During
ball-milling the powder is placed in a jar with ceramic balls typically ten times the sample
mass. The jar is then either rotated or shaken at high speeds, subjecting the material to
both shear and tensile stresses.2,113 Shear action mills grind the material by way of
rotating crushing elements113 and shock action (air-jet) mills use air pressure to collide
two streams of particles, with the impaction causing a reduction in particle size. All three
methods apply force to the particle surface and act to reduce their size in the first
instance. Eventually the force applied will no longer cause a reduction in size but will
instead begin to disrupt the crystal structure at the surface. The resulting material will be
only partially amorphous (1-5 %), but as the glass sits at the surface of the particles it
has the potential to dominate the powder properties.2 Vitrification by milling is
temperature dependent and must be carried out at a temperature sufficiently low (in
relation to the Tg of the material being processed) that recrystallisation does not occur
during or soon after processing. However, the use of low temperatures has the
advantage of avoiding degradation of the sample, and the lack of solvent reduces costs
and has positive ecological consequences.113 As milling involves disruption of the
crystalline state it is often difficult to distinguish whether a truly amorphous material or a
highly defective crystalline state has been formed. This is not always simple, as has been
described in a recent review by Descamps and Willart.117
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1.1.9.4. Physical vapour deposition
Physical vapour deposition (PVD), a method little explored in the context of
pharmaceuticals,12–14,111 is a process in which a crystalline solid sample is placed in a
vacuum and heated so that it vaporises. A substrate is placed above the sample and the
vapour deposits onto the substrate. Varying the temperature at which the sample is
heated affects the rate at which it vaporises, and so the rate of deposition onto the
substrate. It is also possible to vary the substrate temperature. The combination of the
two variables affects the physical properties of the resulting deposited film.118–120
The ability of PVD to vitrify organic materials has long been known but, until recently, it
was considered only to result in high energy, thermodynamically unstable
products.112,121–124 The last decade has seen this theory challenged and it is now known
that PVD can produce glasses with stabilities far in excess of those formed by quench
cooling of the liquid, so long as the rate of deposition and the temperature of the substrate
are appropriate.118–120,125–129 A more detailed explanation of the theory is given in Chapter
5.
In 2007 Swallen et al.129 used PVD to create high density glasses with high
thermodynamic and kinetic stability using low deposition rates and substrate
temperatures near 0.85 Tg. It was proposed that this could be beneficial for amorphous
pharmaceuticals. This substrate temperature was again reported to produce the most
stable glasses in a paper examining the effect of substrate temperature on the stability
of amorphous indomethacin (IMC) prepared by PVD. It was also stated that glasses
produced at 0.6 Tg were unstable.119 Following this, in 2008, Kearns et al.127 studied the
effect of varying the deposition rate on the stability of IMC glasses and found a slower
deposition rate to give a more stable product.
In 2009 Dawson et al.118,130 published data on IMC and showed that stable glasses
prepared by PVD at 0.84 Tg and a deposition rate of 0.2 nm s−1 absorb fivefold less water
than those prepared by quench cooling (a property attributed to higher stability), but that
diffusion in the stable glass occurred 5-10 times faster than the quenched material. They
also prepared glasses by PVD that had similar stabilities to quench cooled melts and
absorbed similar amounts of water.130 X-ray diffraction (XRD) was utilised to characterise
the local structure of PVD IMC glasses and compare it to that of quench cooled samples.
The deposited samples had an undefined different packing arrangement, characterised
by a broad high intensity peak at low angles, to that of the quench cooled glass and
supercooled liquid, which were the same. Over long annealing times (in excess of 8
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hours) the molecules in the PVD material reoriented to give the same WAXS pattern as
that of the quenched glass. It was suggested that this was a result of an underlying first
order liquid-liquid phase transition.118
More recently, glasses were deposited at 0.99 Tg and 0.85 Tg by Sepúlveda et al. in an
effort to examine the mechanism of molecular diffusion. The results support the theory
mentioned above that very stable glasses are produced at 0.85 Tg, and that low stability
glasses are produced at 0.99 Tg; the former and latter were referred to as stable and
ordinary glasses respectively. Differences in the mechanism by which the two
amorphous forms transformed into the supercooled liquid when heated were described.
Ordinary glasses follow Fickian diffusion in which molecules throughout the matrix begin
to diffuse and this continues at a rate inversely proportional to the fraction of equilibrium
supercooled liquid present until the entire material has transformed. In contrast, in stable
glasses the molecules are so efficiently packed that they are effectively trapped, and
only those at the free surface have sufficient mobility to move. This mobility moves into
the sample at a constant velocity as a growth front. The supercooled liquids resulting
from both glasses have the same translational mobility. This is in contrast to previously
reported data, and is attributed to lower levels of impurities in the samples prepared in
Sepúlveda’s study.128
Work in the last few years has shown that stable glasses prepared by PVD have
anisotropic structures, owing to the time allowed for molecular configuration sampling at
the free layer. These structures allow for stronger intermolecular interactions than a more
disordered matrix, whilst still lacking the lattice enthalpy of a crystal.131,132 A study in 2017
by Laventure et al.133 looked at the influence of H-bonding on the stability of glasses of
triazine derivatives (Figure 1-17) prepared by PVD. They found that, although all three
compounds studied exhibited properties commonly associated with highly stable vapour
deposited glasses (e.g. high density and anisotropic molecular packing), the derivative
containing a functional group with greater propensity for H-bonding was only slightly
more stable than the corresponding quench-cooled glass. In contrast, the other two
compounds formed glasses with relatively high kinetic stability.
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Figure 1-17. Structures of the three triazine derivatives examined by Laventure and co-
workers.133
So far much of the literature has concentrated on making stable glasses from molecules
that readily form glasses: in particular, IMC (a very good glass former) has been used as
a model drug. The mechanism by which the molecules diffuse within the matrix when
annealed and upon heating has been the subject of much work, but so far there is little
information on stable glasses prepared from drugs known to be poor glass formers and
which either cannot be vitrified by any other method, or that revert to crystallinity very
quickly after vitrification.
1.6 Conclusion and Aims
Solubility and dissolution are major barriers to the successful development of new solid
state medicines. The formulation of drugs in the amorphous or metastable forms and co-
crystallisation all have the potential to overcome this problem. However, current methods
of vitrification are incapable of producing amorphous matrices of adequate stability and
methods of screening possible co-crystals are slow and expensive. Methods of
stabilising metastable polymorphs using molecular additives are well known, but detailed
knowledge of concurrent calorimetric and structural changes at transitions between the
polymorphs of drugs is lacking. More significantly, knowledge of the interactions
occurring between additives and APIs, and consequently which additives to use, is
lacking. This thesis will present a rapid method for the screening of co-crystals, and
additives for stabilising metastable polymorphs, and a second technique for preparing
amorphous materials from poor glass formers.
Chapter 2 of this thesis describes the development of the novel hyphenated technique
of simultaneous synchrotron X-ray diffraction and differential scanning calorimetry (DSC-
XRD). It goes on to demonstrate the utility of the method and its advantages over using
the two methods separately for studying phase transitions in pharmaceutical materials,
using two compounds that display enantiotropic polymorphism.
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Chapter 3 is concerned with the use of DSC-XRD to study polymorphic phase transitions
in three pharmaceutically relevant compounds, and in particular the stabilisation of the
polymorphs of paracetamol through the addition of saccharides; as, although the use of
additives to stabilise the metastable form is well known (as described in Section
1.1.4.3.1), a detailed understanding of how they function is lacking. Calorimetric and
structural data have not previously been collected simultaneously on the same sample
and differences in sample mass and volume between analytical techniques used have
led to discrepancies in the observation of phase transitions. The work described in this
chapter aims to provide additional understanding of these processes.
Chapter 4 explores the formation of co-crystals by four different routes: evaporation,
thermal inkjet printing, co-melting, and milling. Particular attention is paid to the
application of DSC-XRD for the simultaneous formation and analysis of four co-crystals,
three of which are novel. This method has the potential to be an incredibly useful
technique for the screening of new co-crystal forming systems. Combining the technique
of co-melting in a DSC with high energy synchrotron XRD will enable, for the first time,
structural analysis of the reactants and co-crystal products as a function of temperature
as they co-crystallise upon heating. The data will give an insight into the mechanism by
which theses co-crystals form and the phase transitions that occur.
PVD has the potential to produce highly stable glasses (see Section 1.1.9.4) but is yet
to be tested on a drug known to be a poor glass former. Chapter 5 outlines the
development of a vacuum chamber, previously used for depositing films of amorphous
solid water, for the purpose of depositing films of amorphous pharmaceuticals. It further
demonstrates the ability of the apparatus to vitrify a number of pharmaceutical materials,
two of which show little evidence in the literature of previous glass formation.
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2. Simultaneous synchrotron X-ray powder diffraction –
differential scanning calorimetry for the in situ
investigation of phase transitions in pharmaceuticals
2.1. Introduction
Differential scanning calorimetry (DSC) is an extremely widely used tool for studying
temperature-driven phase changes in solid materials.134 Its utility stems from the fact that
nearly all phase changes are accompanied by a change in heat content and so it can be
applied to virtually any sample. Heat flux DSC measures the difference in temperature
of a sample compared to that of an inert reference as they are simultaneously subjected
to an identical heating programme within a furnace (Figure 2-1). Transitions in the
sample will be either endothermic (e.g. melting) or exothermic (e.g. crystallisation).
Endothermic samples will heat more slowly and exothermic more quickly than the
reference. If we consider a sample heated at a linear rate (e.g. 10 °C min-1), as it
experiences a transition its temperature will deviate from linear behaviour for a time
(Figure 2-2). This deviation is used to calculate the difference in power required to
maintain the sample at the reference temperature and subsequently the enthalpy
associated with the transition.
Figure 2-1. A schematic illustration of a heat flux DSC.
Heat transfer, however, is a ubiquitous parameter that does not provide molecular or












decomposition, sintering, separation, foaming and bubbling, and creep of melts may give
rise to heat changes that are not actually a result of phase transitions in the sample.
Thus, while DSC analysis in isolation can be extremely informative, absolute assignment
of the changes in physical form which occur with each phase transition is impossible
without ancillary data.
Figure 2-2. A schematic showing the effect of an endothermic transition on the temperature of a
sample compared to that of the reference as they are heated in a heat flux DSC.
Two common experimental approaches to interpret thermal data and to identify and
assign phase changes are to change the DSC operating conditions or to analyse the
sample with thermogravimetric analysis (TGA). Changing the DSC heating rate
determines whether phase transitions are thermodynamic (e.g. melting) or kinetic (e.g.
recrystallization) in nature, because thermodynamic transitions do not show a
dependence on heating rate while kinetic transitions do. TGA allows determination of
whether the sample loses volatile components or degrades with temperature. However,
while both approaches aid interpretation, neither affirms what actual structural changes
in phase have occurred.
It is of course possible to take sample material directly from the DSC and analyse it with
another technique, but this approach can only be used to identify the material at the
measurement temperature and the assumption must be made that the sample does not












for metastable or intermediate phases). The best option therefore is in situ analysis of
the sample while it is being heated in the DSC itself, by linking a second instrument to
the calorimeter (so called hyphenated techniques).135 Such an approach ensures that
the temperature of the sample is known and controlled throughout the measurement and,
if the secondary method of analysis is sufficiently rapid, information on physical form can
be collected in real time for all the phases the material may progress through. The
additional analysis should ideally be non-invasive, so as not to affect the temperature of
the sample or to introduce further erroneous heats, and hence spectroscopic probes are
often used. For instance, DSC has been hyphenated with Fourier-Transform infra-red
(FTIR),136 near infra-red (NIR)137 and Raman81,138–141 spectrometers, and light
microscopy (to make simple optical observations).142
While these approaches have proved extremely powerful, the ‘gold-standard’ analytical
tool for the characterisation of physical form remains X-ray diffraction (XRD). XRD
analysis can provide absolute determination of the position of atoms and molecules
within unit cells, and laboratory variable-temperature XRD has led to useful insights in
the changes occurring to the structure of a sample upon heating.143,144 Unfortunately,
standard equipment is not able to deliver the high heating rates and short data collection
times used in DSC, and thus its application to in situ DSC analysis is limited. However,
the data collection time can be reduced significantly if a synchrotron X-ray (SX) source
is used.
Synchrotrons generate X-rays of a much shorter wavelength and higher energy than
sealed glass X-ray tubes (the most common laboratory X-ray source for powder
diffraction). Generation of X-rays in a synchrotron begins with an electron gun, which
produces a beam of electrons that is then accelerated by a linear particle accelerator
(also known as a linac) (Figure 2-3). Following this the electrons pass into a booster ring,
which further accelerates them before feeding a larger storage ring. As the beam passes
around the ring it is accelerated to nearly the speed of light and its path directed by
bending magnets. This change in direction causes the particles to emit an intense beam
of radiation over a wide range of frequencies. This radiation can then be intensified and
monochromated to a specific wavelength for powder diffraction studies. A typical
laboratory diffractometer will utilise a copper X-ray source, which produces X-rays with
a wavelength of ca. 1.5 Å (8 keV), whereas the I12: Joint Engineering, Environmental
and Processing (JEEP) beamline at Diamond Light Source (Didcot, UK) produces X-rays
in the range 50-150 keV.16
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Figure 2-3. A schematic showing a synchrotron and its main particle accelerating components.
Researchers have for around 20 years employed SX to explore the mechanisms and
kinetics of solid-state reactions, initially using powerful white beams of X-rays to
penetrate bulky reaction vessels.145 This energy-dispersive technique suffered from poor
spatial resolution, making high-quality structural information difficult to obtain. Recent
developments in both synchrotron and detector technologies allow the combination of
high-energy monochromatic X-rays and exquisitely sensitive detectors to obtain high-
resolution diffraction patterns in as little as 1 s or less.146 Hence, it is now feasible to
obtain high-quality data suitable for structural (Rietveld) refinement from the direct
hyphenation of SX and DSC.
Researchers have combined calorimetric analysis with diffraction techniques for over
three decades. The earliest example, from Russell and Koberstein,147 describes the
melting and crystallisation of polyethylene using DSC and small angle X-ray scattering
(SAXS). This was achieved by modifying a Mettler FP84 combined hot stage
microscope/DSC so that it could be mounted in the beamline of a synchrotron.
Modification required removal of all glass windows in the instrument and mounting of the
sample pan vertically by altering its base so that it could be held by a press fit in the hole
through which the incident beam passed. The data collected gave valuable insight into
the melting and crystallisation behaviour of the sample upon heating and cooling,
respectively. Several other groups have used a similar set up for both SAXS and wide
angle X-ray scattering (WAXS), employing the FP84148–153 or FP82154 mounted vertically
Storage ring
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and modifying the sample pan so that the horizontal beam will pass through the material.
Although effective these studies have all involved significant effort to modify and mount
the DSC.
Other groups have carried out similar experiments with a Linkam TMH600 hot stage or
DSC600 mounted vertically in the beam. Ryan et al.155 modified sample pans, fitting them
with mica windows and gluing them, once loaded, to a thermocouple to examine the
crystallinity and lamellar thickness of polyethylene. Bras and co-workers156 have also
reported the utility of this set up for materials characterisation. Gilbert et al.157 studied the
influence of quenching on the phase separation of unstable n-alkane blends with DSC-
wide-angle X-ray scattering. This geometry required replacement of glass windows in
the beamline with other materials and also some mechanical method of supporting the
pan in position.
Yoshida et al.158 modified a different model of DSC (a Seiko DSC 200). Again the heat
sink and sample and reference pans were mounted at 90° to the standard laboratory
configuration with holes added to the instrument and sample pan to allow passage of the
beam. Sample pans consisted of four pieces for solids and additional silver or Teflon ring
spacers were incorporated for liquid samples. The groups of Keller et al.159 and Brubach
et al.160 utilised the alternative design of a Microcalix version 2.0 microcalorimeter to
study the potential of the combined techniques and explore transitions in glyceryl
behenate, respectively. The Microcalix is a microcalorimeter that employs a glass
capillary as a sample holder rather than a sample pan.
All of these studies, with the exception of the two involving the Microcalix, have involved
complex modifications of either the DSC pans, the DSC itself or both, to permit
transmission of the synchrotron X-ray beam. These include adding mica windows to the
pans, mounting the cell vertically and holding the pan in position on the thermocouple
via a mechanical method such as a press fit, rubber O-rings or a spring. These
modifications have the potential to alter the pathways of heat-transfer from the sample
to the DSC, and so affect the DSC data. The same can also be said for the capillaries of
the Microcalix. The apparatus required is also complex and the experiment difficult to
implement in comparison to a simple lab DSC.
Although these effects might be small, in this work efforts were made to determine
whether it would be possible to construct an experiment to use unmodified DSC pans in
a synchrotron source, and so minimise errors in DSC measurement and maximise the
ease by which lab DSC protocols can be translated into DSC-XRD. The DSC 2010 series
of heat-flux DSC instruments (TA Instruments LLC, USA) have the advantage that the
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element used to heat the sample and reference pans is coiled around the cell (Figure
2-4). The heat generated is transferred to the DSC head via a metal shield (ca. 5 mm
thickness). Ordinarily this shield would be impenetrable to a synchrotron X-ray beam, but
it is possible to drill holes through it to allow the beam to pass unhindered. It is also
advisable to carefully separate the coils of the element and to apply heat sink paste to
allow space for the beam to pass and to insulate against short circuiting of the instrument,
respectively. Correct placing of the holes means that the sample pan can be located in
the direct path of the synchrotron X-ray beam, with the reference pan to one side.
Further, the pans themselves are located on pedestals (which contain the
thermocouples), which means that the diffracted X-ray beam can exit the instrument
without contacting any part of it (Figure 2-4 and Figure 2-5). The pans are made of thin
aluminium, through which the synchrotron beam can pass. Although X-rays are scattered
by aluminium, this gives only a few Bragg reflections which can easily be modelled or
excluded from analysis. With this arrangement, DSC data and diffraction patterns can be
collected simultaneously on a single sample, using a standard laboratory calorimeter.
Figure 2-4. Photographs of the DSC 2010 furnace showing the (a) sample pedestal and
reference pedestal, each of which contains a thermocouple, and (b) the path of the X-ray beam
through the holes drilled in the cell.
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Figure 2-5. Photographs of (a) the modified DSC 2010 head and hole diameters and (b) the
DSC positioned on Beamline I12 at the Diamond Light Source and (c) a schematic showing the
maximum attainable 2θ with the experimental geometry. The red lines describe the path of the 
X-ray beam.
This chapter details the modifications to the DSC required to allow the use of unmodified
pans and applies the method to the analysis of two model compounds, both of which
have enantiotropically-related polymorphs: glutaric acid and sulfathiazole.
2.2. Materials and methods
Sulfathiazole (99 %) and glutaric acid (99 %) were purchased from Alfa Aesar, UK.
Sulfathiazole was used as received. Due to its large particle size, glutaric acid was gently
ground in a pestle and mortar before loading into the sample pan.
Simultaneous differential scanning calorimetry and synchrotron X-ray powder diffraction
(DSC-XRD) experiments were carried out on the Joint Engineering Environmental and
Processing beamline I12 (JEEP) at the Diamond Light Source.161 The beamline produces
a continuous spectrum of X-rays in the energy range 50-150 keV, which for these
experiments was monochromated to 53.16 keV (λ = 0.233 Å). The diameter of the beam 
was 0.5 mm. A Thales Pixium RF4343 detector was positioned 1.9 m behind the sample.
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Detector calibration was performed using cerium dioxide. Diffraction patterns were
recorded every few seconds (data were collected for 2 s with a pause between
collections).
DSC measurements were performed with a TA 2010 instrument (TA Instruments LLC).
The DSC furnace was modified by drilling a hole either side of the sample holder to allow
unhindered passage of the X-ray beam through the sample. Prior to drilling, the heating
coils were carefully separated such that they were placed either side of the holes. Heat
sink paste was applied post-drilling to insulate against short circuiting of the instrument.
The entry hole was 3 mm in diameter and the exit hole 5 mm (to account for diffraction
of the X-ray beam), as shown in Figure 2-5(a). Calibration was performed with a certified
indium standard according to the manufacturer’s instructions. Samples (ca. 30 mg) of
glutaric acid or sulfathiazole were held in Tzero aluminium pans and heated at 10 °C
min–1 from 30 °C to 180 °C and 220 °C respectively. It was found that the X-ray beam
was sufficiently intense to pass through the thin aluminium pans, and so no modification
of the pans was necessary. DSC data were recorded with the TA Advantage software
package, analysed with TA Universal Analysis, and plotted with Origin 9.1.
XRD data were analysed as follows. The large grain size of the samples resulted in
unrepresentative spots of high intensity in the 2D Pixium data, and thus the DAWN
Science Workbench was first used to mask these regions of the 2D data. The same
software was used to convert the 2D data into 1D diffraction patterns.162 Contour plots of
the raw XRD data were then plotted using bespoke software routines. Selected patterns
were first analysed by Dr. Tim Prior (University of Hull) using the Rietveld method
implemented within GSAS,163 in order to obtain realistic values for the unit cell
parameters at elevated temperatures. Backgrounds were fitted using a 6-term shifted
Chebyshev polynomial of the first kind. Lattice parameters and a single Gaussian peak
shape parameter were refined. In cases where more than one phase was present, the
peak shapes for each phase were constrained to be the same. Where more than one
phase was present, the phase fraction was refined. The models used came from the
CCDC (details are given below). The atom positions were not refined. Atom
displacement parameters, Uiso were set to be 0.15 Å2 in each phase.
The TOPAS-Academic suite of programs164 was further employed to perform batch
refinements of all datasets collected, using the same procedures as in GSAS. No zero
point was refined as entire diffraction patterns were collected using a 2D area detector.
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2.3. Results and discussion
2.3.1. Apparatus
Before analysing any samples it was necessary to assess the effect of drilling holes in
the DSC furnace. Calibration was carried out with a certified reference sample of indium
and a clear single melt was observed with onset and enthalpy values within the
manufacturer’s specified tolerances. Temperature versus time data for the modified DSC
2010 were recorded and compared with the same heating profile on an unmodified DSC,
and can be seen in Figure 2-6. It is clear from the linear nature of the heating rate and
its similarity to that of the unmodified DSC that the ability of the DSC 2010 to control
temperature and heat was not compromised by the addition of the holes.
Figure 2-6. Measured temperature versus time data for the modified DSC 2010 (red line) and an
unmodified Q20 DSC (black crosses).
2.3.2. Sulfathiazole
The polymorphism of sulfathiazole has been the subject of extensive research by
both the crystallographic and pharmaceutical communities since it was first
reported in 1941,165 and it has been known to exist in at least five crystal forms
since 1999.166,167 As a result of the high number of studies and the authors’ lack
of attempts to reconcile their work with previous publications 27 there is
inconsistency in the identification of polymorphs and their nomenclature.
Fortunately a recent investigation168 has attempted to reconcile this by listing the
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works and relating the identities of the polymorphs reported in each to those of the
Cambridge Structural Database (CSD). All references to polymorphs in this work
utilise the same nomenclature as the CSD.
To aid interpretation of the data, the XRD patterns were first converted to contour
plots; these show peak intensities as a colour-scale as a function of temperature
and permit easy visualisation of changes in crystalline form. DSC-XRD data for
sulfathiazole are given in Figure 2-7. The DSC data show two clear endotherms with
onsets at 154 °C and 202 °C. The former corresponds to a stark change in the diffraction
pattern, while the latter is coincident with the complete disappearance of all diffracted
intensity and agrees well with the reported melting point of sulfathiazole form I at 201
°C.169 It is important to note that there are no unexpected events in the DSC data, and
that the observed transitions all occur at the expected temperatures based on the
literature. We have calculated the X-ray absorption cross-section of the samples, and
even on the most pessimistic assumptions find heating from the X-ray beam to be <0.1
°C min-1. Hence, while a small amount of local heating of the sample by the beam may
occur, the DSC is able to effectively compensate for this and the heating profile is
unaffected by the exposure to X-rays.
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Figure 2-7. DSC-XRD data for sulfathiazole. (a) A contour plot of the diffraction data and (b) the
corresponding DSC trace. The 1D diffraction pattern is an example of those collected at
temperatures above the melt and reflections marked * are a result of the experimental set up.
The changes in the diffraction pattern are complete at the apex of the first endotherm in
the DSC trace, indicating the phase transition is complete here and the return of the heat
flow to baseline can be attributed to the instrument and not the sample. Form III is
reported to be the most stable form of sulfathiazole between 10 °C and 100 °C169 and
the temperature of the first endotherm corresponds well to literature values for a solid-
solid phase transition from form III to I, reported to occur between 150°C and 170°C.170
To verify the assignment of the phases present in each segment of the contour
plot, selected patterns at 29°C and 161°C were analysed using the Rietveld
method. A relatively poor fit was obtained at 29°C when considering only form III in the
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model (Figure 2-8), and a more detailed analysis revealed that in fact the material
present at this temperature was a mixture of forms III (67.6 %) and IV (32.4 %) (
Figure 2-9). This was somewhat unexpected as form III is reported to be the most stable
polymorph at room temperature,169 although the stability difference between form III and
IV is relatively small.169 As expected, form I was not observed to be present at this
temperature. In contrast, after the transformation endotherm the diffraction pattern can
be successfully fitted using the known structure for form I. Selected final fits and unit cell
data are presented in Figure 2-10, Figure 2-11 and Table 2-3. It should be noted that the
imperfect final fit of the patterns can be attributed to the presence of some larger
crystallites in the samples, which resulted in spots of intense diffraction rather than
the smooth rings expected of a finely ground powder.
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Figure 2-8. TOPAS Rietveld fit of sulfathiazole form III (pink) to the observed pattern (top black) at 29°C. Tick marks show the expected positions for form III, and the
difference between the calculated and observed diffraction profiles is shown as the lower line.
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Figure 2-9. Initial observed pattern for sulfathiazole at 29 °C and the corresponding contributions of sulfathiazole polymorphs III and IV. Distinct reflections in the
observed pattern that can only be matched with the inclusion of form IV are marked *.
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Figure 2-10. Powder X-ray diffraction patterns for sulfathiazole at 29°C and 161°C. The tick marks show the positions of allowed reflections from the polymorphs
labelled in the corresponding colour.
61
Figure 2-11. Powder X-ray diffraction patterns for sulfathiazole at 161°C. The tick marks show the positions of allowed reflections.
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Table 2-3. Refinement parameters for sulfathiazole. The starting models were taken from the
CSD (form III: SUTHAZ02; form IV: SUTHAZ04; form I: SUTHAZ43).
Property Form III Form IV Form I
T / °C 29 161
Space group P21/c P 1 1 21/n P21/c
a / Å 17.564(1) 10.864(1) 10.574(1)
b / Å 8.560(1) 11.441(2) 13.715(2)
c / Å 15.572(2) 8.543(2) 16.893(3)
α / ° 90 90 90
β / ° 112.932(9) 90 108.596(19)
γ / ° 90 91.852(12) 90
Cell volume / Å3 2156.1(4) 1061.2(3) 2321.8(7)
Rwp 0.0561 0.0242
Rwp-bkd 0.1907 0.2632
Phase fraction* 67.6 % 32.4 % 100 %
*Due to the graininess of the sample, representative errors cannot be calculated.
However, the author conservatively estimates the error to be in the region of 5 %. Phase
fractions for the initial mixture of sulfathiazole are reported as individually refined patterns
in Figure 2-9.The quality of the data collected permitted batch refinement of the lattice
constants and scale factor for each form present against all the patterns, giving fits with
weighted profiles (Rwp) in the range 0.0242 to 0.0561. The unit cell parameters could be
extracted from these and plotted as a function of temperature (Figure 2-12, Figure 2-13
and Figure 2-14). As expected, increasing the temperature of the sample causes
expansion of the unit cell in all three dimensions for all three polymorphs present, with
the exception of the c axis of form I which exhibited little change. This appears to be
the first time that the structures of purely organic species have been refined using
data collected on JEEP and also the first example of refinement using data
collected during a live DSC run.
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Figure 2-12. Lattice constants as a function of temperature for sulfathiazole polymorph III: (a)
the a (black squares) and b (red circles) parameters; (b) the c parameter; (c) the β angle.
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Figure 2-13. Lattice constants as a function of temperature for sulfathiazole polymorph IV: (a)
the a (black squares) and b (red circles) parameters; (b) the c parameter; (c) the γ angle.
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Figure 2-14. Lattice constants as a function of temperature for sulfathiazole polymorph I: (a) the
a (black squares) and b (red circles) parameters; (b) the c parameter; (c) the β angle.
In the past it has sometimes been assumed in the literature that when phase transitions
between forms are observed in DSC experiments, there is a melt of one form followed
by recrystallization of a new form.171,172 The constant presence of reflections in the XRD
contour plot indicates that there is no wholesale melt here, however: if the entire sample
melted we would expect to see a diffraction pattern devoid of reflections. This suggests
that the transition between the crystalline forms of sulfathiazole occurs via a direct solid-
solid pathway, rather than by melt-recrystallisation. That said, these measurements are
bulk averaged over many particles and microscopic transient melting on a per particle
basis cannot be ruled out.
In order to gain a more quantitative understanding of the transformation, the individual
contributions of each polymorph to the overall pattern at each temperature were
integrated and the results normalised to obtain a phase fraction. The results are given in
Figure 2-15. Below 155 °C the relative contributions of the three polymorphs are
constant, with 67.6% form III and 32.4% form IV present and form I absent.
Subsequently, the amount of form I begins to increase, whilst those of III/IV diminish
simultaneously until 166 °C when the conversion is complete. If the phase fractions of
form III and IV are summed, a plot of their combined phase fraction vs. temperature
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crosses that of form I around 0.5 indicating a solid-solid phase transition (Figure 2-16).
It is of particular interest that the transition to form I occurs simultaneously for both forms
III and IV.
Figure 2-15. Plot of phase fraction vs temperature for the heat- induced transformation of
sulfathiazole from a mixture of forms III and IV to form I.
Figure 2-16. Sum of phase fractions of sulfathiazole forms III and IV (red circles), and the phase
fraction of form I (black squares) as a function of temperature.
The transformations of forms III and IV to form I are known to occur in the temperature
range 150-170°C.170 Form III is reported to undergo conversion via either a melt140 or a
solid-solid pathway173 depending on the purity of the sample, and form IV has been
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shown to undergo a solid-solid transformation.170 The data collected here show that when
a mixture of forms III and IV are heated both undergo a solid-solid transformation to form
I simultaneously. The differences in the structure of these forms170 are very small, and
evidently not sufficient to make the transition from one to the other energetically more
favourable than their conversion to the high temperature polymorph. It is unlikely to be
coincidental that the conversion happened at the same temperature for both.
For many years the separate existence of sulfathiazole polymorphs III and IV was a
source of confusion in the scientific community. In 1971 Mesley174 discussed the
existence of two low temperature forms, designated IIA and IIB, referred to here (and in
the CSD) as form III and form IV, respectively, pointing out that the mixture of the two
was commonly mistaken for a distinct form and that all commercial samples tested were
in fact a mixture of these two polymorphs. The author also highlighted the similarities
between the two forms in relation to their hydrogen bonding, as observed by infrared
spectroscopy, and concluded that the similarity in the enthalpy of transition from each
metastable species to form I indicates they must have very similar structures.
More recently, structural analysis of the different polymorphs of sulfathiazole has shown
that, in forms II, III and IV, the molecules exist as dimers175,176 linked by hydrogen
bonding. The dimers are orientated in the same conformation in all three species, but it
is the position of these dimers relative to each other that defines the crystal structure of
each polymorph. Blagden et al175 described the relationship of pairs of dimers as being
enantiomeric and labelled them L and R. In all three structures these pairs link to form a
chain of a repeating combination of four molecules. This single monolayer is then
hydrogen bonded to another parallel monolayer of the same construction. Within the
crystal structures of forms II, III and IV there are two arrangements of the monolayers.
One having dimers of the same “enantiomer” adjacent (e.g. LLLL) and the other
alternating (e.g. LRLR). Gelbrich et al176 described the two arrangements as A-type
(adjacent) and B-type (alternating) bilayers. Polymorph II consists solely of layers
connected by the A mode and polymorph IV only the B mode. The bilayers in polymorph
III alternate (e.g. ABAB).
The unit cells used for Rietveld refinements for forms III and IV were taken directly from
the CSD and are given in Table 2-4.
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Table 2-4. Unit cells used for Rietveld refinements. Data from Dr Tim Prior (University of Hull).















cell volume/ Å3 1062.97
Z 4
The cell for form IV can be reset in the standard form of P21/n as described in Table 2-
5.
Table 2-5. Unit cells given in standard settings. Data from Dr Tim Prior (University of Hull).















cell volume/ Å3 1062.97
Z 4
Form IV can be reset into P21/c for comparison with Form III, as detailed in Table 2-6.
Table 2-6. Unit cells quoted in P21/c. Data from Dr Tim Prior (University of Hull).















cell volume/ Å3 1062.97
Z 4
The relationship between these two cells is not a trivial doubling of one of the axes, for
example. In the revised set of cells the b and c parameters are similar, which reflects
some similarity in the packing, but crucially a and β are very different.
The structures (i.e. the arrangement of molecules) of these two forms are very similar




Figure 2-17. Views down the b axis in sulfathiazole (a) form III, and (b) form IV (set in P21/c).
The structure of form III has two independent sulfathiazole molecules in the asymmetric
unit. Form IV has a single sulfathiazole molecule in the asymmetric unit. A phase change
between the forms (III  IV) would render the two molecules equivalent and then be
associated with a change of unit cell. It is notable that in both forms (Table 2-6) there are
hydrogen-bonded layers that run parallel to the (10-2) plane. Adjacent layers are related
by inversion centres and stacked in an ABAB fashion along the crystallographic b
direction. In practical terms these two forms are very similar, and thus it is unsurprising
that they co-exist at low temperatures and simultaneously transform to form I as the
temperature is raised.
The unit cell of form I is not related to that of form III or IV, and the structure is different.
Form I contains a 3-D hydrogen bonded network that is sustained by a variety of classical
hydrogen bonding interactions, notably a centrosymmetric R22(8) embrace (shown in
Figure 2-18), not present in form III or IV.
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Figure 2-18. The centrosymmetric R22(8) motif of form I sulfathiazole.
If these structural similarities are taken into account it is unsurprising that the existence
of forms III and IV was a source of consternation for some time.
2.3.3. Glutaric acid
Figure 2-19 shows the contour plot for glutaric acid (GA) and the corresponding
thermal trace recorded by the DSC. It is immediately apparent from the contour
plot in Figure 2-19(a) that GA exists in two distinct crystalline phases, with an abrupt
change in the diffraction pattern at 72 °C. There is then a complete loss of
diffracted intensity at ca. 100 °C. The DSC data in Figure 2-19(b) contain two clear
endotherms, one with an onset at 72 °C and one at 98 °C. The latter occurs at the
same temperature as the loss of diffracted intensity in XRD, and corresponds to
the known melting point of the  form of GA.177
The former corresponds to the abrupt changes in diffraction pattern seen at ca. 72
°C, and thus can be ascribed to the previously reported transition between the 
(low temperature) and  (high temperature) forms of GA. As for sulfathiazole, the
changes in the XRD contour plot are complete at the apex of the first endotherm,
and the return to baseline is attributable to the instrument rather than the sample.
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Figure 2-19. DSC-XRD data for glutaric acid. (a) Contour plot of the diffraction data and (b) the
corresponding DSC thermogram. Reflections marked * are a result of the experimental set up.
As for sulfathiazole, Rietveld refinements were undertaken on selected patterns.
The results are depicted in Figure 2-20 and Figure 2-21 with refinement parameters
in Table 2-7. The lower temperature pattern can be successfully fitted using an
expanded version of the known structure for β-GA (recorded at –153°C),178 and
that at 94°C similarly with the α-form. The fit parameters are all acceptable, and it
is clear that a single phase exists at both temperatures.
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Figure 2-20. Powder X-ray diffraction patterns for GA at 27°C. The tick marks show the positions of allowed reflections from β-GA. [The * shows a reflection from the
presence of a persistent impurity].
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Figure 2-21. Powder X-ray diffraction pattern for GA at 94°C. The tick marks show the positions of allowed reflections from α-GA. [The * shows a reflection from the
presence of a persistent impurity].
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Table 2-7. Refinement parameters for glutaric acid. The starting models for both α and β forms 
were taken from the CSD (IDs: GLURAC06 and GLURAC12 respectively).
Property β-glutaric acid α-glutaric acid
T / °C 27 94
Space group C2/c C2/c
a / Å 12.902(1) 25.577(3)
b / Å 4.826(0) 5.015(0)
c / Å 9.960(1) 10.200(2)
α / ° 90 90
β / ° 96.838(8) 92.531(10)
γ / ° 90 90
Cell volume / Å3 615.7(1) 1307.2(3)
Rwp 0.0623 0.0267
Rwp-bkd 0.2310 0.1929
As for sulfathiazole, batch refinements were carried out on the entire data set.
Rietveld refinements yielded Rwp values ranging from 0.0238 to 0.0623. Due to
the smaller, side-centred, unit cells, and the presence of just two polymorphs,
there were fewer instances of overlapping reflections than for sulfathiazole and
so, in addition to Rietveld, it was possible to carry out batch Pawley refinements
(resultant Rwp between 0.0120 and 0.0197). Both sets of refinements show that
upon heating, rather than the unit cell expanding in three dimensions as might be
expected, it expands in the b and c axes and a and β contract. This is true for both
the β and α forms of GA (Figure 2-22 and Figure 2-23).
Figure 2-22. Lattice constants as a function of temperature for β-GA: (a) the b (black squares)
and c (red circles) parameters; (b) the a (black squares) parameter and β (red circles) angle.
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Figure 2-23. Lattice constants as a function of temperature for α-GA: (a) the b (black squares)
and c (red circles) parameters; (b) the a (black squares) parameter and β (red circles) angle.
As for sulfathiazole, the contribution of each polymorph was obtained via Rietveld
refinement and the phase fraction calculated. A plot of phase fraction VS. temperature is
given in Figure 2-24. As with sulfathiazole, the curves for the two forms cross at ca. 0.5,
indicating that conversion between them occurs via a solid-solid transition with no
observable melt or intermediate phase.
Figure 2-24. Plot of phase fraction vs temperature for the heat induced transformation of GA
from the β phase to the α phase.
These observations are in agreement with the literature. Jorunn and Samuelsen179 used
Raman spectroscopy to study the effect of temperature on the crystal structure of the β
polymorph and Espeau et al.177 investigated the effects of an increase in pressure on the
nature of the phase transition. Both report a solid-solid transformation from β to α.
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2.4. Conclusions
It has been shown that hyphenated DSC-synchrotron XRD experiments can easily be
performed by making only a simple modification to a laboratory DSC instrument. Using
a high-intensity synchrotron X-ray source (Beamline I12, Diamond Light Source) it is
possible to collect diffraction patterns on a sample mounted in a conventional DSC pan
in a few seconds, permitting a single sample to be effectively interrogated both in terms
of its thermal and structural features. The potency of the approach is demonstrated
through a study of two systems displaying enantiotropic polymorphism. Of particular
interest is the potential of the technique to provide information on otherwise hidden
phases, as exhibited in the data recorded for sulfathiazole. Direct solid-solid phase
transitions are observed, with no wholesale melting of the sample. That said, care should
be taken not to discount the possibility of microscopic transient melting on a per particle
basis. The XRD data obtained here are of sufficient quality to permit Rietveld refinements
to be performed and, in favourable instances, Pawley refinements. Batch refinements
were undertaken allowing a rapid (< 30 min) analysis of the hundreds of patterns
comprising each dataset. This provided a detailed description of structural changes as a
function of temperature. DSC-XRD thus comprises a simple and powerful analytical tool
with much promise in pharmaceutical science and materials chemistry.
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3. Phase transitions in 10,11-dihydrocarbamazpine,
carbamazepine and paracetamol
3.1. Introduction
Solid crystalline materials may exist in many different physical forms, each of which will
have different physicochemical properties such as: solubility, dissolution rate, stability,
hygroscopicity, strength, flowability and compressability.9 All of these properties will have
a significant effect on the utility of the compound as a pharmaceutical material. It is
therefore essential that as much as possible is known about the physical form of an
active ingredient and how it will behave under different conditions before it can be used
as a medicine. Accessing and stabilising metastable polymorphic forms of active
pharmaceutical ingredients remains a major challenge in pharmaceutical product
innovation.22,180 Systemic approaches to understanding polymorphic diversity in organic
solids remain elusive.
Carbamazepine (CBZ) (Figure 3-1) is an anticonvulsant commonly used to treat epilepsy
and trigeminal neuralgia.181 There has been much research into CBZ, reaching as far
back as its first use as an anticonvulsant in the 1960s.181 It has extremely poor solubility
in water182 and is therefore an ideal candidate for screening for metastable polymorphs.
To date there have been five polymorphs reported,39,183–186 and their structures have
been characterised with enough rigour to be published in the CSD. The most stable form
at room temperature is form III,186 and that at high temperatures is form I.185 The majority
of the known polymorphs of CBZ (modifications I–IV) pack as dimers with the two
molecules connected anti to each other by H-bonds between the oxygen and nitrogen
atoms of the carbamoyl group.39,185,187 The differences in structure stem mainly from the
way in which these dimers are packed relative to each other. The most recently
discovered form (V) is the only known polymorph of CBZ to pack catemerically, without
forming dimers; its discovery was achieved by templating crystal growth on the surface
of a crystal of 10,11-dihydrocarbamazepine (DHC) (Figure 3-1) form II, an analogue of
CBZ chosen due to its unit cell’s similarity to the previously predicted but unobserved
structure of CBZ V.39 The difference between the two molecules is the presence or
absence of a double bond directly opposite the nitrogen of the azepine ring (Figure 3-1).
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Figure 3-1. Chemical structures of carbamazepine and 10,11-dihydrocarbamazepine.
As previously stated, structurally CBZ forms I–IV have strong similarities, with all four
consisting of almost identical dimers with the molecules in an almost identical
conformation, which is unusual for polymorphic materials.185 Calorimetrically it has been
shown that upon heating at 20 °C min-1 form II undergoes a solid–solid phase transition
to form I between 140 °C and 160 °C and form III undergoes a melt–recrystallisation to
form I in the range 168–175 °C. At the same heating rate form IV melts at 188 °C and
partially converts to form I, but slower heating results in a more complete conversion. In
all four cases form I was shown to melt at 192–194 °C.185 It is clear from these results
that form I is the stable form at high temperatures.
10,11-dihydrocarbamazepine (Figure 3-1) has four known polymorphs188–191, three of
which display a catemeric H-bonded motif similar to that of CBZ V. In contrast, the most
recently discovered form (IV) displays a dimer motif in the same form as the one seen in
CBZ forms I–IV. There has been little research into DHC and a literature search revealed
no results relating to phase transitions between polymorphs or describing the behaviour
of any of its forms upon heating. Here both topics will be discussed.
Paracetamol (PCM) exists in three polymorphic forms; a stable phase (I) and two
metastable phases (II, III). Form I packs with a herringbone motif, while forms II and III
display layered structures.47,49,192 The structure of form I results in poor compactibility,
leading to poor tablet quality.192 However, difficulties in producing suitable quantities of
either form II or III have limited research into their physical properties. While form III has
been reported as highly unstable in air, even being referred to as ‘elusive’,49 recent
reports indicate that surfaces such as glass53 and silica193 can promote its growth, and
careful control of heating and cooling rates during melt crystallisation have also been
demonstrated to lead to form III.26,194 Additionally, inclusion of hydroxypropyl
methylcellulose (HPMC) into the paracetamol melts can alter the kinetics of the
crystallisation of the two metastable phases.51,57
The addition of molecular additives to alter the kinetics of the crystallisation process to
obtain metastable polymorphs has been a frequent topic of study.27,29 The inhibition of
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the formation of a stable phase through preferential interactions between the additive
and the surface available functional groups of the crystal may lead to slowing of crystal
growth,30,195–198 while preferential interaction of the additive with an unstable phase may
lead to stabilisation of this phase or alter the balance of the kinetic growth rates of the
two phases.198 Design or selection of a suitable additive may then be used to control the
crystallisation processes and tailor the creation of a desired polymorph.
Here we report studies into the polymorphism of DHC, CBZ and PCM, and pay particular
attention to phase transitions between polymorphs and the effect of temperature on the
unit cell. There is also discussion of work with PCM that indicates a promising role for
the ‘excipient’ matrix to direct and stabilise metastable forms and the importance of in
situ characterisation of polymorphism for formulation design.
3.2. Materials and Methods
3.2.1. Materials
Carbamazepine (98 %) forms II and IV were supplied in a personal communication by
Dr. Vijay Srirambhatla, paracetamol (USP) and trehalose (TRH, USP) were purchased
from Sigma-Aldrich, UK and used as received. Lactose (LCT) was procured from Acros
Organics, BE and used as received. Hydroxypropyl methylcellulose K100M (HPMC,
METHOCEL) was obtained from Colorcon, UK and used as received. 10,11-




To obtain glasses of PCM, paracetamol and each of the three excipients HPMC, TRH
and LCT (PCM: 90 % w/w) were mixed in a glass sample tube using a vortex mixer. Each
of the four samples were then weighed into a Tzero aluminium DSC pan without a lid.
The samples were heated from ambient temperature to 180 °C at 10 °C min-1 and held
for 2 minutes to melt the mixture, before removing from the DSC and air cooling to
ambient temperature to generate an amorphous phase. Finally, the product was
reheated to 180 °C at 10 °C min-1.
DSC Measurements were performed with either a TA 2010 instrument (TA Instruments
LLC) modified as described in Chapter 2 or with a Q20 instrument, modified by drilling a
hole either side of the sample holder (Figure 3-2), as with the 2010. Calibration was
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performed with a certified indium standard according to the manufacturer’s instructions.
Attempts to vitrify selected samples were made by melting in the DSC and immediately
quenching the melt by removing the pan from the furnace and placing it on the bench.
Samples of all materials (5.1–26.9 mg) were held in Tzero aluminium pans and heated
at 10 °C min–1 from ambient to slightly above the melting point of the most stable
polymorph.
Figure 3-2. Photograph of modified Q20 DSC cell, showing holes drilled either side of the
sample pedestal to allow passage of the beam.
3.2.2.2. Data analysis
The DAWN Science Workbench was first used to convert the 2D data into 1D diffraction
patterns.162 Contour plots of the raw XRD data were then plotted using OriginPro 2016.
Selected patterns were analysed using the Rietveld method implemented within the
TOPAS-Academic suite of programmes,164 in order to obtain realistic values for the unit
cell parameters at elevated temperatures. Backgrounds were fitted using a shifted
Chebyshev polynomial of the first kind with between 6 and 15 terms. Lattice parameters
and peak shape parameters were refined. In cases where more than one phase was
present, the peak shapes for each phase were constrained to be the same and the phase
fraction was refined. The models used came from the CCDC (details are given below).
The atom positions were not refined. Atom displacement parameters, Uiso were set to be
0.15 Å2 in each phase. Once starting parameters were obtained batch refinements were
performed on all datasets collected. No zero point was refined as entire diffraction
patterns were collected using a 2D area detector.
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3.3. Results and Discussion
3.3.1. 10,11-dihydrocarbamazepine
Combined DSC-XRD data for a sample of DHC can be seen in Figure 3-3.
Figure 3-3. DSC-XRD data for 10,11-dihydrocarbamazepine. (a) A contour plot of the diffraction
data showing the phases present; DHC II (II), DHC I (I), and liquid DHC (L). (b) The
corresponding DSC thermogram
The contour plot of XRD data clearly shows three distinct phases. Two of these phases
are represented by horizontal lines indicating the occurrence of Bragg reflections and
the third is conspicuous by its lack of reflections. The DSC thermogram shows no events
until the sample reached ca. 190 °C where there is a small endotherm. At the same
temperature there is also a change in the positions of Bragg reflections in the XRD data.
Following this, at ca. 207 °C, there is a much larger endothermic event coinciding with
the total loss of Bragg reflections in the contour plot..
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3.3.1.1. Polymorph II
Rietveld refinement of a number of DHC crystal structures from the CSD against the
pattern recorded for the initial starting material at 56.3 °C (Figure 3-4, Table 3-1) confirms
that it was mostly polymorph II with a very small amount of polymorph I present. The
refinements fit with a Rwp of 0.0349, and all subsequent refinements were carried out
using the starting models VACTAU01 (form I) and VACTAU02 (form II) from the CSD.
From 56 °C to 190 °C there are no events in the DSC thermogram, and so there are no
phase transitions occurring. However, there are subtle changes in the diffraction data.
Some, but not all, of the reflections relating to form II gradually shift to lower 2θ angles.
This is a consequence of the expansion of the unit cell as it is heated. In fact, the b
dimension expands significantly more than either the a or c dimensions. As was the case
in Chapter 2, the quality of the data permitted batch Rietveld refinement against all
patterns, with Rwp values ranging from 0.0271 to 0.0449.
s
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Figure 3-4. Rietveld refinement data for 10,11-dihydrocarbamazepine at 56 °C. Tick marks show the positions of allowed reflections of 10,11-dihydrocarbamazepine
form II (upper) and form I (lower).
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Table 3-1. Refinement parameters for 10,11-dihydrocarbamazepine at 56.3 °C and 202.5 °C.
The starting models were taken from the CSD (form I: VACTAU01; form II: VACTAU02).
Property Form II Form I
T / °C 56.3 202.5
Space group Pbca P21/c
a / Å 9.0412(9) 5.5573(2)
b / Å 10.5748(8) 9.1969(6)
c / Å 24.914(2) 24.433(1)
α / ° 90 90
β / ° – 96.505(4)
γ / ° 90 90
Cell volume / Å3 2382.0(5) 1240.7(1)
Rwp 0.0349 0.0440
Rwp-bkd 0.1487 0.1944
Phase fraction* 94.7 % 99.0 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
Unit cell expansion and intermolecular bonding
Figure 3-5 shows plots of the lattice constants as a function of temperature. Each of the
three plots has been fitted with a linear trend line and the slopes calculated to allow
comparison of the expansion of the cell in each direction. The growth in b is larger per
degree increase in temperature than that in a and c by factors of 9 and 4 respectively.
This is a consequence of the alignment of the molecules relative to each other in the
crystal and so the distances between them; this affects both the length and strength of
the intermolecular bonds. The dominant intermolecular force in the structure of
polymorph II is hydrogen bonding between one hydrogen from N2 and the oxygen of an
adjacent molecule189 (O1) (Figure 3-6 and Figure 3-7). This is in fact the only hydrogen
bonding throughout the lattice and is relatively weak for an H-bond with an H···O distance
of 2.206 Å.189,199 That being said, it is the strongest interaction holding the crystal
together. The N2 of the second molecule forms a similar bond with the O1 of a third
adjacent molecule and so strings of molecules are formed in one direction. This
corresponds exactly to the lattice constant a.
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Figure 3-5. Lattice constants as a function of temperature for 10,11-dihydrocarbamazepine
polymorph II. Each of the three x-axes are depicted on the same scale to allow for easy
comparison.
Figure 3-6. Molecular structure of 10,11-dihydrocarbamazepine with atoms numbered for ease
of identification [Image produced using Mercury 3.8].
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The second hydrogen of the NH2 group interacts with the benzene ring centroid of the
adjacent molecule (Figure 3-7). This enables interaction between the proton and the π-
electrons, which appears to stabilise the one dimensional chains.189 In fact, when viewed
in the ac plane it is clear that these two interactions stabilise the crystal in both the a and
c directions.
Figure 3-7. Intermolecular bonding in 10,11-dihydrocarbamazepine II in the ac plane of the unit
cell, showing N—H···O hydrogen bonds and N—H···π interactions. All C bound H have been
omitted for clarity.
When viewed in the bc plane (Figure 3-8) it can be seen that the chains are arranged in
pseudo-sheets with the orientation of the carbamoyl group alternating with each new
layer. Bonding in the b direction is much weaker than in any other direction as there are
no H-bonds to speak of and there can only be interactions between π electrons of the
aromatic rings. Harrison et al.189 have suggested that these interactions must be
relatively weak as the shortest centroid···centroid separation between adjacent
molecules is 4.82 Å. Bonding in the c axis is a little more interesting. As previously stated,
the N—H···O H-bonds between the carbamoyl groups and the supporting N—H···π
interactions form chains in the a dimension and offer some support in c. Nevertheless,
between the chains in this direction there are no hydrogen bonds and interactions are
similar to those in the b axis, but slightly weaker, with the shortest C···C separation being
4.077 Å. This intermolecular bonding structure fits well with the unit cell expansion
pattern observed.
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Figure 3-8. 10,11-dihydrocarbamazepine II viewed in the BC plane of the unit cell. All H have
been omitted for clarity.
At 190 °C the form II reflections fade away and new ones grow in at different angles; a
small endotherm also appears in the thermogram. These two events indicate a phase
transition. Rietveld refinement of the diffraction pattern recorded at 202.5 °C (Figure 3-9)
shows that the second phase is DHC I. Thus, the phase transition occurring is form II
converting to form I. It is notable that, as was seen in Chapter 2, the presence of
crystalline material in the beam was constant. The results of integration of the calculated
patterns for the two forms as a function of temperature can be seen in Figure 3-10. It is
clear that the initial sample consisted almost entirely of form II. As the temperature rises
the content of form II appears to increase, whilst the amount of form I remains relatively
constant. One explanation for the apparent growth of form II may be that there was some
amorphous material present in the initial sample and that the energy supplied upon
heating allowed sufficient molecular mobility for crystallisation. However, glassy DHC
would produce a broad shallow “hump” rather than sharp peaks in a diffraction pattern.
Further inspection of the initial pattern (Figure 3-4) reveals no indication of the presence
of amorphous material. There is a visible curve to the background but this persists
throughout all of the data collected on all of the samples during this beamtime. More
significantly, there are no exothermic events in the DSC trace and crystallisation is an
exothermic process. Therefore there must be another explanation for the increase in
form II. It may be a consequence of the expansion of crystals in the sample resulting in
more material being lifted from the bulk into the passing beam.
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Figure 3-9. Rietveld refinement data for a diffraction pattern recorded for DHC at 202.5 °C. The structure fits the data with a Rwp of 0.0440. Tick marks show the
positions of allowed reflections of DHC form II (upper) and form I (lower).
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3.3.1.2. III phase transition
At ca.150 °C the amount of form I in the beam begins to increase, whilst the growth of
form II slows. Following this, at 175 °C, the amount of form II in the beam begins to
decrease and the rate of growth of form I rises sharply. The growth and decay of these
two crystal structures continues more or less linearly until the sample reaches 200 °C
and there is no more form I present. The small endotherm in the calorimetric data covers
the same temperature range and the combination of these results indicates the
occurrence of a phase transition from form II to form I. As was explained in Chapter 2,
the crossing of the two curves at around half the maximum quantity of either of the two
species indicates the transition does not occur via a complete melt of the sample. Instead
it is likely a solid-solid transition or possibly the result of many smaller melt-
recrystallisation events on a particle by particle basis. The absence of an exotherm in
the thermogram and the presence of the endotherm suggests the latter. Analysis of the
gradient of the two curves has shown the decline of form II content to be -0.78 °C−1 and
the growth of I to be 0.81 °C−1 between 191 °C and 196 °C (the most linear part of the
curves). The similarity between these two numbers indicates that the conversion was a
one step or continuous process and agrees with these hypotheses.
Figure 3-10. Plot of integrated total diffracted intensity for calculated patterns of 10,11-
dihydrocarbamazepine form I and form II as a function of temperature.
90
3.3.1.3. Polymorph I
Following the III conversion, crystalline material is only present in the beam over a
temperature range of around 10 °C before total loss of reflections is observed in the XRD
data and the integrated data. The large endotherm in the DSC trace at 207 °C confirms
that the sample has melted.200 Although polymorph I was not present for long, it has been
possible to extract the lattice constants from the refinements and plot them as a function
of temperature (Figure 3-11). There are fewer data points than those obtained for form
II but it is still possible to see a trend in the expansion of the unit cell.
Figure 3-11. Lattice constants as a function of temperature for 10,11-dihydrocarbamazepine
polymorph I. Each of the three x-axes are depicted on the same scale to allow for easy
comparison.
3.3.1.4. Unit cell expansion and intermolecular bonding
As with form II the unit cell expands in three dimensions as the temperature increases
but at different rates in the order c > a > b. Growth in c per degree temperature rise is
greater than that in a and b by factors of 3.5 and 7 respectively. The reasons for this are
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similar to those for form II. Table 3-1 lists the unit cell data for the two forms calculated
from refinements of patterns recorded at two different temperatures when each
polymorph was the only species present. Form I exhibits the same molecular chains held
together by weak hydrogen bonding between N2 and the O1 of the adjacent
molecule188,189 and stabilised by N—H···π interactions between N2 of the second
molecule and a benzene centroid of the first, but instead of the a direction, they
propagate along b (Figure 3-12).
Figure 3-12. Intermolecular bonding in 10,11-dihydrocarbamazepine I in the bc plane of the unit
cell. Showing N—H···O hydrogen bonds and N—H···π interactions. All C bound H have been
omitted for clarity.
When viewed in the ac plane (Figure 3-13) the difference between the two structures is
clear. In both, the chains are arranged in pseudo sheets, but where in form II, the
orientation of the carbamoyl groupings alternates with each layer (Figure 3-8), form I
presents them in the same orientation. In both forms the layers are positioned so that
the ring structures of each molecule are adjacent to ring structures in another molecule,
allowing for π···π interactions.
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Figure 3-13. 10,11-dihydrocarbamazepine I viewed in the ac plane of the unit cell. All H have
been omitted for clarity.
It is interesting that the order of growth in the unit cell parameters as a function of
temperature is different for the two forms. For both, the smallest expansion is observed
in the same direction as the propagation of the chains (form II – a, form I – b). This is to
be expected as this is the direction in which the strongest intermolecular interactions are
observed. However, the greatest growth and so the weakest interactions are seen in
different relative directions. Form II expands most in b (equivalent to a in form I),
effectively increasing the area of the pseudo sheets, whereas form I expands most in c
(equivalent to c in form II), increasing the space between the pseudo sheets. Both of




There has been some confusion over the nomenclature of CBZ polymorphs in the
literature, so this work uses the numbering of the CSD (Table 3-2).
Table 3-2. Unit cell information and CSD identifiers for VBZ forms I-IV.
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Property Form I Form II Form III Form IV
CSD identifier CBMZPN11185 CBMZPN03184 CBMZPN01183 CBMZPN12186
T / °C -115 10-30 10-30 -115
Space group P-1 R-3 P21/c C2/c
a / Å 5.1705(6) 35.454(3) 7.529(1) 26.609(4)
b / Å 20.574(2) 35.454(3) 11.148(2) 6.9269(10)
c / Å 22.245(2) 5.253(1) 15.470(2) 13.957(2)
α / ° 84.124(4) 90 90 90
β / ° 88.008(4) 90 116.17(1) 109.702(2)
γ / ° 85.187(4) 120 90 90
R-Factor 0.0506 0.069 0.035 0.0357
DSC-XRD data for a sample of anhydrous CBZ can be seen in Figure 3-14. The
diffraction data are similar to those of DHC, with the occurrence of one crystalline to
crystalline and one crystalline to liquid transition. Data collection began at 52 °C and no
major structural changes occurred until 182 °C, at which point there is a change in the
2θ positions of the Bragg reflections. The second crystalline phase is present until the
sample reaches ca. 192 °C and all reflections disappear. The DSC trace shows a small
endotherm-exotherm event coinciding with the crystalline–crystalline transition.
Immediately following this and superimposed upon it there is a much larger endotherm,
resulting from melting of the material, evident from the total loss of diffracted intensity at
the same temperature. The proximity of these events indicates that, at a heating rate of
10 °C min-1, the two transitions occur at very similar temperatures. Unfortunately, a
consequence of the overlapping thermal events is that there can be no accurate
quantification of the associated enthalpies. It may however be possible to separate the
events and carry out quantitative analysis using a slower ramp rate. This will be
discussed later in this section.
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Figure 3-14. DSC-XRD data for carbamazepine. (a) A contour plot of the diffraction data and (b)
the corresponding DSC thermogram.
As with previously discussed samples, batch Rietveld refinement was carried out on all
patterns recorded and selected patterns were examined individually. Initially, selected
patterns were analysed to establish which of the five reported forms of CBZ39,184–186,203
were present throughout the experiment. These analyses found evidence of forms I and
IV but no other species. All further refinements were carried out using starting models
from the CSD (form I: CBMZPN13, form IV: CBMZPN12). Unit cell data are presented
inTable 3-3. Refinement of the initial pattern recorded at 52 °C and a pattern recorded at
189 °C can be seen in Figures 3-15. Evidently, the initial sample was entirely form IV,
and the structural refinements fit with a Rwp of 0.0441.
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Figures 3-15 (a-b). Rietveld refinement data for diffraction patterns recorded at (a) 52 °C and (b) 189 °C when heating a crystalline sample of carbamazepine from
52 °C to 217 °C in a DSC. Tick marks show the positions of allowed reflections of carbamazepine form IV (upper) and form I (lower).
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Table 3-3. Refinement parameters for carbamazepine. The starting models were taken from the
CSD (form IV: CBMZPN12; form I: CBMZPN11).
Property Form IV Form I
T / °C 52.2 188.5
Space group C2/c P21/c
a / Å 26.517(1) 5.3585(3)
b / Å 7.076(0) 20.522(1)
c / Å 13.949(1) 22.472(2)
α / ° 90 84.318(6)
β / ° 109.578(5) 87.363(6)
γ / ° 90 85.540(5)
Cell volume / Å3 2465.9(2) 2449.8(3)
Rwp 0.0441 0.0401
Rwp-bkd 0.1671 0.2071
Phase fraction* 98.8 % 98.4 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
Polymorph IV unit cell expansion and intermolecular bonding
Although CBZ is analogous to DHC with some of its polymorphs having similar structures
to those of DHC already discussed, the structure of form IV (Table 3-2) is not one of
these and so will be discussed independently. Unsurprisingly, plotting the lattice
parameters as a function of temperature (Figure 3-16) has revealed that the unit cell of
form IV expands upon heating, with expansion in b being around twice that of a and c.
As has been discussed for other materials, the relative magnitude of growth for each of
the three cell lengths can be linked to the intermolecular bonding in the crystal. It has
previously been shown that CBZ IV packs as dimers, held by two H-bonds (1.86 Å)
through the carboxamide group with the two molecules anti to each other186 (Figure
3-17).
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Figure 3-16. Lattice constants as a function of temperature for carbamazepine IV. Each of the
three x-axes are depicted on the same scale to allow for easy comparison.
Figure 3-17. Graphical representation of a CBZ IV dimer, showing hydrogen bonding.
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The oxygen also takes part in another interaction (2.28 Å) with a hydrogen on the seven
membered ring of an adjacent molecule, and so chains of molecules are formed, which
propagate along c (Figure 3-18). These chains are held together along a and b by
centroid-centroid interactions at a distance of 3.809 Å. The bonding pattern in a
alternates between the two H-bonds forming the dimers and centroid–centroid
interactions linking each dimer with the next (Figure 3-19).
Figure 3-18. Intermolecular bonding in CBZ IV along the c axis of the unit cell, showing N—
H···O H-bonds within dimers and C—H···O interactions between dimers.
Figure 3-19. Intermolecular bonding in CBZ IV along the a axis of the unit cell, showing N—
H···O H-bonds within dimers and centroid···centroid interactions between dimers.
Figure 3-20 shows the three types of intermolecular bonds present throughout the
crystal. It is immediately apparent that, with regard to the b axis, the H-bonds exist as
individual units and offer very little support in this dimension. As a result, bonding in this
direction is dominated by benzene ring interactions, which do form very clear chains, but
the interactions in these chains are much weaker than in the other two dimensions. This
becomes clear when comparing the distances between the interacting species (N—
H···O, 1.86 Å, C—H···O, 2.28 Å; centroid···centroid, 3.809 Å).
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Figure 3-20. Intermolecular bonding in CBZ IV along the b axis of the unit cell with c
perpendicular to the page, showing N—H···O H-bonds within dimers and C—H···O H-bonds
and centroid···centroid interactions between dimers.
Clearly the domination of H-bonding in c makes the interactions in this direction stronger
than a, which has a combination of both H-bonds and π···π interactions, and a in turn
has stronger intermolecular interactions than b, which exhibits almost entirely π 
interactions. It comes as no surprise then that expansion in the a axis then is slightly
larger (x 1.39) per °C than that in the c axis and that in b is larger than a and c, by factors
of 2.35 and 3.26 respectively.
IVI phase transition
Subsequent to this expansion of the unit cell the data show a small endotherm–exotherm
and a sharp change in profile of the diffraction patterns. Together these events strongly
suggest the occurrence of a solid–solid phase transition. Rietveld refinement of the
pattern recorded after the profile change and the peak of the exotherm (188 °C), at 189
°C, (Figures 3-15(b)) identifies the second phase is CBZ polymorph I with a trace of IV
remaining. Plotting the integrated total diffracted intensity for each pattern as a function
of temperature (Figure 3-21) reveals that the lack of form I below 170 °C is constant and
the amount of form IV seems to grow as the temperature increases. This may be due to
crystal growth within the pan or possibly thermal expansion resulting in more material
being lifted into the beam as it heats. This peaks at 152 °C, at which point it begins to
decrease before leading to a very sharp drop which flattens out at 192 °C. This signifies
the total loss of all form IV crystal content in the sample. At 172 °C form I begins to grow;
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this is around the same point at which the decrease in form IV accelerates. The two
changes considered together suggest that form IV converts to form I upon heating.
Figure 3-21. Plot of integrated total diffracted intensity for calculated patterns of CBZ I and IV as
a function of temperature, with inset plot of phase fraction as a function of temperature.
As with previous samples, the integrated data were converted to phase fractions and
plotted as a function of time (Figure 3-21 (inset)). The curves cross at 0.5 and so the
transition occurred without any wholesale melt. With difficulty, as the curves are not
completely straight at any point, a linear fit of the integrated data has been carried out
around the intersection. It appears that the decline of form IV (-5.100 °C−1) occurs at a
slightly faster rate than the evolution of form I (3.567 °C−1). This is unsurprising as melting
is a thermodynamic event and occurs very quickly, since the molecules are not required
to rearrange into any particular position relative to their neighbours. In contrast,
crystallisation is a kinetic event and requires the molecules to reorient into an ordered
structure, which takes time. The presence of the endotherm–exotherm in the DSC trace
(Figure 3-14) offers strong support to the theory of co-crystallisation via a melt as melting
is endothermic and crystallisation is exothermic.
The initial small endotherm has an onset of 180 °C and represents the melting of form
IV. Unfortunately the onset of the subsequent exotherm is hidden due to the events
overlapping but its presence signifies crystallisation of the melted portions of the material
to form I. The reason for the overlap is that the temperature at which the material
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crystallises to I is reached by the instrument before all of form IV has melted. As has
been stated previously, were the experiment to be carried out at a different heating rate
the two might be separated. A slower rate would allow more time for the melt to complete
before the onset of crystallisation, which could separate the two events. For these
reasons a sample of the same material was analysed by DSC-XRD at a ramp rate of 2
°C min−1 (the results can be seen in Appendix 1) but even at this low rate the events
were found to be overlapping. It appears that the transformation of CBZ IV to CBZ I must
occur by a melt–recrystallisation mechanism at these heating rates. The possibility of a
separate melt and recrystallisation occurring at a lower heating rate cannot be ruled out.
Following the conversion it can be seen that the maximum form I content barely reaches
70 % of the maximum form IV content prior to the conversion (Figure 3-21). This,
however is not due to loss of material, but rather incomplete recrystallisation to form I. It
is another consequence of the heating rate. At 10 °C min-1 the DSC reached the melting
temperature of form I204 (represented by the large endotherm, onset 191 °C in Figure
3-14(b)) before the material had all been able to crystallise, and so that which had already
crystallised melted and any liquid remained in that state. When repeated at 2 °C min-1
the crystallisation was allowed ample time to complete and the total content of form I
after the conversion had completed was similar to that of form IV. This agrees with work
by Grzesiak et al.185
3.3.2.2. Carbamazepine II
DSC-XRD data for a sample of carbamazepine form II are given in Figure 3-22. The DSC
data show a small exotherm-endotherm with an onset at 126 °C, and then a large
endotherm with two peaks and an onset at 190 °C. The former corresponds to a complete
change in the diffraction pattern, while the latter is concurrent with the complete loss of
all Bragg reflections and is in agreement with the reported melting point of CBZ form
I.204,205 The reason for the double peak is unclear, however it may be explained by the
large sample size (12.1 mg). In all DSC-XRD experiments it was necessary to use a
sample size significantly larger than the 5 mg recommended for DSC by TA Instruments
to ensure that there was always sample in the X-ray beam.
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Figure 3-22. DSC-XRD data for a sample of carbamazepine (procured as form II) heated from
42 °C to 215 °C at 10 °C min-1. The inset in (b) shows magnified view of DSC events between
110 °C and 180 °C. Dashed lines indicate the position of phase transitions visible to both DSC
and XRD.
It is interesting that the initial change in diffraction pattern is accompanied by an
exotherm-endotherm in the DSC trace, as this suggests crystallisation followed by
melting. Following the transition there is clearly a crystalline material present, but a
portion of the material appears to be melting while some crystallises. This might indicate
that the initial sample may have been a mixture of polymorphs rather than pure form II
as expected. Furthermore, form II is reported to undergo exothermic conversion to form
I between 140 °C and 160 °C at a heating rate of 20 °C min-1.185 The onset of the
exotherm in this experiment occurs at 119 °C, which can be accounted for by the slower
heating rate (10 °C min-1) but the endotherm cannot be attributed to the same conversion.
Unfortunately the onset occurs whilst the preceding exotherm is ongoing and so cannot
be accurately determined, but it must begin above 119 °C. Additionally, due to the small
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enthalpy of the endotherm it is unclear whether the signal subsequently returns to
baseline or if there is another exotherm prior to the melt.
Phase identification
Phase identification was carried out on patterns collected at 42 °C and 178 °C using the
Rietveld method. Similarly to sulfathiazole (Chapter 2) a relatively poor fit was obtained
at 42 °C when considering only form II in the model, leading to a more detailed analysis
in which the structures of all five reported polymorphs were introduced. The conclusion
of these refinements was that the initial sample was in fact a mixture of forms I (3.5 %),
II (87.8 %) and III (8.7 %) (Figures 3-23(a)). All further refinements were carried out using
starting models from the CSD (summarised in Table 3-2). Upon closer inspection of the
pattern recorded at 42 °C (Figures 3-23(a)) it appears that all form I content was
attributable to a shift in the background curve and that there were no specific reflections
assigned to that structure; as a result, we believe the detection of form I was an artefact
and it was excluded from refinements at low temperature. Refinement of the higher
temperature pattern (Figures 3-23(b)) revealed that following the phase transition almost
all of the material had converted to form I (96 %) with a very small quantity of form II (2
%) and III (2 %) remaining. However, as with form I in the low temperature pattern, there
were no characteristic reflections of form III remaining in the observed data at 178 °C
and the 2 % can again be accounted for by a slight discrepancy in the background curve.
Final unit cell data for the patterns discussed are presented in Table 3-4. It should be
noted that the high Rwp values are a direct result of including aluminium in the
refinements. As the sample pan was a single piece of aluminium both the peak shape
and intensity were poor and as such were difficult to fit.
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Figures 3-23 (a-b). Powder X-ray diffraction patterns for carbamazepine at (a) 42 °C and (b) 178 °C, including calculated patterns for the contribution of each
polymorph. The tick marks show the positions of allowed reflections from carbamazepine form I, form II and form III and the asterisks denote characteristic
reflections of form III.
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Table 3-4. Refinement parameters for carbamazepine II. The starting models were taken from
the CSD (form I: CBMZPN13; form II: CBMZPN03; form III: CBMZPN26).
Property Form II Form III Form I Form II
T / °C 42 178
Space group R-3 P21/n P-1 R-3
a / Å 34.830(1) 7.515(3) 5.3435(8) 35.25(4)
b / Å - 11.128(4) 20.510(3) -
c / Å 5.3209(4) 13.883(9) 22.440(3) 5.372(12)
α / ° 90 90 84.272(13) 90
β / ° 90 92.85(4) 87.440(18) 90
γ / ° 120 90 85.476(16) 120
Cell volume / Å3
Rwp 0.1301 0.1337
Rwp-bkd 0.2324 0.2438
Phase fraction 91.0 % 9.0 % 98.0 % 2.0 %
Unit cell expansion and intermolecular bonding
Batch refinements were carried out and fits were obtained with Rwp values between
0.0944 and 0.1401. Figure 3-24, Figure 3-25 and Figure 3-26 show plots of lattice
constants as a function of temperature for the three forms of CBZ present. As with all
previous materials, increasing the temperature of the sample causes expansion of the
unit cell in all three dimensions for all three polymorphs. In all three structures the
molecules pack as very similar dimers to those already discussed for CBZ IV (Figure
3-17), held by intermolecular H-bonds between the carboxamide groups. Polymorph II
expands over 5 times more per °C in the a and b dimensions than it does in the c
dimension. The dimers in the structure arrange to form pseudo-layers in the ab plane.184
These layers stack with translational symmetry that runs parallel to the c axis. It is clear
from these data that the sum of the intermolecular bonding in the c axis is much stronger
than in the other dimensions resulting in the broadening of the layers as the sample is
heated, whilst the chains of stacked dimers increase in length more slowly.
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Figure 3-24. Lattice constants as a function of temperature for carbamazepine form II. Each of
the three x-axes are depicted on the same scale for ease of comparison.
Expansion differences between the three lattice constants of form III are far less
pronounced than those of form II. The intermolecular bonding in this structure consists
of the H-bonds forming dimers, two centroid···centroid interactions of slightly different
lengths, two C—H···O interactions, a N—H···π contact and a C—H···π interaction.206
This combination of intermolecular bonding is complex and has clearly led to more evenly
spread bond strengths throughout the structure, hence the more uniform expansion of
the unit cell upon heating.
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Figure 3-25. Lattice constants as a function of temperature for carbamazepine form III. Each of
the three x-axes are depicted on the same scale for ease of comparison.
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Figure 3-26. Lattice constants as a function of temperature for carbamazepine form I. Each of
the three x-axes are depicted on the same scale for ease of comparison.
Intermolecular bonding in polymorph I is also complex and has many similarities with
form III. In both forms the oxygen is involved in dimer formation as well as interactions
with the same vinylic carbons of adjacent molecules. A more detailed description is given
by Grzesiak and co-workers.185 Using this description it was possible to examine the
packing of the crystal using Mercury 3.8. Initially it appeared that the interactions in the
b and c axes were similar and the difference in rates of growth upon heating was a source
of consternation. However, when only the H-bonds which form the dimers are considered
(Figure 3-27), it can be seen that three of the four pairs of bonds are orientated so that
they offer support along b and only one of the pairs offers support to c. As these are the
dominant intermolecular interactions in the crystal this explains the much larger degree
of growth in c.
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Figure 3-27. Graphic representation of the unit cell of CBZ I, showing H-bonds.
Phase transitions
As can be seen from the contour plot (Figure 3-22), the presence of solid crystalline
material in the path of the beam was constant from 42 °C to 196 °C. However, as the
initial sample was a mixture of two polymorphs it cannot be determined from this plot
alone whether either of the components melted at any point. Figure 3-28 shows the
amount of each polymorph present in the sample as a function of temperature. Below
100 °C the relative contributions of the three polymorphs is constant, with no form I, a
little form III and the sample consisting mainly of form II. As with DHC and CBZ IV the
total content of form II appears to increase with the temperature until it reaches 100 °C,
at which point the first phase transition begins. This increase is probably a result of
thermal expansion. Form I begins to grow in at around the same temperature and the
gradients of both curves become much steeper at 120 °C, which coincides with the onset
of the exotherm in the DSC trace (119 °C) and suggests crystallisation from II to I. A
linear fit was carried out at the straightest section of the curves around the point at which
they cross (132-144 °C) and the rate of decay of form II (-3.794 °C−1) and the rate of
growth of form I (3.164 °C−1) are similar, with form I growing a little more slowly, as is to
be expected when comparing crystallisation (kinetic) to melting (thermodynamic). During
this time form III appears to grow at an increasing rate until its content peaks at around
140 °C and immediately begins to decay. It is difficult to say whether form II melts or
converts directly to form I, however, the presence of the endotherm in the DSC data
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suggests a melt. A plot of the sum of the calculated contributions of forms I and II shows
a dip in the crystalline content in the beam between 120 °C and 160 °C, during the phase
transition and prior to the waning of form III. This supports the hypothesis that there is
some melting of form II involved in the transformation, but disagrees with the literature
which describes a solid–solid transition, based on a combination of thermomicroscopy
and DSC carried out on separate samples.185 However, presumably there must be a
point during the transition at which the structure of the material sits somewhere between
those of the two crystals and is disordered, unless the conversion is simultaneous and
instantaneous for all molecules in the crystal lattice; this may be what causes the drop in
overall crystalline content at ca. 140 °C, and may not strictly be described as a melt.
Figure 3-28. Plot of integrated total diffracted intensity for calculated patterns of CBZ I, II, III,
their sum and CBZ I + II as a function of temperature, with an inset plot of phase fraction as a
function of temperature.
Plotting the sum of the content of the three polymorphs as a function of temperature
(Figure 3-28) it can be seen that the total crystalline content is lower following the phase
transition. A thorough investigation of the thermal relationship between forms I and III
was carried out by Behme and Brooke207 who concluded that the heating rate has a
strong effect on the behaviour of form III. At 2 °C min-1 there is sufficient time allowed for
the full conversion to form I, via a sublimation–condensation mechanism between 150
and 170 °C, with no apparent melting. However, once increased to 10 °C min-1 they state
that “the endotherm recorded in the range 165–175 °C reflects several thermal events”,
113
representing the combination of some conversion to form I via sublimation and some
melting. At all rates studied in the range 2–40 °C min-1 the endotherm was followed by
an exotherm resulting from the crystallisation of form I from the melt. This melt–
recrystallisation pathway is well documented in the literature.185,204,205,207–209 It is likely that
the drop in overall diffracted intensity is a result of some form III subliming and moving
out of the incident beam whilst in the gas phase and condensing in another area of the
sample or being lost from the pan, which was left open for these experiments. Hence, it
seems that there are two distinct phase transitions occurring simultaneously by three
mechanisms. Form II is undergoing melt–recrystallisation to form I on a microscopic
particle by particle basis and form III is undergoing part sublimation–recrystallisation and
part melt–recrystallisation to form I.
The conversion data presented here are consistent with the literature, except that the
conversion of III occurs at a lower temperature than expected. This may be due to the
presence of form II destabilising it. Due to the overlapping events in the thermogram and
the open pan it is impossible to quantify either the enthalpy of conversion of form IIII
or the enthalpy of conversion of III. Consequently, the amount of form III lost by
sublimation cannot be determined via enthalpic calculations. However, the diffraction
data were used to calculate a rough fraction of III lost by calculating the difference
between the maximum total crystal content prior to the phase transition and the
equivalent immediately following. This was compared to the maximum area under the
curve for form III and the resulting figure suggests that only 30 % recrystallised to form I
following the melt and 70 % was lost from the beam. This may be partially prevented in
future work by using hermetically sealed DSC pans; however, this would not prevent
recrystallisation from the vapour phase in areas of the sample not interrogated by the
incident beam.
3.3.3. Paracetamol
Melt synthesis of air-stable PCM form III utilises the sugar-based excipients lactose
monohydrate and HPMC. Crystallisation from II to I from the melt utilises trehalose,
another sugar based excipient. The crystallisation process has been followed with time-
resolved X-ray diffraction-DSC experiments. Critically, computational modelling of the
interfacial interactions at the predicted major faces of the respective paracetamol crystals
and the excipient indicate significant drivers to the stabilisation of form III through
hydrogen bonding.
114
Telford et al.210 used computational modelling to examine interactions between lactose
monohydrate and PCM forms I and III (Figure 3-29), through the minimisation of the
intermolecular interactions between crystal surfaces of the differing paracetamol
polymorphs and a lactose molecule. The dominant crystal faces for each phase, as
indicated by several morphology prediction methods, were investigated.
Figure 3-29. Computational model of the interactions between the lactose molecule (yellow) and
the dominant crystal faces of PCM (a) form I and (b) form III.
For a single lactose molecule, significantly stronger interactions were indicated with the
surfaces of form III compared to form I. As can be seen in Figure 3-29, the match
between hydrogen bonding groups is greater for form III than form I. It appears that the
repeat of the location of the OH groups on this surface matches the lactose molecule
ensuring a number of hydrogen bonds can be formed between the two systems. This
matching of system size and orientation of hydrogen bonding functional groups may be
the source of the stabilisation of form III and points to an active role for the excipient in
stabilising the metastable form. Here the effect of sugar based excipients on the
stabilisation of metastable polymorphs of PCM will be examined by in situ DSC-XRD.
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3.3.3.1. Pure paracetamol
Figure 3-30 displays a contour plot of PXRD data above a DSC trace for a sample of
melt quenched paracetamol. In contrast to the data sets depicted thus far, the x-axis
represents time and the temperature data are linked to the lower right hand y-axis.
Paracetamol is known to have three crystalline polymorphs.57,211 Research by Rossi et
al in 2003 showed that if an amorphous sample of paracetamol is heated to 113 °C in a
DSC and cooled spontaneously to ambient temperature it crystallises to form III.51
Further research has shown that form III will crystallise from the amorphous phase
without the need for an isothermal step at 113 °C.26 Therefore, in an attempt to observe
the most phase transitions possible for paracetamol, rather than simply heating, the
decision was taken to heat an amorphous sample at 10 °C min-1 from ambient
temperature to 200 °C with a 5 minute isothermal interval at 113 °C. It was hoped that
the interval would ensure evolution of form III would complete before any further
transitions began.
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Figure 3-30. DSC-XRD data for paracetamol. The x-axis shows time, as the temperature profile
was not linear. Dashed lines indicate positions of phase transitions visible to both DSC and
XRD.
Initially the X-ray data show only those reflections that may be attributed to the
experimental apparatus and a “halo” (Figure 3-31) characteristic of amorphous material.2
The glass transition (Tg) temperature of paracetamol occurs at 23 °C,212,213 however the
apparatus used for this experiment did not include a cooler for the DSC and so it was
not possible to cool below ambient temperature. The lowest temperature recorded for
this sample was 26 °C, making it impossible to observe the Tg. Notwithstanding,
synchrotron XRD has been shown to have a limit of detection (LOD) of crystalline content
in an amorphous material of 0.2% w/w.214 This is sufficient to say that, although no Tg
could be observed, the sample was successfully vitrified.
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Figure 3-31. Diffraction pattern for glassy paracetamol at 26 °C. All reflections are attributable to
the experimental set up. The background “halo” is characteristic of amorphous material.
Upon heating, the first change in the sample is indicated by a small exotherm in the DSC
trace with an onset of around 56 °C. This event does not have any accompanying change
in structure visible in the X-ray data. The second exotherm (onset 75 °C, ca. 350 s) is
clearly caused by the crystallisation of the amorphous material as, at this time point,
there is a dramatic change in the contour plot and a number of Bragg reflections grow in
very quickly. Subsequently there appear to be two small events in the DSC trace, the
first endothermic and the second exothermic, at around 500 s and 800 s. However, if the
temperature data are considered, it can be seen that these events correspond directly to
the beginning and end of the isothermal portion of the heating profile, respectively, and
are in fact artefacts of the instrument.
It should be noted that, although the instrument was programmed to hold the temperature
at 113 °C it only achieved 111 °C. This is likely due to the holes being drilled in the head
and the fact that heat shielding could not be used as it would have diffracted too much
of the incident beam intensity before reaching the sample. This is unlikely to have had
an effect on the results as the crystallisation was complete before the sample reached
this temperature, as can be seen in the X-ray data. From this point and until the material
melts, changes in the diffraction pattern do not appear in the DSC data. The reflections
that appear at 75 °C reach a maximum intensity very quickly, and this then begins to
decrease more slowly. Another set of reflections begin to grow in at the same time, but
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much more slowly than the first, and reach a maximum at 111 °C (ca. 740 s) before
fading and then disappearing altogether. This disappearance is coincident with the final
event in the DSC thermogram, a large endotherm (onset 158 °C, ca. 1100 s).
It was thought that the first exothermic event (56 °C) may be due to the presence of a
contaminant or impurity in the sample, but this would need to be non-crystalline before
and after the exotherm as there are no Bragg reflections relating to the event. In an
attempt to identify the cause of the exotherm the experiment was repeated by quench
cooling paracetamol in an unmodified Q20 DSC a number of times then following the
same heating regime as previously described (Figure 3-32). The event was not
reproducible. In all collected data no events were observed prior to that at 75 °C, the
same temperature as the second exotherm in Figure 3-30. For this reason it is taken to
be an artefact, probably related to the modifications to the cell.
Figure 3-32. DSC data for paracetamol quenched in situ and reheated at 10 °C min-1 with an
isothermal period at 113 °C. [Different colours represent different samples. Peak marked *
denotes signal resulting from the hold].
Polymorph III
Rietveld refinement of the pattern recorded at 82.3 °C (just prior to the apex of the second
exotherm in Figure 3-30) can be seen in Figure 3-33. As can be seen from the calculated
patterns the initial exotherm can be attributed to the crystallisation of the sample from
amorphous to paracetamol form III.26 The angles of reflection all match the expected
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positions and this is the behaviour expected of amorphous paracetamol.26,57 Again, as
the experimental set up did not allow for spinning of the sample and as the sample itself
was not a powder but began as a single piece of amorphous material, the intensity ratios
of the reflections are not a perfect representation of the structure of form III. There are
however, no characteristic reflections of any other polymorphs of PCM present in the
recorded pattern. The Rietveld refinements fit with a Rwp of 0.0801.
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Figure 3-33. Rietveld refinement data for a diffraction pattern recorded at 82.3 °C when heating an amorphous sample of paracetamol. Tick marks show the
positions of allowed reflections of paracetamol form III.
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Phase transitions
It has previously been stated that, following the initial crystallisation to form III
paracetamol is stable until a solid–solid phase transition, which occurs at ca. 125 °C
(when heating at 10 °C min−1) and is characterised by a small exotherm of −1.0 kJ 
mol−1.26 This was not the case during this experiment. Rietveld refinement of a pattern
recorded within the isothermal period at 111 °C (Figure 3-34) clearly shows the presence
of both form II and form III at this temperature in approximately equal measure. Clearly
the content of form II is growing in relation to form III. Unfortunately the calorimetric data
do not contain any useful information relating to this, due to the isothermal portion of the
heating programme, but refinement of a further pattern at 143.1 °C (Figure 3-35) shows
the transformation of the material to form II is complete.
122
Figure 3-34. Rietveld refinement data for a diffraction pattern recorded at 111 °C when heating an amorphous sample of paracetamol from 26 °C. Tick marks show
the positions of allowed reflections of paracetamol form II (upper) and form III (lower).
123
Figure 3-35. Rietveld refinement data for a diffraction pattern recorded at 143.1 °C when heating an amorphous sample of paracetamol from 26 °C. Tick marks show
the positions of allowed reflections of paracetamol form II (upper). Asterisks denote reflections caused by the experimental set up.
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Batch refinements were carried out on the data as described in Chapter 2; the results
can be seen in Figure 3-36. It is clear that form III begins to grow in from the amorphous
phase after 285 s (70 °C) and rapidly reaches its maximum content after 347 s (82 °C),
which agrees closely with the second exothermic peak in the DSC trace and the
literature.26 Following this the form III intensity begins to decline immediately until its
contribution to the diffraction pattern is negligible. It appears that form II also grows in at
around the same temperature. This agrees with the conclusions drawn by Gaisford et
al.57 that both forms II and III grow in from the amorphous form as pure paracetamol is
heated, and Burley et al.26 who observed that there is a temperature range within which
the two forms co-exist. Although both groups suggest the growth of III presupposes that
of II, the data here suggest both metastable polymorphs begin to crystallise from the
amorphous form at the same temperature. However, form III grows in more rapidly than
form II, and at its maximum form III represents ca. 96 % of the content of the sample.
Figure 3-36. Plot of integrated total diffracted intensity for calculated patterns of paracetamol
form II and form III versus time. The solid blue line represents the temperature of the sample.
The arrow highlights the point at which the rate of decay of form III increases, which matches
the maximum intensity of form II. [Green circles indicate artefacts from the refinements caused
by a slight change in the background. Data points between 855 s and 1109 s have been
removed as the data could not be fitted in this range].
It appears that form II develops in two stages as the profile of the curve between 350 s
(83 °C) and 600 s (111 °C) can be split into two gradients. From 350 s to 450 s the rate
of growth is far slower than that after 450 s. Presumably the initial growth can be
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attributed to crystallisation from the amorphous material and the second stage is a result
of the conversion from form III. There is a slight increase in the rate of decay of form III
coincident with this increase in rate of formation of form II. Approximations of the rate of
conversion for each form have been carried out using OriginPro 9.1; these indicate that
the average rate of growth of form II between 460 s and 550 s was around 9 °C−1 and
the corresponding decay of form III was 10.5 °C−1. The similarity between these two
figures appears to support the theory of a IIIII conversion. The initial decay of form III
is much faster than the growth of form II and is therefore unlikely to be attributable to a
conversion between the two. It begins at 340 s and increases at 445 s when the proposed
conversion to form II begins. It is interesting to note that the quantity of form III at 445 s
is very similar to that of the maximum quantity of form II after the transition is complete.
This suggests that the portion of the material decaying during the initial part of the
transition does not recrystallise to form II, or in fact any other form (as no other Bragg
reflections are observed). It must therefore be melting.
Unlike melting, which is a thermodynamic event and requires only thermal energy,
crystallisation is a kinetic event and so it requires time as well as energy for the molecules
present to rearrange themselves into the correct relative orientation so that
intermolecular bonds can develop and form the crystal lattice.9 The rate of crystallisation
of polymorph II from the glass is slower than that for its conversion from polymorph III.
The molecules in an amorphous material have no long range order and are effectively
randomly orientated, similar to the structure of a liquid. There is essentially no regular
arrangement and so it will take a relatively long time and large amount of energy for the
molecules to move into the exact positions required to form the crystal lattice. In contrast,
the molecules in a crystal are arranged uniformly in a repeating array. The structures of
forms II and III of paracetamol are closely related49 as can be seen by the similarity in
their diffraction patterns (Figure 3-37). Therefore, the molecules are required to make
much smaller positional adjustments to transform between the two crystalline
polymorphs than to convert from the amorphous to form II. For this reason the second
stage of growth of form II is much faster than the first.
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Figure 3-37. Diffraction patterns for paracetamol recorded at 82 °C and during the isothermal step at 111 °C. Insets present the structures of the two polymorphs
showing the similar stacked layers. The patterns are clearly very similar, particularly with reference to the main reflections.
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Unfortunately, as both II and III begin to evolve from the glass at the same temperature
there is no way of separating the relative energies from the exotherm in the DSC trace.
However, as the diffraction data show, the growth of form III begins at 285 s (70 °C) and
completes at 347 s (82 °C). This time/temperature range corresponds directly to the
position of the crystallisation exotherm in the thermogram. Since, at the apex of the
thermogram, the diffracted intensity is 96 % form III it is reasonable to assume that the
enthalpy of the exotherm is almost entirely due to this form.
The growth profile of form II is not typical of the behaviour of amorphous paracetamol,
as shown by Burley et al.26 and further supporting DSC studies (Figure 3-32). This
suggests there may have been some seed crystals of form II in the glassy material.
Although the diffraction data show that the sample was amorphous the presence of a
small amount of crystalline material cannot be ruled out. The X-ray beam passed through
a maximum cross sectional area of the sample of 0.5 mm x 0.5 mm. Any crystals outside
of this would not have been detected.
3.3.3.2. Paracetamol and HPMC
Combined DSC and diffraction data for a melt-quenched mixture of PCM with 10 % w/w
HPMC K100M can be seen in Figure 3-38. As was seen with pure paracetamol the
quenched sample was completely amorphous with no Bragg reflections occurring in the
X-ray data. The sample remained this way until 90.9 °C, at which point there is a large
endotherm (peaking at 100 °C) coinciding with the appearance of Bragg reflections in
the diffraction pattern. This indicates that the sample has undergone a phase transition
from the glass to PCM III, which was confirmed by Rietveld refinement (Figure 3-39).
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Figure 3-38. DSC-XRD data for a quench cooled sample of paracetamol and 10 % w/w HPMC
K100M heated from ambient to 194 °C at 10 °C min-1. Reflections in the liquid phase marked *
are a result of the experimental set up.
Immediately following the phase transition the tail of the exotherm leads into an
endotherm in the DSC trace, which peaks at 135 °C. This coincides with a sharpening of
the reflections in the diffraction data and results from the growth of crystals of form III in
the sample. It seems from both datasets that this growth occurs very quickly, immediately
before a phase transition from form III to form II, represented by an endo-exo event in
the thermogram and the loss of all reflections relating to form III in the diffraction pattern
(Figure 3-40). The final exotherm is inseparable from the subsequent large endotherm
which peaks at 161.7 °C and is caused by the melting of form II,26,49,53,57,192,210,211 and
coincides with the loss of all sample related reflections in the X-ray patterns.
129
Figure 3-39. PXRD pattern for a quench cooled sample of a mixture of paracetamol with 10 % w/w HPMC K100M recorded at 102.3 °C. Reflections marked * are a
result of the experimental set up.
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Figure 3-40. PXRD pattern for a quench cooled sample of a mixture of paracetamol with HPMC K100M (10 % w/w) recorded at 143.0 °C. Reflections marked * are a
result of the experimental set up.
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Unit cell expansion of polymorph III
Unit cell growth for polymorph III can be seen in Figure 3-41. As expected from the
structure of the crystal, which consists of stacked hydrogen bonded two dimensional
layers in the ab plane,49 the unit cell exhibits no growth in the b dimension upon heating
and little in a (6.39 x 10-4 Å °C−1). Whereas, in the c direction there is 1.10 x 10−3 Å °C−1
expansion over the temperature range 100–120 °C. The same is seen in polymorph II
(Figure 3-42), where the 2D layers sit in the bc plane and the unit cell expands by 1.04
x 10−3 Å °C−1 along a but very little along the other two axes. These values are similar to
those seen in many of the other materials discussed in this chapter and reflect the
difference in intermolecular bonding patterns along each axis of the crystal.
Figure 3-41. Plot of lattice constants as a function of temperature for a sample of paracetamol III
with 10 % w/w HPMC K100M and the structure of PCM III viewed down the a axis.
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Figure 3-42. Plot of lattice constants as a function of temperature for a sample of paracetamol II
with 10 % w/w HPMC K100M and the structure of PCM II viewed down the b axis.
Phase transitions
Plotting the integrated refinement data as a function of temperature (Figure 3-43) reveals
that the sample remained amorphous until ca. 90 °C, at which point form III grew very
rapidly to a maximum content at ca. 100 °C. Unlike the sample of paracetamol alone, in
which form II grew in at ca. 70 °C, here it did not form until ca. 135 °C and appears to be
the result of a conversion from form III, with none growing from the glass. These data
suggest that the addition of HPMC to PCM is able to promote the growth of form III from
the glass whilst suppressing the growth of form II.
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Figure 3-43. Plot of integrated total diffracted intensity for calculated patterns of paracetamol
form II and form III as a function of temperature.
Giordano et al.52 reported that upon heating a sample of PCM with 10 % HPMC K4M, at
93 °C it crystallised from the glass into a mixture of forms II and III. Following this at 139
°C form III underwent a melt-recrystallisation to form II (as opposed to the solid-solid
conversion reported in the literature)26,52,57,215 and finally form II melted at 156 °C. The
DSC data presented by those authors is similar to that shown in Figure 3-38. Giordano
suggested that both forms II and III crystallise from the glass, but offered no explanation
of the assumption that form II is present. This work has shown this not to be the case
and that amorphous paracetamol with 10 % HPMC K100M crystallises to pure form III at
90.9 °C. Giordano also neglected to discuss the cause of the first endotherm in the DSC
trace (herein observed at 135 °C) and appear to have ascribed it to the IIIII conversion,
as have Rossi et al.51 Here it has been shown to be a consequence of molecular
rearrangements within the bulk form III present in the sample. The data are in agreement
with the work of Gaisford et al.57 who have shown that the addition of HPMC to PCM
favours the formation of form III and acts to prevent the crystallisation of form II.
3.3.3.3. Paracetamol and Lactose
The aim of this experiment was to vitrify a sample of paracetamol and lactose by quench
cooling the melt in the DSC pan and then subject the glass to a linear heating programme
(10 °C min-1) for analysis by DSC-XRD, analogous to the HPMC experiments described
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in Section 3.3.3.2. It is immediately apparent when viewing the combined diffraction data
(Figure 3-44(a)) that the quenching did not result in an entirely amorphous sample as
there are Bragg reflections in the initial pattern. This is an unfortunate consequence of
the experimental set up. There was no active cooling element attached to the calorimeter
and so quenching could only be carried out by removing the sample from the cell and
allowing it to cool to ambient temperature. Faster cooling would have produced a fully
amorphous matrix.
Figure 3-44. DSC-XRD data for a sample of paracetamol with 10 % w/w lactose heated from 40
°C to 176 °C at 10 °C min-1. Dashed lines indicate position of phase transitions visible to both
DSC and XRD.
Upon reheating of this sample, the DSC trace (Figure 3-44(b)) shows a broad exotherm
with a maximum at ca. 85 °C, followed by a second exotherm at 130 °C and an
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endotherm at just below 160 °C. The latter corresponds to the melt of form II, and XRD
patterns collected above this temperature show no diffraction features. The two
exotherms correspond to distinct changes in the XRD patterns. The first exotherm is
coincident with the crystallisation of forms II and III from the amorphous material present.
The second exotherm corresponds to the conversion of form III present into form II,
resulting in pure form II above 130 °C; this persists until the mixture melts at 154.6 °C in
agreement with the literature.49,50,57 A parallel study of the melt synthesis of form III with
lactose was undertaken using hyphenated in situ Raman-DSC (Figure 3-45), using
similar protocols to the DSC-XRD studies.210 The results obtained upon reheating the
quenched melt are in support of the results reported here.
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Figure 3-45. (a) DSC thermograms and (b) Raman spectra recorded at (i) 30 °C before heating
[PCM I], (ii) 30 °C after quench cooling [amorphous] and (iii) 110 °C [PCM III] after reheating for
a 10 % lactose containing sample of paracetamol (annotated with key spectral shifts observed).
Reproduced with permission from ref 210.
Phase identification and transitions
Each pattern was analysed using the Rietveld method (selected datasets are given in
Figure 3-46) and the area under the diffraction pattern from each phase was calculated
(Figure 3-47). It appears from the pattern recorded at 40 °C that the initial sample
following the quench was a mixture of both forms II and III. However, the intensities of
all reflections were very low, indicating that the majority of the material was in fact
amorphous, and the material was not an ideal powder so the familiar problem of poor
intensity ratios was encountered again. Therefore it was concluded that there was no
form III present in the initial sample. Had there been any form III it is likely that this would
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have seeded the growth of more from the beginning and the integrated data plot would
be similar to that of form II, with the quantity of form III increasing from the start of the
experiment.
The increasing content of form II in the sample throughout the experiment up to the
melting point is clear, as is the fact that form III grows in during the first exotherm and is
converted to form II at the second. The formation of form II is a relatively gradual process
that is continuous from the beginning of the experiment. This may be why there is no
exotherm visible for the formation of II from the amorphous system. In contrast, the
formation of III is a very quick process, occurring over a period of 20 °C (2 min) and so
there is a large, sharp exotherm. The peak of the first exotherm corresponds to the point
at which the growth of form III halts and it is at its maximum content for the experiment.
It is clear that the amount of form III present is largely constant between the two
exotherms, despite the fact that form II crystals are also present. The amount of form II
present increases throughout the experiment until the second exotherm, presumably a
result of seeding of crystallisation from the amorphous material. Thus the lactose additive
is able to stabilise form III even in the presence of form II crystals. The absence of form
I throughout the experiment indicates the presence of lactose has either a stabilising
effect on form III or destabilising effect on form I, in good agreement with the




Figure 3-46 (a-c). Powder X-ray diffraction patterns for a mixture of paracetamol and lactose at (a) 40 °C, (b) 94 °C, and (c) 151 °C, including calculated patterns for
the contribution of each polymorph present. The tick marks show the positions of allowed reflections from paracetamol forms II (blue) and III (pink).
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Figure 3-47. Plot of integrated total diffracted intensity for calculated patterns of paracetamol in
a binary mixture with lactose as a function of temperature. Form II and form III. The continued
presence of form III between 130 °C and 160 °C is a result of the poor intensity ratio of
reflections resulting from a grainy sample.
As with previous samples, the lattice constants of the two polymorphs observed were
plotted as a function of temperature and can be seen in Figure 3-48 and Figure 3-49. In
the temperature range 100–120 °C the order of growth of the unit cell parameters of
PCM III and the behaviour of the a and b constants is the same as that seen in the
mixture with HPMC. However, there is a significant difference in the magnitude of growth
in c, with that in the lactose mixture growing 75 % more per °C than in the HPMC mixture.
Suggesting that HPMC may interact more strongly with PCM form III than lactose was
predicted to by Telford and co-workers.210
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Figure 3-48. Lattice constants as a function of temperature for paracetamol III in a sample of
quench cooled paracetamol with 10 % w/w lactose heated from ambient to 176 °C at 10 °C
min−1.
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Figure 3-49. Lattice constants as a function of temperature for paracetamol II in a sample of
quench cooled paracetamol with 10 % w/w lactose heated from ambient to 176 °C at 10 °C
min−1.
The data discussed in this section have been published in the journal Chemical
Communications.210
3.3.3.4. Paracetamol and Trehalose
As with the paracetamol–lactose mixture, the quenching process did not produce a fully
amorphous sample here. Upon reheating of this sample, the DSC data (Figure 3-50)
shows a broad exotherm with a maximum at ca. 79 °C, followed by a second much
smaller exotherm at 116 °C, a small endotherm at just below 160 °C and a much larger
endotherm at 170°C. The first endotherm corresponds to the melt of form II, the latter
corresponds to the melt of form I, and XRD patterns collected above this temperature
show no diffraction features relating to the sample. These data are in good agreement
with the literature.53,192 The first exotherm corresponds to an increase in the intensity of
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the reflections present, and the second to distinct changes in the XRD patterns. The first
exotherm is coincident with the crystallisation of form II from the amorphous material
present. The second exotherm corresponds to the conversion of form II present into form
I, resulting in almost phase pure form I with some residual form II above 130 °C; this
persists until the mixture melts.
Figure 3-50. DSC-XRD data for a sample of paracetamol and 10 % w/w trehalose heated from
43 °C to 174 °C at 10 °C min-1. Dashed lines indicate the position of phase transitions visible in
both DSC and XRD. The reflection marked * in the liquid phase is a result of the experimental
set up.
Phase identification and transitions
Selected Rietveld refinement datasets are presented in Figures 3-51 and phase
quantification data are given in Figure 3-52. It is clear from the low relative intensities of
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the reflections recorded at 43 °C (Figures 3-51) that the majority of the sample was
amorphous. As with previous samples, the lack of active cooling prevented the
attainment of an entirely amorphous matrix, and some reflections attributable to






Figures 3-51 (a-d). Powder X-ray diffraction patterns for a mixture of paracetamol and trehalose at (a) 43 °C, (b) 112 °C, (c) 124 °C, and (d) 162 °C including
patterns calculated by Rietveld refinement for the contribution of each polymorph present. The tick marks show the positions of allowed reflections from paracetamol
forms I (blue) and II (pink). Gaps in the data are regions excluded from the refinements due to reflections arising from the experimental set up.
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The absence of form I remains constant below 113 °C, whereas the reflections
representing form II grow stronger in intensity as the sample is heated. At 112 °C (Figures
3-51 (b)) the pattern recorded clearly shows that the form II content of the sample has
grown significantly whilst there is still no form I present. This is a result of form II growing
from the amorphous phase, in all likelihood by seeding from the residual form II present
in the sample following quenching of the melt. This growth can be seen clearly in (Figure
3-52).
Figure 3-52. Plot of integrated total diffracted intensity for calculated patterns of paracetamol in
a binary mixture with trehalose, as a function of temperature. Form I, form II and the sum of
forms I and II. The inset shows a plot of phase fraction as a function of temperature. Gaps in the
data are regions excluded from the refinements due to reflections resulting from the
experimental set up.
The quantity of form II in the sample reaches its maximum at 113 °C and then
immediately begins to decline. At the same temperature Bragg reflections from form I
begin to grow in, and rapidly increase in intensity. Patterns recorded at the point at which
the phase quantity curves intersect (Figures 3-51 (c)) show strong sharp reflections
belonging to both polymorphs and the sample at this temperature (ca. 124 °C) is
effectively a 1:1 ratio of the two forms. It is obvious from the plot of phase fraction as a
function of temperature that the sample does not undergo a wholesale melt and that form
II is converting to form I between 113 °C and ca. 131 °C. Interestingly, the conversion
appears to occur as a two-step process. The initial growth of form I is much faster than
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the decline in form II, suggesting that it is growing from the residual amorphous material
as well as transforming from form II.
At 124 °C (the point of intersection (Figures 3-51 (c))) the rates of growth of I and
reduction of II increase significantly. It may be that, at this temperature, the energy in the
system is sufficient that the conversion occurs by a different, faster mechanism than
below 124 °C. Unfortunately, due to the growth of form I from both amorphous material
and conversion from form II it is impossible to separate the contribution of the two phase
transformations. The fact that the amount of form I present continues to grow, even after
the almost total disappearance of form II, up until its melting temperature proves that
some glass remained throughout the experiment. It is interesting that the growth of
polymorph I from the glass results in no exothermic events in the DSC thermogram. This
may be due to the large temperature range over which the crystallisation occurs. As it is
constant and occurs throughout the experiment the exotherm would be too broad to be
easily visible by DSC and may in fact be characterised by a change in the baseline of
the data. Another interesting feature is the small endotherm in the trace resulting from
the melt of form II. The X-ray data suggest that all form II has converted to form I at ca.
131 °C, well below the melt at 154 °C. The most likely explanation for this is that some
of the sample in the pan remained as form II but none of it was in the beam and so no
characteristic Bragg reflections of form II were recorded. This suggests that the sample
may not have been homogeneous. Paracetamol has been shown by Nanubolu and
Burley194 to crystallise from the glass to polymorphs I and II via surface crystallisation if
left uncovered but to form III by crystallisation from the bulk if confined between a glass
slide and coverslip. It may be that, in this work, the open pan allowed some surface
crystallisation whilst the remainder of the material, which was confined by the pan,
crystallised to form III from the bulk.
Unit cell expansion
It appears from these data that trehalose stabilises form II at the expense of form III. This
is also the only sample in which PCM polymorph I was observed, suggesting that
trehalose not only stabilises form II at the expense of form III but also that it promotes
the conversion of form II to form I. As the conversion occurs at 116 °C it was not possible
to plot meaningful data for the lattice constants of form II as a function of temperature
over the same range as the mixtures with HPMC and lactose (142–150 °C) for
comparison. However, plots over different temperature ranges can be seen in Figure
3-53 and Figure 3-54. Polymorph II follows the same trend seen in the other paracetamol
samples, with little growth in the b and c directions and 1.09 x 10−3 Å °C−1 in a. This is
152
strikingly similar to the growth in the same direction in the sample mixed with HPMC
(1.04 x 10−3 Å °C−1), and suggests that these two additives may interact with the drug in
a similar way. These findings also support the theory that lactose destabilises form II in
the a direction, effectively weakening the interactions between the pseudo-sheets so that
they undergo greater separation upon heating.
Figure 3-53. Lattice constants as a function of temperature for paracetamol II in a sample of
quench cooled paracetamol with 10 % w/w trehalose heated from ambient to 175 °C at 10 °C
min−1.
Observation of the growth of the unit cell of form I as it was heated (Figure 3-54) reveal
that there is little growth in either a or c, yet b expands significantly at a rate of 1.75 x
10−3 Å °C−1. The structure of paracetamol form I has been described as pleated sheets
in the ac plane, which are stacked along b (Figure 3-54).47 Thus, the heat expansion
behaviour observed is a result of the separation of the pleated sheets, which are held
together more weakly than the molecules within the sheets. This is much like the
behaviour seen here and with both HPMC and lactose for form II, and for form III in the
systems with HPMC and lactose.
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Figure 3-54. Lattice constants as a function of temperature for paracetamol I in a sample of
quench cooled paracetamol with 10 % w/w trehalose heated from ambient to 175 °C at 10 °C
min-1 and a graphical representation of the structure of form I viewed down the a axis of the unit
cell.
3.4. Conclusions
Heat induced phase transitions in DHC II, CBZ II, CBZ IV and PCM glass were studied
by simultaneous DSC-XRD, following which PCM glasses prepared with the addition of
10 % w/w of one of three sugar based excipients (HPMC, lactose and trehalose) were
examined. The phase transitions in all the systems investigated have been shown to be
more complex than previously reported. The combination of XRD and DSC data initially
allows for identification of the phases present at any temperature, including during
transformations. Furthermore, batch analysis of the data has revealed that many
transitions considered to occur via a solid–solid pathway, actually involve what may be
considered a transitional melt phase. However, this melt is so quickly followed by
recrystallisation to the subsequent crystalline phase that regions of the sample melt and
recrystallise before other regions begin to melt. Consequently the presence of crystalline
material in the sample is continuous, hence the prior solid–solid assumption.
Batch refinements have also allowed monitoring of the expansion of the unit cell as a
function of temperature of many of the polymorphs. It has been shown that these data
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can then be used in conjunction with structural information to confer a directional order
of stability in relation to the lattice constants. Perhaps predictably the dimensions which
contain stronger intermolecular bonding (e.g. H-bonds) have shown smaller growth per
°C than those with weaker interactions (e.g. π···π). Additionally, growth in unrelated
polymorphs of different molecules is has proven to occur at similar rates.
DHC II was shown to undergo a conversion to form I by what appears to be a localised
melt phase. CBZ IV converted to form I at 182 °C, by either a solid–solid pathway or a
localised intermediate melt phase. CBZ II was in fact found to contain a small amount of
form III. Form II converted to form I at 119 °C by a pathway that appears to have included
some melting and form III underwent what appears to be a part melt-recrystallisation and
a part sublimation-recrystallisation to form I.
Pure PCM glass crystallises to both form II and form III upon heating, although much
more rapidly to form III which then goes on to immediately convert to form II at ca. 125
°C. Form II goes on to melt at 158 °C. The addition of HPMC to PCM proved to stabilise
form III which crystallised alone from the glass and remained phase pure until ca. 135
°C, at which point it converted to form II which melted at ca. 160 °C. No form II grew from
the glass.
PCM with the addition of lactose was incompletely vitrified and the initial sample
contained some residual form II, however even in the presence of this polymorph form
III grew in from the amorphous and remained stable until 130 °C, at which point it
converted to form II. Thus it seems lactose is able to stabilise form III even in the
presence of form II crystals.
As with the sample containing lactose, that mixed with trehalose was not completely
vitrified and there remained some form II crystals. Upon heating, at ca. 70 °C form II
crystallised from the glass and subsequently converted to form I at 116 °C There
remained a small amount of form II in the sample, which then melted at 160 °C, followed
by form I at 170 °C.
For PCM the introduction of 10 % w/w of different plasticisers to the drug has
demonstrated an ability to selectively alter the rate of growth in specific axes as well as
selectively stabilising polymorphs. With HPMC and lactose stabilising form III and
trehalose stabilising form II and promoting the growth of form I.
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4. Novel pharmaceutical co-crystals
4.1. Introduction
Co-crystallisation is a method by which the chemical and/or physical properties of a
molecule can be altered without making or breaking any covalent bonds.58 This can
directly affect the physical properties of a compound and may improve its solubility and/or
rate of dissolution. As a consequence of the substance existing in a crystalline form, co-
crystals are likely to be more stable, reproducible and easier to purify than other solid
forms of a drug and therefore more desirable.58 Aakeröy defined a co-crystal as “a
crystalline material that consists of different molecular (and electrically neutral) species
held together by non-covalent forces”,216 and Vishweshwar et al defined pharmaceutical
co-crystals as “co-crystals that are formed between a molecular or ionic API and a co-
crystal former that is a solid under ambient conditions,”.67 It is important to ensure that a
suitable non-toxic co-former is used that will not interact covalently with the drug, to alter
its chemical structure, and that a stoichiometric ratio of all components is used.58
Isonicotinamide (INCT, Figure 4-1) has been shown to exhibit anti-inflammatory
activity217 and has been associated with a reduction of Huntington disease related cell
toxicity.218 More commonly it has been used extensively as a pharmaceutical co-crystal
co-former to improve the solubility of an active pharmaceutical ingredient (API) without
compromising its efficacy or stability,219–228 and is a component of at least 40 co-crystals
reported in the Cambridge Structural Database (CSD).229,230 The pyridine derivative’s
utility as a co-crystal co-former stems from its distinct but relatively strong hydrogen
bonding moieties (the pyridine nitrogen and the amide) and its ability to form crystals with
different components.231
Due to the aforementioned properties, INCT was employed in this work with a range of
co-formers. Vishweshwar et al have reported data for a 1:1 co-crystal232 between the
antimicrobial and antioxidant233 API 4-hydroxybenzoic acid (HBA, Figure 4-1) and INCT
formed by crystallisation from hot methanol. 4-hydroxyphenylacetic acid (HPAA) and 3,4-
dihydroxyphenylactic acid (DHPAA, Figure 4-1) are also antioxidants234 and were chosen
for study as they are analogues of HBA and so were presumed to have high potential for
co-crystallisation with INCT. L-ascorbic acid (LABA), another antioxidant, is taken as a
supplement to aid wound healing235 and to prevent scurvy236 and was chosen as it has
six hydrogen bonding moieties and so a high potential for co-crystallisation.
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Figure 4-1. Chemical structures of INCT, 4-hydroxybenzoic acid (HBA), 4-hydroxyphenylacetic
acid (HPAA), 3,4-dihydroxyphenylacetic acid (DHPAA), and L-ascorbic acid (LABA).
There are a range of routes which have been explored for co-crystal formation, all of
which have advantages and disadvantages. Traditionally, solvent evaporation has been
the most commonly employed method for the preparation of pharmaceutical co-
crystals.237 However, due to the use of organic solvents it is ecologically unsound. It is
also time consuming, with evaporation of the solvent occurring over days and weeks
required just to grow a single crystal. Recently, thermal inkjet printing has proven to be
a rapid method for the preparation of pharmaceutical co-crystals, with Buanz et al
suggesting “the technique would appear to offer potential for early phase pharmaceutical
co-crystal screening”.81 Inkjet printing takes minutes to produce crystals of sufficient
quantity and high enough quality for analysis (albeit inferior to crystals grown by solvent
evaporation). However, the materials must first be in solution before they can be printed
and so the “green” problem remains.
Grinding or co-grinding of stoichiometric amounts of two dry powdered crystalline
materials has been known to produce co-crystals since as early as 1893, although it was
unpopular in academic laboratories until the late 2000s.104 The method has advantages
over solvent evaporation and thermal inkjet printing in that it is both fast (over the minutes
scale) and clean/green (requires no solvent). However, it produces fine powders and not
the single crystals required for full structure elucidation by X-ray diffraction.
In 2013 Yamashita and co-workers examined a number of binary systems for their ability
to form co-crystals as a result of heating.86 Using binary phase diagrams they identified
two possible routes to forming a co-crystal which could be characterised by different
thermal events, easily investigated via DSC. They state that only a mixture capable of
forming a co-crystal will exhibit exothermic events. That is, crystallisation is an
exothermic event and so the formation of a co-crystal will result in an exothermic signal
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on a DSC thermogram. Two stable crystalline species which cannot form a co-crystal will
only melt and give one or two endothermic signals, characteristic of melting (this is not
true for metastable species, however). Yamashita et al. supported their DSC analysis
with X-Ray-DSC and polarisation microscopy and found that all of the seventeen
systems reported to be capable of co-crystal formation exhibited an exothermic peak in
the DSC data. Interestingly, no exothermic peaks were seen in the three systems in
which co-crystals had never before been reported, suggesting this is a good indication
of the existence of co-crystals.
This chapter will discuss data collected during attempts to co-crystallise INCT in
combination with each of the four antioxidants via: solvent evaporation, thermal inkjet
printing, ball milling and the simultaneous DSC-XRD technique discussed in Chapter 2.
4.2. Materials and Methods
4.2.1. Materials
4-Hydroxyphenylacetic acid, 3,4-dihydroxyphenylacetic acid, 4-hydroxybenzoic acid, L-
ascorbic acid, isonicotinamide and absolute ethanol were obtained from Sigma-Aldrich
and used as received. Distilled water was used when water was required.
4.2.2. Fourier transform infrared spectroscopy (FTIR)
FTIR spectroscopy was conducted on a Perkin Elmer Spectrum 100 instrument. All
spectra were recorded between 650 and 4000 cm-1 with 64 scans at a resolution of 4
cm−1.
4.2.3. Thermogravimetric analysis (TGA)
TGA measurements were performed using a TA Instruments Discovery machine.
Samples were loaded into aluminium cups and heated from ambient to 300°C at a 10°C
min-1 with a nitrogen purge of 25 mL min-1.
4.2.4. Single crystal X-ray diffraction (XRD)
X-ray diffraction experiments were performed by Dr. Gary Parkinson on an Oxford
Diffraction, Xcalibur microfocus NovaT X-ray diffractometer, using Cu Kα radiation. Titan
CCD image data were processed by CrysalisPro (Agilent Technologies), and the
structure was solved by direct methods using ShelXS238 and refined using SHELXL.239
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All non-hydrogen atoms were refined by full-matrix, least squares with anisotropic
temperature factors, with hydrogen atoms positioned using normal geometry.
4.2.5. Powder X-ray Diffraction (PXRD)
PXRD was carried out at room temperature on a Rigaku Miniflex 600 diffractometer at
40 kV and 15 mA fitted with a CuKα source, over the range 3 to 50° with a 0.02° step
size and 2° min-1 scan rate.
4.2.6. Differential scanning calorimetry (DSC)
DSC measurements were performed on a TA Instruments Q2000 machine. Samples
were loaded into Tzero aluminium pans with non-hermetic lids. Calibration was
performed with a certified indium standard according to the manufacturer’s instructions.
Samples were heated to a maximum of 220°C at 10°C min-1 with a nitrogen purge of
50mL min-1.
4.2.7. DSC-XRD
DSC-XRD data were collected and analysed using the methods described in Chapter 2.
4.2.8. Single crystal growth via solvent evaporation
INCT and each of the co-formers were combined in molar ratios determined by work
carried out previously in the group and specified in Table 4-1, and dissolved in ethanol
to the highest concentration possible (i.e. ethanol was added whilst stirring until all solids
had dissolved). The solutions were transferred to glass vials sealed with Parafilm. The
Parafilm was pierced with a needle to allow the solvent to evaporate. Further
experiments were performed where in place of the glass vials solutions were transferred
to 96-well polymerase chain reaction (PCR) plates, which were covered with Parafilm
and pierced in the same manner.
Samples were stored at ambient temperature in a fume cupboard, 9 °C in an incubator,
5 °C in a fridge, or 4 °C in an incubator. Selected single crystals were analysed by XRD.
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4.2.9. Thermal inkjet printing
Solutions (3 % w/v in 10 mL of a solvent system comprising EtOH; EtOH:H2O, 9:1 (v/v);
EtOH:H2O, 7:3 (v/v)) of each of the binary mixtures were loaded into an empty HP 344
Tri-color ink cartridge (foam removed) in an HP Officejet 100 mobile printer. A 10 cm x
10 cm square was printed onto an A4 acetate sheet at 300 dpi (fast draft) with 20
overlays. The printed crystals were removed from the acetate sheet with a spatula and
analysed with FTIR, PXRD, TGA and DSC. A more detailed description of the method
used can be found in the literature.240
4.2.10. Heat induced co-crystallisation
Binary mixtures of INCT and the four co-formers in the ratios described in Table 4-1 were
prepared using a vortex mixer. A second set was prepared by grinding each of the
components separately in a pestle and mortar for 30 seconds. Both sets were analysed
by FTIR, PXRD and TGA prior to heating to rule out any spontaneous interactions or any
caused by the mixing process. Samples were heated by DSC using the instrument and
parameters described in Section 4.2.4. The experiments were repeated using the DSC-
XRD experimental set up described in Chapter 2.
4.2.11. Co-crystallisation by ball milling
As received samples of all raw materials were loaded into the grinding jar of a Retsch
MM 200 ball mill and milled at 20 Hz for 15 minutes, INCT and LABA were milled for 1
minute as any longer resulted in vitrification.
4.3. Results and Discussion
4.3.1. Crystallisation from Solution
Attempts were made to grow co-crystals of INCT with the four co-formers by evaporation
from solution in ethanol. The aim was not to investigate an exhaustive collection of
methods and solvents in an effort to grow single crystals, but rather to produce single
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co-crystals using the simplest procedures possible. A prior study has shown INCT and
HBA are amenable to co-crystallisation from hot methanol,232 however there are no
reports of co-crystal formation between INCT and any of the other three materials.
Although, previous work in the group has produced co-crystals between INCT and
DHPAA.
Many attempts were made at growing co-crystals from each of the four systems, initially
with limited success due to the rate of solvent evaporation. The best results were
obtained by transferring the solutions to 96-well PCR plates and storing at 4 °C. Single
crystals of sufficient quality for structure determination were grown between INCT and
the remaining three co-formers. Diffraction data for each of the co-crystals grown can be
seen in Table 4-2.
Table 4-2. Structural information for co-crystals of INCT with four co-formers (HBA, HPAA,
DHPAA, and LABA) and a model from the CSD (VAKTOR).232 All experimental crystals were




Crystal system Monoclinic Monoclinic Triclinic Triclinic Orthorhombic
INCT:co-former
ratio
1:1 1:1 2:1 1:1 1:2
T / °C -120 -166 -73 - -168
Space group P21/c P21/c P-1 P-1 P212121
a / Å 6.0729(1) 10.5720(3) 6.7543(6) 5.4891(3) 5.1690(5)
b / Å 9.4013(2) 29.8495(9) 12.3422(14) 9.8742(6) 11.4943(9)
c / Å 22.0762(4) 7.6215(3) 12.6520(12) 13.1825(9) 33.570(2)
α / ° 90 90 111.976(10) 71.679(6) 90
β / ° 111.185(10) 97.887(3) 96.764(8) 82.455(5) 90
γ / ° 90 90 99.604(9) 89.408(4) 90
Cell volume / Å3 1260.40 2382.36 945.448 672.04 1994.53
Z 4 4 4 2 4
R-Factor 0.0411 0.0422 0.0527 0.0475 0.0620
*INCT–DHPAA crystals were grown by Dongpeng Yan. **Inspection of the structure following
refinement indicates that INCT and LABA reacted rather than co-crystallised.
4.3.1.1. INCT-HBA
Of the four systems, only INCT–HBA has previously been shown to form co-crystals.
When compared to the literature structure (VAKTOR) it is immediately obvious from the
data in Table 4-2 that the crystal grown in the experiments reported here is not the same
as that reported by Vishweshwar et al232 and must therefore be another polymorph.
The previously reported co-crystal between INCT and HBA has been described as
forming zigzag tapes through phenol···pyridine heterosynthons and acid···amide R22-
(8)241 bimolecular cyclic hydrogen-bonded motifs, with adjacent tapes being held
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together by N–H···O hydrogen bonds from acid to amide and other weak C–H···O
interactions (Figure 4-2 (a)).232 The co-crystal grown here (Figure 4-2 (b)) forms similar
tapes via phenol···pyridine heterosynthons and acid···amide R22(8) heterosynthons as
well as acid···acid and amide···amide R22(8) homosynthons, with adjacent tapes
interacting through N–H···O hydrogen bonds from acid to amide. However the
interactions in the new co-crystal extend to form pseudo-sheets that stack along the b
axis rather than just tapes.
Figure 4-2. Structures of (a) VAKTOR and (b) the INCT-HBA co-crystal grown from solution in
this work.
Simulation of interactions in the raw materials and VAKTOR from single crystal data
shows that the amide of pure INCT (Figure 4-3 (a)) is involved in two hydrogen bonds,
one for each hydrogen, whereas in the co-crystal (Figure 4-3 (b)) one of the hydrogens
acts as a donor for two H-bonds and so the amide forms three in total. HBA also
experiences a change in H-bonding (Figure 4-3 (c)) with the phenolic hydroxide group
reducing its interactions from two to one and the carboxyl hydroxide gaining an H-bond
through interactions as both donor and acceptor with two INCT molecules. The carbonyl
oxygen also gains an interaction and becomes an acceptor for two INCT molecules at
the amide. Also depicted in Figure 4-3 (d) are the two bonding environments in which
INCT and HBA sit in the new co-crystal grown in this work, although this crystal was not
observed in the printed samples.
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Figure 4-3. Graphical representation of the asymmetric unit of (a) INCT polymorph I
(EHOWIH01),242 (b) the previously reported structure of INCT-HBA (VAKTOR),232 (c) HBA,243
and (d) the new INCT-HBA co-crystal grown in this work showing hydrogen bonding.
4.3.1.2. INCT-HPAA
The dominating features of the structure of the INCT-HPAA co-crystal grown from
solution can be seen in Figure 4-4. As with the two INCT-HBA co-crystals the molecules
are arranged in tapes. The tapes are formed via acid···pyridine heterosynthons at either
end of the HPAA terminated by amide···amide R22(8) homosynthons and are linked
together by N–H···O hydrogen bonds from the amide to the acid group of the HPAA and
also between adjacent INCT molecules.
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Figure 4-4. Structure of INCT-HPAA co-crystal.
The asymmetric unit of the co-crystal (Figure 4-5 (a)) has two INCT molecules and one
HPAA. Each of the two INCT molecules has slightly different H-bonding. One molecule
has five associated H-bonds, with four interactions around the amide in a similar pattern
to that of the pure INCT crystal (Figure 4-3 (a)), and acts as an acceptor at the cyclic
nitrogen to the hydrogen of the phenolic hydroxide of HPAA. The other INCT unit has
only three H-bonds at the amide group, with the carbonyl losing one, and an interaction
at the cyclic nitrogen with the carboxylic hydroxide.
Figure 4-5. Graphical representation of the asymmetric unit of an INCT-HPAA co-crystal grown
by evaporation from solution in ethanol, showing hydrogen bonding.
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Hydrogen bonding around the HPAA molecule in the co-crystal (Figure 4-5 (b)) is largely
similar to that of the pure crystal except for the loss of one bond at the phenolic hydroxide
group, where the oxygen no longer acts as an acceptor.
4.3.1.3. INCT-DHPAA
INCT and DHPAA do not form any of the R22 (8) observed in the structures of INCT-HBA
and INCT-HPAA. Instead they form staggered chains (Figure 4-6 (a)) with alternate INCT
and HPAA molecules linked by phenol···acid and phenol···pyridine hydrogen bonds. The
chains are cross-linked by N–H···O and O–H···O hydrogen bonds between molecules
of alternating species.
Figure 4-6. Structure and bonding in INCT-DHPAA viewed down (a) the a axis and (b) the b
axis.
In the pure DHPAA crystal244 each of the hydroxyl groups are involved in two H-bonds
(Figure 4-7), with the hydroxyl in the 3 position acting as a hydrogen donor for two bonds
and the other two OH groups acting as both donors and acceptors for two molecules.
The carbonyl oxygen is also involved in two H-bonds as an acceptor. This pattern of
interactions is very different to that observed in the co-crystal (Figure 4-8), where each
of the oxygen containing functional groups are involved in only one H-bond. All of the
hydroxyls act as hydrogen donors and the carbonyl acts as an acceptor.
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Figure 4-7. Graphical representation of the asymmetric unit of the previously reported structure
of DHPAA,244 showing hydrogen bonding.
Figure 4-8. Graphical representation of the asymmetric unit of an INCT-DHPAA co-crystal
grown by evaporation from solution in ethanol by Dongpeng Yan, showing hydrogen bonding.
Changes in H-bonding around the INCT molecule (see Figure 4-3 for the asymmetric
unit of polymorph I and the associated bonding) are fewer than around DHPAA, with only
one of the amide hydrogens acting as a donor and the cyclic nitrogen acting as an
acceptor for a new H-bond. The carbonyl oxygen acts as an acceptor for two interactions
in both the pure INCT I crystal and the INCT-DHPAA co-crystal.
4.3.1.4. INCT-LABA
Structural refinements (Figure 4-9) of the crystal grown from a solution of INCT and LABA
revealed the materials had reacted and crystallised, with proton transfer occurring from
one of the OH groups on the ring structure of LABA to the nitrogen on the pyridine of
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INCT. As the aim was to form co-crystals without reactions the crystal structure will not
be discussed further.
Figure 4-9. A graphical representation of the relationship between the INCT (right) molecule and
one of the LABA molecules (left) from the crystal grown between the two. The gold sphere
represents a hydrogen that appears to have undergone proton transfer from LABA to INCT.
4.3.2. Thermal inkjet printing
4.3.2.1. INCT-HBA
PXRD
Crystals were formed when printing three ethanolic solutions of INCT and HBA in
equimolar proportions. There are a number of different variables that can be adjusted
when using thermal inkjet printing as a technique for printing crystals. Figure 4-10
displays a number of diffraction patterns recorded for crystals collected from acetate
sheets following printing from ethanolic solutions of equimolar mixtures of INCT and
HBA. Initially it was necessary to establish the best print settings with respect to the
number of dots of solution being printed per inch of acetate (dpi). The two standard
settings are 300 dpi and 600 dpi and so crystals were printed using each. The peak
shape and intensity to noise ratio was similar for both print resolutions, however the
higher resolution setting (600 dpi) resulted in a high volume of solution being printed onto
the acetate and so the sheets were very wet when ejected from the printer, consequently
a smearing of the solution was observed, which may have affected the crystal growth.
There was also one extra reflection (2θ = 16.5°) observed in the diffraction pattern
recorded using this setting compared to those recorded at 300 dpi. This reflection is not
present in either of the starting materials or any of the patterns recorded from crystals
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formed using different settings, and is believed to be an unknown impurity. It was
therefore decided to continue the experiments using 300 dpi.
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Figure 4-10. Diffraction patterns for crystals printed from equimolar solutions of INCT and HBA in EtOH, and EtOH and water.
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The second variable was the rate of evaporation of the solvent. Crystals were printed
from solutions of 100 % ethanol or mixtures of ethanol and water in ratios of either 9:1
v/v % or 7:3 v/v % respectively. Water was added to slow the evaporation of the solvent
after printing and so slow the rate of crystallisation in an effort to encourage co-
crystallisation. The three patterns recorded for 20 layers of crystals printed at 300 dpi
(Figure 4-10) are clearly all representative of the same crystal structure and so it was
decided to continue the experiments using solutions in ethanol without water. Crystals
were printed over 20 layers so that sufficient material could be collected for analysis.
The diffraction patterns recorded for the crystals following printing have some significant
differences to those of the raw materials (Figure 4-11). There are unique reflections
present in the printed crystals at 13.0°, 16.0°, and 28.8° that are absent in the raw
materials. There are also significant absences of raw material reflections in the patterns
collected from the printed material, at 21.0°, 24.5°, and 30.9°. When compared to the
predicted powder pattern of the structure of the known crystal from the CSD
(VAKTOR)232 and that of the crystal formed by solvent evaporation and discussed in
Section 4.3.1 (Figure 4-12) it is clear that the pattern of the printed crystals is similar to
the previously reported co-crystal. The data recorded here are of much lower resolution
due to the small crystal size and sample size but all of the reflections occur at the correct
2θ angles and the intensity ratios are also very similar to those of the known structure.
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Figure 4-11. Diffraction patterns for INCT I, HBA, a physical mixture of the two and crystals printed from an equimolar ethanolic solution of the two.
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Figure 4-12. Diffraction pattern recorded for crystals of INCT-HBA. Tick marks show the positions of allowed reflections for VAKTOR.
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DSC and TGA
Results of the DSC analyses of these crystals can be seen in Figure 4-13. All three of
the thermograms relating to the printed mixtures show a single endotherm with an onset
at 181-182 °C followed by a steady drop in heat flow, caused by decomposition of the
material at temperatures above 190 °C. The lack of events prior to the endotherm at 181
°C suggests that the crystals are stable at low temperatures. Thermograms for the raw
materials exhibit endotherms with onsets at the melting points of each of the two
components (157 °C, INCT II; 215 °C, HBA), with an additional small endotherm (onset
115 °C) in the INCT data representing a conversion from polymorph I to polymorph II. It
is particularly significant that neither of the endotherms observed in the trace for INCT
are seen after printing. Consequently the INCT must be involved in some kind of
interaction that prevents these events occurring, i.e. formation of a co-crystal. The sharp
endotherm at ca.181 °C for the products of printing indicates that there is melting
occurring. This event occurs at a higher temperature than the reported melting point of
form II of INCT245–247 and is not present in the trace associated with HBA and so suggests
the formation of a co-crystal.
Figure 4-13. DSC thermograms for crystals formed by inkjet printing a solution of INCT and HBA
in EtOH, EtOH and H2O (9:1 v/v), and EtOH and H2O (7:3 v/v) and the two raw materials; INCT
and HBA.
173
Examination of the TGA data (Figure 4-14) shows that decomposition of the printed
crystals begins at a lower temperature than either of the individual components, and also
that of a physical mixture of the two. It also levels off at around 20 % mass rather than
continuing to decay to 0 %, suggesting that printing has resulted in some kind of
interaction.
Figure 4-14. TGA traces for INCT, HBA, a mixture of INCT and HBA, and crystals printed from a
solution of INCT-HBA in EtOH.
FTIR spectroscopy
A spectrum was recorded for a physical mixture of the two raw materials (Figure 4-15)
and compared to that of the printed crystals to ensure that they were not simply a physical
mixture of the two components with no new interactions. The two spectra have significant
differences between 3100 cm−1 and 3500 cm−1, which suggests that co-crystals have
formed. There are no significant differences observed below 1800 cm−1.
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Figure 4-15. FTIR spectra for a physical mixture of INCT and HBA and crystals printed from an
equimolar ethanolic solution of INCT and HBA.
FTIR spectra for the raw materials and the printed crystals can be seen in Figure 4-16.
The most obvious difference between the spectra is a significant shift of the sharp N—H
stretch peak at 3360 cm−1 in INCT to 3455 cm−1 in the printed crystals, which occurs with
a concomitant reduction in intensity of the second N—H stretch in INCT (3180 cm−1) and
the broad strong O—H stretch seen at 3360 cm-1 in the HBA spectrum. The rest of the
spectrum of the printed crystals displays all of the peaks associated with the raw
materials, as would be expected, with the exception of the region between 1200 cm−1
and 1300 cm−1 where there is a slight shift to a lower wavenumber of the band relating
to the C—O bond of the carbonyl of HBA.
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Figure 4-16. FTIR spectra for INCT, HBA and crystals printed from an equimolar ethanolic
solution of the two.
All of the shifts described are consistent with a change in hydrogen bonding interactions
within the materials and support the formation of a co-crystal. Furthermore, simulation of




Examination of diffraction patterns collected for crystals printed from three solutions of
INCT and HPAA (molar ratio: 2:1) in either ethanol or ethanol and water in two different
ratios (Figure 4-17) reveals that all three solutions resulted in crystals with the same
structure. The Bragg reflections all occur at the same 2θ angles and the intensity ratios
are all similar. Unlike INCT-HBA, the addition of water to the solution does appear to
have improved the quality of the crystals slightly. The reflections of the pattern for crystals
printed from EtOH:H2O (7:3 v/v) solution are better resolved and they are slightly
narrower than those of the other two solutions. Also, the intensity to noise ratio is higher,
as can be seen when looking at the lower intensity reflections at 7.5°, 14° and 17°.
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Figure 4-17. Powder diffraction patterns for crystals printed from ethanolic solutions of INCT and HPAA in a molar ratio of 2:1 respectively.
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Powder diffraction patterns were recorded for both INCT and HPAA as well as for a
physical mixture of the two in molar ratio of 2:1. When compared to the pattern recorded
for the printed crystals (Figure 4-18) the positions of reflections and their intensities are
very different. Had there been no interactions and had the two components recrystallized
from solution into separate crystal entities then the pattern collected should consist of
Bragg reflections with 2θ angles matching the patterns of the raw materials and with
similar intensity ratios. This however is not the case. Particularly obvious is the absence
of reflections from INCT I in the data for the printed crystals at 23.4°, and 30.9° and 11.3°,
and at 30.3° from HPAA. There are also characteristic reflections of the printed crystals
at 7.6°, 14.0°, 16.8°, and 21.9° which do not appear in the raw materials.
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Figure 4-18. Diffraction patterns for INCT, HPAA, a 2:1 molar ratio physical mixture of the two, and crystals printed from a 2:1 molar ratio solution of INCT and HPAA
in EtOH:H2O (7:3 v/v).
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It is possible that the two materials may have crystallised separately into different
polymorphs from those recorded prior to dissolution. For this reason the printed crystal
pattern was compared to powder patterns (Appendix 2) of the known polymorphs of the
two components. These patterns were predicted from structures collected from the CSD
(INCT: EHOWIH01-05; HPAA: QAPBAL) and none were a good match.
Finally, the printed crystal pattern was compared to the powder pattern predicted from
the refined structure of the single crystal grown by solvent evaporation and discussed in
Section 4.3.1 (Figure 4-19). The quality of the collected pattern was not such that
refinements could be carried out, due to the small size of the crystals produced by inkjet
printing. However, the pattern of the printed crystals agrees well with the predicted
pattern. The profiles of the patterns are very similar, albeit with much lower resolution for
the printed crystals, and the ratios of intensities are also very similar for both. Diffraction
for the printed crystals occurs at slightly lower angles than for the single crystal data.
This is simply a result of the temperature difference between the measurements. Data
for the printed crystals were collected at ambient temperature (ca. 25 °C), whereas the
single crystal data were collected at -73 °C. At higher temperatures the unit cell of the
crystal would be larger, resulting in larger d-spacings and so lower angles of diffraction.
Had more crystals been printed or longer collection times been used then it may have
been possible to resolve more of the peaks to increase confidence in the similarity of the
patterns. Nevertheless, the data quality is sufficient to suggest that the two materials
have the same structure, especially considering the differences when compared to
powder patterns for all of the known polymorphs of the two contributing materials.
180
Figure 4-19. Powder diffraction pattern for crystals printed from a solution of INCT:HPAA (2:1 molar ratio) in EtOH:H2O (7:3) and a predicted powder pattern for
crystals grown from a similar solution by solvent evaporation.
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DSC and TGA
As with the crystals printed from INCT and HBA the DSC traces (Figure 4-20) for crystals
printed from solutions of INCT and HPAA in ethanol and ethanol/water have a different
profile to those of the raw materials. All three of the printed crystal thermograms have
only one endothermic event with an onset at 125-126 °C and an enthalpy of ca. 150 J
g−1. It is likely that this event is the melting of the co-crystal formed between the two
components. The highest temperature melting endotherms for INCT and HPAA have
onsets at 157 °C and 150 °C and have associated enthalpies of fusion of 184 J g -1 and
194 J g-1 respectively. These temperatures and enthalpies are much higher than those
observed for the printed crystals. It is unlikely that the combination of INCT and HPAA
would have had such a destabilising effect on each other that they would both melt
simultaneously more than 24 °C below their reported melting points.
Figure 4-20. DSC thermograms for crystals formed by inkjet printing a solution of INCT and
HPAA in EtOH, EtOH and H2O (9:1), and EtOH and H2O (7:3) and the two raw materials; INCT
and HPAA.
INCT has another endotherm with an onset at 115 °C with an enthalpy of 13 J g-1.
However, this occurs around 10 °C lower than the event in the traces of the proposed
co-crystals and the enthalpy is lower by a factor of more than 11. These data strongly
suggest the occurrence of intermolecular interactions between molecules of the two
components, particularly the presence of a single endotherm in the DSC trace of the
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printed crystals. TGA data show that the printed crystals begin to lose mass at
temperatures 25-30 °C below that recorded for either of the crystalline components
individually or in a physical mixture at the same ratio used for printing and solvent
evaporation (Figure 4-21). This offers support to the summation that a co-crystal has
been formed by inkjet printing, although sample size may be a factor as the printed
crystal mass was much less than that of either of the raw materials.
Figure 4-21. TGA data for INCT, HPAA, a physical mixture of the two and crystals printed from
an ethanolic solution of the two.
FTIR spectroscopy
The IR spectrum for a physical mixture of INCT and HPAA in a 2:1 molar ratio is
compared to the spectrum for the printed crystals in Figure 4-22. There are clear
differences, suggesting that the printed crystals are not simply a mixture of the two
materials but that there are intermolecular interactions between the two different
molecules.
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Figure 4-22. FTIR spectra for a physical mixture of INCT and HPAA and crystals printed from a
2:1 molar ratio EtOH:H2O (7:3 v/v) solution of INCT and HPAA.
Comparison of the FTIR spectra of the printed crystals and raw materials (Figure 4-23)
reveals that there have been some band shifts. INCT has two strong bands at 3355 cm−1
and 3175 cm−1 characteristic of stretching of N—H bonds in a primary amide. HPAA has
a strong band at 3245 cm−1 resulting from the stretching of the O—H bond of the alcohol
in the O1 position (Figure 4-24) and a much broader medium intensity band peaking at
2990 cm−1 relating to the stretching of the carboxylic acid O—H bond. The N—H bands
of the INCT have not shifted, but the bands relating to the O—H bonds in HPAA have
moved to higher wavenumbers by 150 cm−1 and 110 cm−1 respectively.
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Figure 4-23. FTIR spectra for INCT, HPAA and crystals printed from a 2:1 molar ratio solution of
the two in EtOH:H2O (7:3).
Changes at lower wavenumbers are more complex, with the most significant being the
shift of the sharp medium intensity band at 1445 cm−1 in the spectrum for HPAA to a
higher wavenumber and the presence of a new sharp absorbance in the crystals at 1275
cm−1 (relating to the C—O bond of the carbonyl group of HPAA). Due to the complexity
of the region below 1800 cm−1 it is difficult to identify this band in the spectra of the raw
materials. There is also a smaller shift to a higher wavenumber of the strong sharp band
at 1655 cm−1 for INCT and to a lower wavenumber for that at 1705 cm−1 for HPAA, both
are associated with the C=O double bond. From these observations it appears that the
carboxyl group of HPAA has undergone significant changes in relation to the
intermolecular bonding, a finding consistent with the formation of a co-crystal.
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Figure 4-24. The HPAA molecule.
Simulation of the hydrogen bonding confirms the changes seen in the FTIR data.
Bonding at the amide is very similar in both the co-crystal and pure INCT and so the lack
of shift of the associated bands in the IR spectra is unsurprising. The loss of a bond at
the carbonyl in half of the INCT molecules explains the small shift in the band at 1655
cm−1.
The largest of the shifts observed in the IR data may be explained by the change in
bonding around the phenolic hydroxide group discussed in Section 4.3.2.2.1. The shift
in the band at 1705 cm−1 relating to the C=O bond is probably a result of the change in
donor identity. In the pure HPAA crystal the bond donor is the hydrogen from the phenolic
hydroxide group, whereas in the co-crystal it is a hydrogen from the amide of INCT.
4.3.2.3. INCT-DHPAA
PXRD
Equimolar solutions of INCT and DHPAA in either ethanol or ethanol and water all
produced powders suitable for analysis. Comparison of the three diffraction patterns
(Figure 4-25) confirms that all three solutions produced crystals with the same structure.
Those printed from ethanol appeared to be very low density and had a very “fluffy”
appearance when removed from the acetate sheet onto which they were printed. This
resulted in them being very difficult to handle and also meant that forming a flat bed of
crystals in the PXRD sample holder was not possible. The material appears to have poor
crystallinity, evident from the low intensity to noise ratio of the reflections and the poor
resolution and peak shape. Conversely, the patterns recorded for crystals grown in
mixtures of ethanol and water are much better. The reflections are well resolved, with
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narrow peak shapes and higher intensity to noise ratios. These crystals appeared to
have a much higher density when removed from the acetate sheet and were generally
much easier to handle. The superior quality of these crystals may be due to the slower
growth caused by the addition of water to the solutions, which reduces the rate of solvent
evaporation after printing. The quality of the crystals printed from both solutions with
water was very similar, but the resolution of the reflections in the pattern for the 9:1
(EtOH:H2O) solution is higher and so all further analysis will be discussed in relation to
these crystals.
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Figure 4-25. Diffraction patterns for crystals printed from equimolar solutions of INCT and DHPAA in EtOH, EtOH with 10 % v/v water and EtOH with 30 % v/v water.
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Comparison of patterns recorded for the printed crystals, the raw materials separately
and a physical mixture of the two can be seen in. The pattern for the printed crystals is
clearly very different to those of the raw materials. The reflections of the printed crystals
at 7.1°, 16.9°, and 23.9° do not appear with either of the raw materials, and the reflection
at 24.6° in the printed crystals’ pattern has a much higher relative intensity than any in
the other patterns at the same angle. Additionally, there are reflections in the data for the
raw materials that are absent in the printed crystals (at 10.9°, 20.9°, 25.8°, 26.1°, and
30.8°). The differences in diffraction patterns are indicative of different crystal structures,
and strongly suggest the formation of a co-crystal.
DHPAA has only one known polymorph but INCT has five and to ensure that it had not
simply crystallised into a different polymorph from that recorded prior to dissolution the
printed crystal pattern was compared to powder patterns of the known polymorphs
(Appendix 3). These patterns were predicted from structures collected from the CSD
(EHOWIH01-05) and none were a good match.
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Figure 4-26. Diffraction patterns for INCT, DHPAA, a physical mixture of the two and crystals printed from an equimolar solution of the two in ethanol and water (9:1).
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Refinement of the structure of a single co-crystal of INCT-DHPAA grown previously in
the group248 was used to create a predicted powder pattern, which is compared to the
pattern recorded for the printed crystals in Figure 4-27. Despite the lower resolution of
the pattern for the printed crystals it can be seen that Bragg reflections occur at very
similar angles for both, and the intensity ratios are also strikingly similar. It appears from
these data that the printed crystals have the same structure as that grown slowly by
solvent evaporation.
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Figure 4-27. Powder diffraction pattern for crystals printed from an equimolar solution of INCT:DHPAA in EtOH:H2O (9:1 v/v) and a predicted powder pattern for
crystals grown by solvent evaporation from an equimolar ethanolic solution by Dongpeng Yan.
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DSC and TGA
DSC thermograms recorded for crystals printed from solutions of INCT and DHPAA can
be seen in Figure 4-28. The thermograms for samples of crystals printed EtOH and 9:1
v/v EtOH/water display endothermic events, with onsets at 118.8 °C and 118.6 °C, peaks
at 122.3 °C and 122.2 °C, and enthalpies of 95.4 J g−1 and 112.0 J g−1 respectively. The
crystals printed from the EtOH:H2O 7:3 solution have an endotherm in a similar position,
with a peak at 120.9 °C, and also a smaller endotherm just prior to this with an onset of
ca. 99.6 °C (Figure 4-28, inset). This may indicate the occurrence of a phase transition
immediately prior to the second endotherm. The lower temperature event appears as a
shoulder to the second much larger event, and as a result it is not possible to accurately
analyse the onset or enthalpies of either of the endotherms in this trace. The larger of
the two events is probably the same as is observed in the thermograms of the crystals
printed from the other two solutions, albeit occurring at a slightly lower temperature. This
earlier onset may be a result of destabilisation caused by the prior event.
Figure 4-28. DSC thermograms for crystals formed by inkjet printing ethanolic solutions of INCT
and DHPAA, and the two raw materials; INCT and DHPAA. The inset plot shows a magnified
view of the endothermic events in the trace for the sample printed from EtOH:H2O (7:3) solution.
It is likely that the large endotherms in all three of the traces for the printed crystals are
a result of the melting of co-crystals formed by printing. As was observed for INCT-HPAA,
the melting endotherms of the two raw materials occur at higher temperatures and with
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much higher associated enthalpies of fusion (INCT: 157 °C, 184 J g−1; DHPAA: 128 °C,
200.6 J g−1) than those of the printed crystals.
TGA analysis (Figure 4-29) shows that the printed crystals decompose at a temperature
higher than INCT but lower than DHPAA or a physical mixture of the two components.
This different behaviour, particularly in relation to the mixture, lends support to the theory
that a co-crystal has formed in the printing process.
Figure 4-29. TGA data for INCT, DHPAA, a physical mixture of the two and crystals printed
from an ethanolic solution of the two.
FTIR spectroscopy
Comparison of the FTIR spectra for printed crystals and a physical mixture of INCT-
DHPAA (Figure 4-30) reveals differences in the materials. The broad band between 3150
cm−1 and 3400 cm−1 is narrower for the printed sample and the band at 3450 cm−1 in the
spectrum for the mixture is missing from the crystals’ data. There is a band at 1730 cm−1
for the printed sample that is absent from the mixture, and there is a band missing from
the printed spectrum at 995 cm−1 (Figure 4-30, inset). Therefore it can be assumed that
the printed crystals are not simply a physical mixture and that there are new interactions
occurring.
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Figure 4-30. FTIR spectra for a physical mixture of INCT and DHPAA and crystals printed from
an equimolar solution of INCT and DHPAA in ethanol and water (7:3 v/v). Inset: data from 900
to 1200 cm−1.
Spectra for the printed crystals and the two raw materials can be seen in Figure 4-31. At
the higher wavenumbers similar behaviour can be seen to that of INCT-HPAA. The two
INCT N—H bands at 3360 cm−1 and 3180 cm−1 appear to experience a small shift to
lower and higher wavenumbers respectively, when printed with DHPAA. The sharp
strong O—H bands, associated with the hydroxyl groups on the benzene ring of DHPAA,
both shift to lower wavenumbers following printing. This is also the case for the broad
medium intensity band at 3000 cm−1 representing the acidic O—H, which undergoes a
large shift to 2500 cm−1. This suggests that changes in interactions involving the OH
groups of the DHPAA, of which there are three, are more significant than those involving
the amide of the INCT. Changes in the fingerprint region are far more complex and
difficult to assign. All of the IR shifts outlined can be accounted for by the changes in
intermolecular interactions described in Section 4.3.2.3.1.
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Figure 4-31. FTIR spectra for INCT, DHPAA and crystals printed from an equimolar solution of
the two in ethanol and water (9:1).
4.3.2.4. INCT-LABA
PXRD
Crystals produced by printing equimolar solutions of INCT and LABA in EtOH and EtOH
with either 10 % or 30 % v/v water all produced patterns with reflections occurring at the
same angles (Figure 4-32). The intensity to noise ratio is higher and the peak resolution
of the patterns collected for crystals printed from the solutions in EtOH and EtOH with 10
% v/v water is far higher than those of the crystals printed from EtOH with 30 % v/v water.
This may be a product of the longer evaporation time due to the higher water to ethanol
ratio of the solvent, resulting in more disruption of the crystal growth as the acetate sheet
remained wet for longer than the other two samples. This opposes the behaviour
observed for the INCT-DHPAA system. However, it appears that the products from all
three printing processes are the same, as all of the Bragg reflections occur at the same
angles in each of the three patterns and the intensity ratios are similar.
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Figure 4-32. Diffraction patterns for crystals printed from equimolar solutions of INCT and LABA in EtOH, EtOH with 10 % v/v water and EtOH with 30 % v/v water.
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As with the three previous samples it was necessary to compare the patterns of the
printed crystals to those of the raw materials and a mixture of the raw materials to confirm
that the printed crystals were not just a physical mixture of the two components. Crystals
printed from solution in ethanol produced diffraction patterns with the narrowest peak
shape and highest resolution and so these were used for all further analysis. Data are
presented in Figure 4-33. There are major differences between the diffraction patterns
of the printed crystals and the raw materials. The most obvious being the absence in the
printed crystal data of the main reflection of LABA at 10.5°. This is a very high intensity
reflection in both the patterns for LABA and the physical mixture and so its absence
suggests a change in the structure of LABA. It should be noted that although the
reflection in the pattern for LABA at 15.7° is absent in that of the printed crystals it is also
absent from the pattern for the physical mixture, and cannot therefore definitely be
ascribed to a change in structure; more likely its disappearance is caused by preferred
orientation. The remaining three high intensity reflections from the LABA pattern,
between 27.5° and 30.5°, are also absent from the pattern of the printed crystals and so
it appears that its structure must have changed in the printing process.
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Figure 4-33. Diffraction patterns for INCT, LABA, a physical mixture of the two and crystals printed from an equimolar solution of the two in ethanol.
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Differences from INCT I are more subtle. The two main reflections at 17.6° and 23.3°
cannot be distinguished from reflections at the same angles in the pattern of the printed
crystals, and neither can any of the lower intensity reflections. There are however new
reflections present in the pattern for the printed crystals at 7.6°, 19.1°, 23.6°, and 24.6°.
These differences indicate the formation of a co-crystal has occurred between the two
materials, although it may be that INCT has recrystallised to the same form as the initial
material and LABA has crystallised to a new form. However, there is currently only one
LABA structure reported in the literature. More likely, it seems that there may have been
excess INCT in the initial mixture and that this has recrystallised to INCT I while the rest
of the material has co-crystallised.
Comparison of the diffraction data for the printed crystals with that predicted from the
single crystal reaction product grown by solvent evaporation can be seen in Figure 4-34.
The two patterns are clearly different, even if the presence of INCT I is taken into account.
The PXRD data therefore indicate that inkjet printing has resulted in a structural change
to LABA, but not the chemical reaction that took place in the solvent evaporation
experiments. However it cannot be definitively concluded that a co-crystal has formed
between the two materials due to the similarities in the pattern of the printed crystals and
that of INCT prior to printing, and the differences between the printed crystal data and
the single crystal data.
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Figure 4-34. Powder diffraction pattern for crystals printed from an equimolar solution of INCT:LABA in EtOH and a predicted powder pattern for crystals grown by
solvent evaporation from an equimolar ethanolic solution.
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DSC and TGA
DSC data for crystals printed from INCT and LABA are presented in Figure 4-35. The
crystals printed from ethanol have what appears to be a small endotherm with an onset
at ca. 42 °C. On closer inspection (Figure 4-35 (b)) it was concluded that there is a
concurrent step change in the baseline at this point, which results from a change in heat
capacity of the solvent and is characteristic of a glass transition in an amorphous
material. The endotherm at the same position is a result of enthalpic relaxation of the
amorphous portion of the sample. This event is visible in the traces from the other printed
samples, but it is so small it can barely be seen. This indicates that the printing process
results in the vitrification of some of the material, however it is not clear whether it is one
or both of the components.
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Figure 4-35. DSC thermograms for (a) crystals formed by inkjet printing solutions of INCT and
LABA and the two raw materials; INCT and LABA, (b) an enlarged plot of the Tg region of the
crystals printed from solution in ethanol, and (c) an enlargement of the trace for crystals printed
from solution in water and ethanol (7:3 v/v).
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At ca. 80 °C, in all three traces, there is a small exotherm. It is so small that it is not
possible to measure the onset temperature or associated enthalpy. It is likely that this is
caused by the crystallisation of the amorphous material that caused the Tg.
Immediately following this crystallisation in the data for the crystals printed from ethanol
with 30 % water (Figure 4-35 (c)) is an endotherm, which peaks at ca. 105 °C. This is
not present in either of the other two traces and occurs at too low a temperature to be
either of the two raw materials melting.246,249 It may however represent melting of a
metastable polymorph of a co-crystal that has formed.
Above 110 °C events in all three traces are similar and consist of two endotherms,
although these occur ca. 20 °C lower for the crystals printed from the 7:3 v/v solution.
For the other two samples the first of these endotherms (onset 139-140 °C) has a higher
enthalpy (125-129 J g−1) than the second and occurs at a temperature lower than either
of the two raw materials, and so must be the result of a new structure forming. The
highest temperature endotherm has an onset of 147 °C with an enthalpy of 24-28 J g−1.
This second endotherm has an onset 10 °C lower than that of INCT and 46 °C lower
than LABA. It is possible that there may have been residual INCT present following
printing and that the presence of the co-crystal has supressed its melting point resulting
in the second endotherm. It is also possible that first endotherm corresponds to the
melting of a metastable form, which then crystallised to the most stable form, and finally
the latter melted, with the exotherm of crystallisation being hidden by the two large
endotherms relating to fusion. The similarity of the two data sets of the crystals printed
from solutions of higher proportions of ethanol is such that the materials produced must
be the same. The differences and poor quality of the other sample is a consequence of
slower solvent evaporation resulting from excess water.
FTIR spectroscopy
Figure 4-36 shows FTIR spectra for crystals printed from an INCT-LABA solution in
ethanol and a physical mixture of the two components. There are a few very obvious
differences. There is a small sharp band at 3525 cm−1 in the spectrum of the mixture that
is absent from the printed crystal data. There is also a strong sharp band at 3180 cm−1
in the mixture spectrum, whereas the same region in the printed crystal spectrum has a
strong but much broader band. There are also subtle differences in the data between
650 cm−1 and 1800 cm−1 that suggest shifts in band positions, possibly due to changes
in H-bonding. It is clear from the comparison of these two spectra that the printed crystals
are not simply a physical mixture of the two materials.
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Figure 4-36. FTIR spectra for a physical mixture of INCT and LABA and crystals printed from an
equimolar solution of INCT and LABA in ethanol.
In the high wavenumber region the differences between the spectra of the raw materials
and the printed crystals are obvious. LABA has four strong sharp bands at 3525 cm−1,
3405 cm−1, 3310 cm−1, and 3205 cm−1 representing OH stretching of the four hydroxyl
groups. In the same region the data for INCT display two strong sharp bands associated
with the NH stretching of its amide group. This region of the printed crystal spectrum has
just one sharp strong band at 3395 cm−1 followed by a broad strong band with a number
of minima superimposed upon it at 3290 cm−1, 3270 cm−1, 3235 cm−1, 3190 cm−1, and
3140 cm−1. These changes are all related to the functional groups in each of the raw
materials that are likely to be involved in hydrogen bonding in a crystal. Changes below
1800 cm−1 are again much more subtle and consist of slight shifts in many of the bands
but both materials appear to be represented in the spectrum of the printed crystals. The
subtlety of these changes suggests the formation of a new crystal structure, possibly a
co-crystal rather than the occurrence of a reaction between the two materials. However,
without single crystal data to support this summation it is not possible to comment on the
changes in intermolecular interactions. Hence, it is not possible to link the FTIR data with
changes around specific bonds.
205
Figure 4-37. FTIR spectra for INCT, LABA and crystals printed from an equimolar solution of the
two in ethanol.
4.3.3. Heat induced co-crystallisation
Heat induced co-crystallisation is a very simple and environmentally friendly method for
screening for co-crystals.86 Its green credentials stem from the fact that it requires no
solvent and its simplicity is due to the method involving no more than heating a mixture
of two or more components. It has even been shown in at least one case that simply
making contact between two single crystals of materials that are amenable to co-
crystallisation, at ambient temperatures, can result in the spontaneous melting of the
components and their recrystallisation as a co-crystal.87
4.3.3.1. INCT-HBA
DSC thermograms were recorded for two different mixtures of INCT and HBA in a 1:1
molar ratio. The first was made up by simply weighing and mixing the two materials in
the condition in which they were received from the supplier. The second was made up
by first grinding each of the two materials separately in a pestle and mortar and then
mixing them. The traces can be compared in Figure 4-38. Both mixtures produced similar
profiles with a number of events. The non-ground mixture has an almost imperceptible
endotherm that peaks at 129.2 °C (onset: 122.9 °C; enthalpy: 3.127 J g−1), followed by
another larger endotherm (onset: 143.2 °C, enthalpy: 50.72 J g−1) peaking at 145.6 °C.
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The ground mixture has a similar set of events with a small endotherm at 132.6 °C (peak:
135.6 °C), immediately followed by a small overlapping exotherm (peak: ca. 137 °C),
which itself is followed by an overlapping endotherm (peak: 144.0 °C). Due to the
overlapping of these events accurate onset temperatures and enthalpies cannot be
calculated. However, estimates show the enthalpies of the two endotherms to be 4.8 J
g−1 and 63.7 J g−1 respectively.
Figure 4-38. DSC thermograms recorded for INCT, HBA, a mixture of the two raw materials as
received, and a mixture of the two materials after grinding them separately in a pestle and
mortar. Inset: an enlargement of the INCT III endotherm.
Both mixtures then go on to experience an endo-exo-endo event beginning at 173.9 °C
(non-ground) and 173.4 °C (ground). Again, the onsets and enthalpies of the succeeding
exotherm and endotherm in both datasets cannot be accurately analysed due to the
overlap of the events. However, a visual comparison indicates the enthalpies are similar
and the peaks of the two events occur at 177.0 °C and 185.0 °C for the mixture and at
176.9 °C and 184.3 °C for the ground mixture. The similarity between all of the events
observed must be a result of the same phase transitions occurring in each of the two
mixtures.
The events observed in the data for the mixtures all occur at temperatures at which there
are no events observed in the thermograms for the raw materials. However, the final
endotherm in both datasets occurs at the same temperature as the endotherm observed
for the printed samples of the same materials (peak: 184.1 °C). The higher temperature
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events in both DSC traces must be caused by the co-crystallisation of the materials
followed immediately by their melting. Furthermore, it appears that the initial co-
crystallisation begins with a melt, characterised by the small endotherm immediately prior
to the exotherm. It should be noted that some effects of decomposition are observed
immediately following the endotherm at 145 °C. However, TGA data recorded for
samples of the same two mixtures (Figure 4-39) show that, although decomposition
definitely begins prior to the second set of events, at 193 °C 92.5 % of the material
remains. It may be coincidental that the endotherm at 185 °C occurs at the same
temperature as that of the printed sample but the data strongly suggest the formation
and subsequent melting of the same co-crystals, despite this decomposition.
Figure 4-39. DSC and TGA thermograms recorded for a simple equimolar mixture of INCT and
HBA and a mixture in which the two constituents had been ground separately in a pestle and
mortar prior to mixing.
The explanation for the lower temperature group of events is less clear. Data for the raw
materials and the printed crystals do not display such an event. To understand this in
more detail, a sample of the physical mixture of the two materials as received was
subjected to combined DSC-XRD analysis. The experiment was stopped at 170 °C to
prevent decomposition of the sample in the DSC cell. The diffraction data and DSC
thermogram (Figure 4-40) display two very obvious phase changes beginning at 123.4
°C (3.72 J g−1) and 141.9 °C (59.02 J g−1). Both transformations involve structural
changes and are endothermic. The events observed are clearly the same events
observed in the two samples previously discussed as they occur at similar temperatures
and have similar associated enthalpies. There is also a third, transient phase that
gradually grows in at around 67 °C and disappears with the phase transition at 123.4 °C.
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Figure 4-40. Simultaneous DSC-XRD data for an equimolar physical mixture of INCT and HBA.
Rietveld refinement against the pattern for the physical mixture recorded at 40 °C in the
DSC can be seen in Figure 4-41. Starting models used for all refinements on this system
are presented in Table 4-3. Refined unit cell data can be seen inTable 4-4. The initial
sample was a physical mixture of INCT I and HBA and so the pattern recorded was
expected to be a combination of the two and initial refinements were carried out using
these materials. However, there was a small unidentified reflection at 2.61° and so other
possible structures were introduced, including all known polymorphs of INCT,
VAKTOR,232 and the co-crystal grown by solvent evaporation (discussed in section
4.3.1). Surprisingly, the best fit was achieved when refining the structure for the new co-
crystal grown in this work. It seems that simply mixing the two materials resulted in
growth of a small amount of the co-crystal. However, at this temperature, only 5.3 % of
the sample was converted and visual inspection of the pattern suggests this may result
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from the poor powder character of the sample and resultant unrepresentative intensity
ratios.
Table 4-3. Starting models used for Rietveld refinement against diffraction patterns collected for
an equimolar mixture of INCT and HBA.
Species Model
INCT form I EHOWIH01*










*taken from the CSD.
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Figure 4-41. Rietveld refinement data for a physical mixture of INCT and HBA at 40 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-4. Refinement parameters for a physical mixture of INCT and HBA at 40 °C. The
starting models were taken from the CSD (INCT: EHOWIH01; HBA: JOZZIH).
Property INCT HBA Co-crystal
This work
T / °C 40
Space group P21/c P21/a P21/c
a / Å 10.2442(8) 18.504(4) 10.656(9)
b / Å 5.7426(5) 5.2373(3) 29.31(12)
c / Å 10.0650(7) 6.3345(13) 7.743(7)
α / ° 90 90 90
β / ° 97.259(7) 93.205(12) 97.82(10)
γ / ° 90 90 90
Cell volume / Å3 587.36(8) 612.95(16) 2396(10)
Rwp 0.0757
Rwp-bkd 0.1843
Phase Fraction* 43.1 % 50.5 % 5.3 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %. As a result the sum does
not equal 100 % as a small portion of the material was assigned to the other structures included
in the refinement.
At 97 °C characteristic reflections of the new co-crystal are much more intense, and
reflections from a fourth structure are present. The results of Rietveld refinements carried
out on the pattern recorded at this temperature can be seen in Figure 4-42 and Table
4-5. The new entity has been identified as the co-crystal already reported by
Vishweshwar et al.232 The relative intensities of the reflections of the two co-crystals
compared to those of the two raw materials are low, as are the relative quantities. As
with samples discussed in Chapters 2 and 3 this sample was relatively grainy and not a
perfect powder, and so the pattern recorded consisted of rings of spots rather than
smooth Debye-Scherrer rings. As a result the intensity ratios of the reflections were not
a true representation of the structure of the material and so, the identity of the new
phase/phases cannot be confirmed with complete certainty at this temperature. That
being said, none of the other refined structures were a good fit, so the most likely
explanation for the new reflections is the co-crystallisation of the materials into these two
structures.
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Figure 4-42. Rietveld refinement data for a physical mixture of INCT and HBA at 97 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-5. Refinement parameters for a physical mixture of INCT and HBA at 97 °C. The
starting models for the raw materials were taken from the CSD (INCT: EHOWIH01; HBA:
JOZZIH; Co-crystal: VAKTOR) and single crystal data reported in Section 4.3.1 was used for
the new co-crystal.




T / °C 97
Space group P21/c P21/a P21/n P21/c
a / Å 10.2815(12) 18.601(4) 5.964(7) 10.722(4)
b / Å 5.7575(6) 5.2598(4) 9.536(10) 29.75(4)
c / Å 10.0893(9) 6.3409(16) 21.253(19) 7.725(4)
α / ° 90 90 90 90
β / ° 96.909(9) 92.837(1) 98.78(9) 98.90(6)
γ / ° 90 90 90 90
Cell volume / Å3 592.91(11) 619.6(2) 1194(2) 2427(3)
Rwp 0.0924
Rwp-bkd 0.2227
Phase Fraction* 37.6 % 50.37 % 5.85 % 6.10 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
At 122 °C the mixture has become extremely complex and refinement (Figure 4-43)
reveals the presence of five species: INCT forms I and II, HBA, and both co-crystals.
Examination of the contour plot (Figure 4-40) at this temperature shows that the pattern
was recorded during the first significant phase transition of the experiment and rather
than a simple conversion from the two initial materials to the known co-crystal there
appear to be numerous transformations occurring. INCT I and II are enantiotropically
related with the III conversion reported by Li et al.246 to occur at 131.7 °C at a heating
rate of 70 °C min−1. At lower heating rates this can be expected to occur at a lower
temperature and samples from the same study by Li were shown to convert to form II at
ca.120 °C. Thus the presence of form II at 122 °C is not unexpected. At this temperature
both forms of the co-crystal are still present. From this pattern alone it is not possible to
deduce whether VAKTOR results from the transformation of the first co-crystal or from
the transformation of HBA with either one or both of the forms of INCT.
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Figure 4-43. Rietveld refinement data for a physical mixture of INCT and HBA at 122 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-6. Refinement parameters for a physical mixture of INCT and HBA at 122 °C. The
starting models for the raw materials were taken from the CSD (INCT I: EHOWIH01; INCT II:
EHOWIH02; HBA: JOZZIH; reported co-crystal: VAKTOR), and the single crystal data reported









T / °C 122
Space group P21/c P21/a P21/c P21/n P21/c
a / Å 10.306(1) 18.653(5) 16.267(6) 6.040(4) 10.628(6)
b / Å 5.7654(7) 5.2696(4) 7.996(7) 9.560(6) 29.18(7)
c / Å 10.107(1) 6.346(2) 9.922(8) 21.16(1) 7.826(5)
α / ° 90 90 90 90 90
β / ° 96.82(1) 92.69(2) 105.66(6) 96.39(6) 98.26(8)
γ / ° 90 90 90 90 90
Cell volume / Å3 596.29(12) 623.1(3) 1242(1) 1214(1) 2402(6)
Rwp 0.0923
Rwp-bkd 0.2191
Phase Fraction* 31.4 % 41.5 % 7.3 % 10.7 % 9.1 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
At 139 °C, the midpoint of the second clear phase in the contour plot and between the
two endotherms in the DSC trace, reflections of INCT I and the low temperature co-
crystal have completely disappeared. Only INCT II, HBA and VAKTOR remain and they
are present in significant quantities. It should be noted that the two single component
crystal species are again present in a 1:1 ratio.
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Figure 4-44. Rietveld refinement data for a physical mixture of INCT and HBA at 139 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-7. Refinement parameters for a physical mixture of INCT and HBA at 139 °C. The
starting models for the raw materials were taken from the CSD (INCT II: EHOWIH02; HBA:





T / °C 139
Space group P21/a P21/c P21/n
a / Å 18.667(5) 16.298(1) 6.060(1)
b / Å 5.2744(4) 7.993(1) 9.547(2)
c / Å 6.354(2) 9.964(2) 21.279(4)
α / ° 90 90 90
β / ° 92.59(2) 105.29(1) 96.26(2)
γ / ° 90 90 90
Cell volume / Å3 625.0(3) 1252.0(3) 1223.8(4)
Rwp 0.0930
Rwp-bkd 0.2280
Phase Fraction* 38.1 % 35.3 % 26.6 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
Refinement of the final pattern recorded at 170 °C (Figure 4-45 and Table 4-8) reveals
that there is very little INCT II left in the sample. Inspection of the plots suggests that the
value of 4.8 % that has been attributed to this form is probably incorrect and that there
is in fact no pure INCT character remaining in the sample. The largest reflection in the
calculated pattern for this species (3.4°) is probably a result of the software
compensating for the disproportionately high intensity reflection present at the same
angle in the pattern of VAKTOR. The vast majority of the remaining crystalline material
can be attributed to the structure of the known co-crystal. However, there remains some
residual HBA that has not co-crystallised. It seems odd that there is pure HBA left but no
INCT as the initial mixture has been shown to be a 1:1 molar ratio and the unit cell of the
co-crystal formed contains one molecule of each. Furthermore, the pattern recorded at
138 °C showed the same ratio of raw materials.
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Figure 4-45. Rietveld refinement data for a physical mixture of INCT and HBA at 170 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-8. Refinement parameters for a physical mixture of INCT and HBA. The starting models





T / °C 170
Space group P21/a P21/c P21/n
a / Å 18.780(11) 16.450(9) 6.064(1)
b / Å 5.2887(9) 8.070(9) 9.571(1)
c / Å 6.381(5) 9.905(11) 21.377(2)
α / ° 90 90 90
β / ° 92.61(4) 105.43(9) 96.442(11)
γ / ° 90 90 90
Cell volume / Å3 633.0(6) 1268(2) 1232.805(11)
Rwp 0.0855
Rwp-bkd 0.2821
Phase Fraction* 9.6 % 4.8 % 73.8 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %. As a result the sum does
not equal 100 % as a small portion of the material was assigned to the other structures included
in the refinement.
Simultaneous DSC and diffraction data can be seen in Figure 4-40. Plotting the total
integrated intensity of each phase present as a function of time (Figure 4-46) it can be
seen that there is little change in the overall content of HBA throughout the experiment
until ca. 145 °C. There is some initial growth, presumably due to heat expansion causing
more material to be lifted into the beam, followed by a gradual decline as the two co-
crystals grow. INCT I experiences a concomitant decline. At ca. 120 °C there is a sharp
drop in the content of INCT I and the new co-crystal, accompanied by equally sharp
increases in the content of INCT II and VAKTOR. It seems that residual INCT I is
converting to INCT II and the new co-crystal is converting to VAKTOR. At 132 °C INCT
I and the new co-crystal have disappeared and the growth of VAKTOR slows before,
soon after, INCT II and HBA undergo conversion to VAKTOR. However, the INCT
disappears at a much higher rate than HBA. Examination of the DSC-XRD data (Figure
4-40) reveals that, coincident with the peak of the second endotherm in the DSC trace
(146.2°), there is an obvious structural change occurring, characterised by the
disappearance of many reflections and a broad increase in background intensity of the
diffraction data (indicated by a subtle change in colour). These changes are caused by
the melting of the remaining INCT II, albeit at a lower temperature than
reported,242,246,247,249 but that is expected behaviour for materials in mixtures.
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Figure 4-46. Plot of relative quantity as a function of time for each of the phases present in a
mixture of INCT and HBA.
4.3.3.2. INCT-HPAA
As crystal growth experiments have shown INCT and HPAA to form a co-crystal in the
molar ratio 2:1 (4.3.1), these were the proportions in which a physical mixture was made
up for co-crystallisation by heating. Initial DSC analysis can be seen in Figure 4-47. The
thermogram recorded for the mixture has three endothermic events, all of which are
absent from the thermograms of the two raw materials. The first is very broad and has
an onset at 94.4 °C and peaks at 97.9 °C. The enthalpy associated with this event can
be approximated as 54.9 J g−1 but there is a visible difference in the baseline before and
after the peak due to the extended lead in to the following endotherm, thus accurate
measurement is impossible. The following events are overlapping, meaning analysis is
significantly impaired. However, the onset of the first occurs at ca. 123.6 °C, with a peak
at 125.2 °C and the second has an onset of ca. 126.3 °C and peaks at 127.7 °C. The
associated enthalpies cannot be assessed. The broad nature of the first endotherm may
conceal a number of events, whereas the second and third are much sharper and may
indicate melting. This cannot be attributed to the melting of either of the raw materials in
their most stable forms, as the temperature is too low. TGA of the mixture and the raw
materials shows that mixing the two has a stabilising effect, with the raw materials
experiencing 10 % mass loss at 193 °C (INCT) and 195 °C (HPAA), and the mixture at
205 °C. This suggests that intermolecular interactions may have taken place. However,
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the TGA trace for the printed co-crystals (Section 4.3.2.2.1) contradicts this, showing 10
% mass loss at 175 °C. Again, sample mass may be a factor as the printed sample was
much smaller than the prepared mixture.
Figure 4-47. DSC thermograms recorded for INCT (black), HPAA (red), and a mixture of the two
raw materials (2:1 molar ratio) as received (blue).
The same physical mixture was subjected to combined DSC-XRD (Figure 4-48). The
diffraction data show two major phase transitions, occurring at ca. 95 °C and ca. 125 °C.
Each of these has a corresponding endotherm in the DSC trace with onsets at 94.6 °C
and 127.0 °C respectively. The thermogram has a very similar form to those discussed
above. The first endotherm is smaller than the second but, rather than being broad, has
a small shoulder on either side, indicating that the event occurring at this temperature
either occurs in multiple stages or is in fact multiple events. The second, larger,
endotherm has the same small event occurring just before it, as is seen in the previous
thermogram, appearing as a shoulder. Again, this suggests a two stage process or
multiple events. The total loss of Bragg reflections following the endotherm at 127.0 °C
confirms the event as a melt.
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Figure 4-48. Simultaneous DSC-XRD data for a 2:1 molar ratio physical mixture of INCT and
HPAA.
Results of Rietveld refinement of the initial pattern recorded for the mixture can be seen
in Figure 4-49 andTable 4-9. The calculated patterns show the initial sample to be made
up of mostly INCT I and HPAA as expected, but surprisingly there was also another
species present. Structures of each of the known polymorphs of INCT were included in
the refinement but none improved the fit. There are no other known polymorphs of HPAA,
but inclusion of the co-crystal grown by solvent evaporation into the refinement showed
it to be a close match to the unknown species. The fit of the calculated pattern to the
data is not as good as for previous systems, with a Rwp of 0.1431. This can be partially
explained by the significant difference in intensity between the data and the refinements
of the reflections at 2.71° and 3.17°, characteristic of INCT. As with previous samples,
this can be attributed to the presence of large grains of material, which resulted in effects
similar to preferred orientation. There are also three low intensity observed reflections at
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0.73°, 2.62°, and 2.92° that are absent from the calculated pattern. The cause of these
reflections is unclear. It is unlikely to be another consequence of the grainy sample as
this would not cause the appearance of new reflections, just differences in observed and
calculated intensities. All three reflections are present from the first recorded pattern and
fade from the data at the same temperature as the HPAA reflections, suggesting they
are related. In contrast, the INCT reflections fade at a higher temperature and the co-
crystal reflections are present throughout the experiment. The three unexplained
reflections may be the result of some impurity in the sample.
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Figure 4-49. Rietveld refinement data for a mixture of INCT and HPAA at 40 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-9. Refinement parameters for a physical mixture of INCT and HPAA at 40 °C. The
starting models for the raw materials were taken from the CSD (INCT: EHOWIH01; HPAA:
QAPBAL) and single crystal data reported in section 4.3.1 was used for the co-crystal.
Property INCT HPAA INCT-HPAA
Co-crystal
T / °C 40
Space group P21/c P212121 P-1
a / Å 10.251(2) 5.3187(9) 6.792(6)
b / Å 5.729(1) 9.027(3) 12.31(2)
c / Å 10.065(1) 15.443(7) 12.81(2)
α / ° 90 90 111.08(9)
β / ° 97.30(1) 90 95.80(9)
γ / ° 90 90 99.36(7)
Cell volume / Å3 586.24(15) 741.4(4) 971(2)
Rwp 0.1431
Rwp-bkd 0.2893
Phase Fraction* 61.8 % 25.0 % 13.2 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
Refinement of the pattern recorded at 113 °C (Figure 4-50), between the two
endotherms, has shown the sample to consist of just INCT and the co-crystal following
the first phase transition, with the majority of the material being the co-crystal. The overall
Rwp and the standard uncertainties (Table 4-10) for the co-crystal are much lower than
those calculated for the same species in the 40 °C pattern. The major reflections in the
co-crystal pattern occur at similar angles to those in the lower temperature pattern, and
the three unidentified reflections are no longer present. This strengthens the argument
that the third species in the initial mixture was the co-crystal. The three unidentified
reflections may be the result of a contaminant or possibly an unknown polymorph of one
of the components. It appears that, like the INCT-HBA mixture, just mixing INCT and
HPAA caused some co-crystallisation to occur.
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Figure 4-50. Rietveld refinement data for a mixture of INCT and HPAA at 113 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-10. Refinement parameters for a mixture of INCT and HPAA at 113 °C. The starting
models for the raw materials were taken from the CSD (INCT: EHOWIH01; HPAA: QAPBAL)
and single crystal data reported in Section 4.3.1 used for the co-crystal.
Property INCT HPAA INCT-HPAA
Co-crystal
T / °C 113
Space group P21/c P212121 P-1
a / Å 10.284(2) 5.24(4) 6.8176(8)
b / Å 5.762(10) 9.14(6) 12.3148(19)
c / Å 10.0956(10) 15.27(9) 12.9137(19)
α / ° 90 90 110.754(10)
β / ° 96.815(11) 90 95.425(11)
γ / ° 90 90 99.067(8)
Cell volume / Å3 594.0(3) 731(8) 987.8(3)
Rwp 0.0678
Rwp-bkd 0.1810
Phase Fraction* 34.0 % 0.8 % 65.2 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
The original stock mixture was made up at an INCT:HPAA molar ratio of 2:1, so it seems
odd that at 113 °C, following the exhaustion of the HPAA, there is still a significant
amount of INCT left in the sample. The integrated area under the curve for the pattern of
each of the reactants at 40 °C was used to calculate the relative amounts of each material
in the beam, it seems there was an excess of INCT of around 22 % of the total sample
in the beam. The remaining 12 % can be accounted for by the melting of some of the
HPAA. This is visible in the diffraction patterns above ca. 100 °C as an increase in the
background intensity (Figure 4-48), characteristic of a liquid or amorphous material.
The evolution of the structures in the sample can be visualised in Figure 4-51. Initially
the material consisted of mostly INCT, with less HPAA and a little of the co-crystal. The
content of all three remained relatively stable until around 80-90 °C when both INCT and
HPAA began to decrease rapidly, whilst the co-crystal content increases. This is the
result of co-crystallisation and coincides with the first endotherm in the DSC trace. This
endotherm arises from multiple events, with both co-crystallisation and melting occurring
simultaneously. As there are three peaks it is probable that both INCT and HPAA
undergo a local melt, and then recrystallise as the co-crystal. The combination of these
two endothermic events presumably masks the exothermic crystallisation peak. Above
ca. 100 °C the HPAA has been exhausted and the remaining INCT continues to melt
while the co-crystal formation slows and eventually stops. Finally the co-crystal melts.
The melting of INCT and the co-crystal coincide with the second endotherm in the DSC
trace, and the occurrence of these two melts explains the presence of the small shoulder
on this event. As with INCT-HPAA the presence of the co-crystal appears to destabilise
INCT so that it melts at a much lower temperature than the pure crystalline powder.
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Figure 4-51. Plot of relative quantity as a function of time for each of the phases present in a
mixture of INCT and HPAA.
4.3.3.3. INCT-DHPAA
Diffraction patterns collected during simultaneous DSC-XRD experiments on a binary
mixture of INCT and DHPAA (Figure 4-52) appear to show the occurrence of two phase
transitions. Reflections of the phases present before and after the first transition overlap
in a broad range of temperatures (ca. 95–115 °C). From these data alone it would appear
that a single event is occurring. However, the DSC thermogram shows that there are in
fact at least three endothermic events taking place between 90 °C and 120 °C. The final
transition is much clearer and is represented by the complete loss of Bragg reflections
and a sharp endotherm, and is the final melting of the sample.
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Figure 4-52. Simultaneous DSC-XRD data for an equimolar mixture of INCT and DHPAA.
Closer examination of the diffraction data between 80 °C and 120 °C does not offer any
explanation of the multiple thermal events in the thermogram. The Bragg reflections
present at the beginning of the experiment are continuous until their disappearance at
ca. 120 °C and the same is true of the reflections representing the second crystalline
phase from their appearance at ca. 90 °C until their disappearance at 126 °C. This then
suggests that the multiple endotherms are probably caused by different stages of the
same process as the crystal lattices of the two materials are first disrupted before
realigning into the lattice of the co-crystal. Figure 4-53 and Table 4-11 show refinement
data for the initial pattern recorded for the sample at 40 °C. Structures of both of the raw
materials achieved a very good fit with an overall weighted profile R-factor of 0.0556.
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Figure 4-53. Rietveld refinement data for a mixture of INCT and DHPAA at 40 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-11. Refinement parameters for a mixture of INCT and DHPAA at 40 °C. The starting
models for the raw materials were taken from the CSD (INCT: EHOWIH01; DHPAA: NELTON).
Property INCT DHPAA
T / °C 40
Space group P21/c Pbca
a / Å 10.2414(7) 16.1356(19)
b / Å 5.7407(4) 11.5933(8)
c / Å 10.0693(5) 7.9176(3)
α / ° 90 90
β / ° 97.253(5) 90
γ / ° 90 90
Cell volume / Å3 587.27(6) 1481.1(2)
Rwp 0.0556
Rwp-bkd 0.1693
Phase Fraction* 54.5 % 45.5 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %.
The pattern recorded at 122 °C (Figure 4-54), after the first phase transition, could not
be fitted by the structures of any of the known polymorphs of the two raw materials or
that of the INCT-DHPAA co-crystal grown by solvent evaporation and described in
Section 4.3.1. Many of the reflections in the pattern collected by DSC-XRD occur at
similar angles to reflections in the predicted pattern (Figure 4-54), but there are
significant absences (in particular the two main reflections at 3.02° and 3.76°). The new
structure must be either the result of co-crystal formation or the crystallisation of a new
polymorph of one of the two raw materials. There is also a high background that is not
present in the lower temperature patterns, indicating the presence of some amorphous
or melted material. This is visible as an increase of the background of the diffraction data
(Figure 4-52) and coincides with the third endotherm.
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Figure 4-54. Powder diffraction pattern for crystals produced by heating an equimolar binary mixture of INCT and DHPAA and a predicted powder pattern for crystals
grown by solvent evaporation from an equimolar ethanolic solution.248
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Plotting the integrated area under the calculated pattern of each species as a function of
temperature (Figure 4-55) it can be seen that the content of both of the raw materials
remains relatively constant until ca. 95 °C, at which point both begin to decline. This
coincides with the onset of the first endotherm in the thermogram (94.2 °C). However,
the total disappearance of DHPAA and INCT does not occur until 108.8 °C and 113.9 °C
respectively. These endpoints match closely the minima of the second (ca. 108 °C) and
third (111.05 °C) endotherms. The overlapping nature of these events and the likelihood
of an invisible exothermic event relating to crystallisation means that a confident
assignment is not possible. That said, it can be deduced that the disappearance of both
structures from the sample is not due simply to melting, as the raw materials have melting
points at temperatures in excess of 120 °C. It is therefore likely to be the result of a
conversion from one solid form to another. It cannot be ascertained from these data
whether that form is a co-crystal or a new polymorph of one of the two individual
components.
Figure 4-55. Plot of integrated area as a function of time for each of the raw materials present in
a mixture of INCT and DHPAA.
4.3.3.4. INCT-LABA
The DSC-XRD data for a binary mixture of INCT and LABA (Figure 4-56) in a 1:2 molar
ratio are more complex than the four systems discussed previously. As before, structural
refinement was carried out on the initial pattern recorded for the physical mixture (Figure
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4-57 and Table 4-12). The fit was poorer than has been seen previously with some of
the other systems and a Rwp value of 0.1098 was the best that could be achieved. The
reason for this can be seen when comparing the observed pattern to the total calculated
pattern. There are obvious differences between the intensities of reflections at 2.67°,
2.71°, 3.03°, 3.22° and 3.85°, resulting from the grainy texture of the powder.
Figure 4-56. DSC-XRD plot for a binary mixture of INCT and LABA in a 1:2 molar ratio. Dotted
lines indicate the first appearance of new Bragg reflections in the diffraction data.
Phase quantification analysis shows that the initial mixture consisted of INCT (22.7 %),
LABA (73.9 %), and the reaction product crystal observed in the single crystal
experiments (3.4 %, Section 4.3.1.4). Closer examination of the calculated pattern for
the reaction crystal reveals that, unlike the previous samples, where clear reflections
corresponding to the co-crystal were visible at the start of the experiment, there are no
obvious reflections assigned to this phase and that the fraction of material apportioned
to this structure is probably a consequence of compensation by the software for a
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combination of the imperfect fit of the background to the data and discrepancies in the
intensities of some of the reflections.
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Figure 4-57. Rietveld refinement data for a 1:2 molar ratio mixture of INCT and LABA at 41 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-12. Refinement parameters for a 1:2 molar ratio mixture of INCT and LABA. The
starting models for the raw materials were taken from the CSD (INCT: EHOWIH01; LABA:





T / °C 40.7
Space group P21/c P21 P212121
a / Å 10.232(2) 6.3969(5) 5.4(1)
b / Å 5.748(2) 6.3546(2) 11.3(4)
c / Å 10.068(2) 17.103(1) 32.7(6)
α / ° 90 90 90
β / ° 97.20(2) 99.341(7) 90
γ / ° 90 90 90
Cell volume / Å3 587.4(2) 686.04(9) 2009(86)
Rwp 0.1098
Rwp-bkd 0.2930
Phase Fraction* 22.7 % 73.9 % 0 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %. It should also be noted that
there are no reflections present that can be assigned to the co-crystal and its presence is
attributed to the imperfect fit of the background curve.
Upon heating the sample underwent a number of phase transitions; the first appearance
of reflections ascribed to each of the new phases is represented by dotted lines in Figure
4-56. The first change can be seen as an endo-exo event in the DSC trace beginning at
90.5 °C. At this point a number of new reflections (phase 1) appear in the diffraction plot,
which remain until 141.8 °C. The next new species appears at 114.9 °C and reflections
remain until 136.6 °C. Calorimetrically this is represented by a low enthalpy broad
endotherm. Reflections of a third species (phase 2) appear at 127.8 °C, the same
temperature at which a number of reflections from the initial pattern disappear, and are
accompanied by the first of two very large energy endotherms. These reflections are also
present until 141.8 °C. Finally, at 136.6 °C a large group of new reflections appear and
remain until the end of the experiment. This growth is coincident with the second of the
large endotherms and also the decay of phase 1 and phase 2.
Rietveld refinement against the pattern recorded at 131.2 °C can be seen in Figure 4-58.
At this temperature there are reflections present from all but the last phase to appear.
Structures of all five known polymorphs of INCT, the only known polymorph of LABA,
and that of the reaction crystal reported in Section 4.3.1 were all refined against the data.
Of the four phases present only two could be identified, INCT form II and LABA (Table
4-13). The original form of INCT (polymorph I) is no longer present and none of the other
structures achieved a good fit to species 1 or 2. Refinements were carried out on selected
patterns in which only one of the unidentified phases was present as well as identifiable
patterns for INCT, LABA and the reaction crystal (or a combination of the three). Neither
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of the structures were a good fit to the data. However, comparison of the pattern collected
at 131.2 °C with the pattern of the printed crystals shows that reflections for one of the
two unidentified species (phase 2) occur at similar angles to the major reflections of the
printed crystals.
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Figure 4-58. Rietveld refinement data for a 1:2 molar ratio mixture of INCT and LABA at 131 °C. Observed reflections from two unidentified phases are denoted by
either a 1 or 2 directly above. Tick marks show the positions of allowed reflections of INCT form II and LABA.
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Table 4-13. Refinement parameters for a 1:2 molar ratio mixture of INCT and LABA. Starting




T / °C 131.2
Space group P21/c P21
a / Å 16.322(8) 6.4060(7)
b / Å 8.005(14) 6.4196(3)
c / Å 9.801(11) 17.135(2)
α / ° 90 90
β / ° 105.89(7) 99.401(10)
γ / ° 90 90
Cell volume / Å3 1231(7) 695.20(13)
Rwp 0.1354
Rwp-bkd 0.4542
Phase Fraction* 3.4 % 96.6 %
*fraction of the identifiable material, not the whole sample.
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Figure 4-59. PXRD patterns collected for crystals printed from an equimolar ethanolic solution of INCT and LABA and for an equimolar physical mixture of the two at
131.2 °C.
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Refinement of the pattern collected at 147 °C, (Figure 4-60 andTable 4-14) shows the
sample to consist of INCT, LABA and the reaction crystal. The presence of INCT I
indicated by the refinements is an error caused by compensation for the imperfect
intensity ratios of the other species present. There is in fact none left as this species
disappears from the diffraction data at 127.8 °C, as previously mentioned. It seems some
of the INCT has reacted with the LABA but not all of it; almost half of the remaining
material at 147 °C is LABA, and they were initially mixed in the appropriate ratio to form
the reaction crystal. Patterns recorded above this temperature were observed to have a
higher background than those below it suggesting some melting of INCT, hence the
remaining LABA.
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Figure 4-60. Rietveld refinement data for a 1:2 molar ratio mixture of INCT and LABA at 147 °C. Tick marks show the positions of allowed reflections of each phase.
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Table 4-14. Refinement parameters for a 1:2 molar ratio mixture of INCT and LABA. The
starting models for the raw materials were taken from the CSD (INCT: EHOWIH01; LABA:





T / °C 146.9
Space group P21/c P21 P212121
a / Å 10.29(2) 6.4079(11) 5.1995(10)
b / Å 5.721(13) 6.4282(4) 11.711(2)
c / Å 10.145(13) 17.171(3) 33.382(6)
α / ° 90 90 90
β / ° 97.64(16) 99.4971(18) 90
γ / ° 90 90 90
Cell volume / Å3 592(2) 697.59(19) 2032.7(7)
Rwp 0.0987
Rwp-bkd 0.4149
Phase Fraction* 3.9 % 44.8 % 51.3 %
*Due to the graininess of the sample, representative errors cannot be calculated. However, the
author conservatively estimates the error to be in the region of 5 %. It should be noted that the
standard uncertainties for INCT are very high and its presence in the refinements is due to the
poor fit of the intensities of the other species.
The evolution of the four identifiable species in the sample can be seen in Figure 4-61.
There is no change in the content of any of the four until 86 °C when the amount of INCT
present begins to decrease before levelling off at 101 °C. The rate of decay initially is
fairly slow, and it appears that the reaction crystal begins to grow here, but this is an
artefact of the refinements and the powder quality. In the same temperature range there
is a step in the content of LABA in the sample. At 117 °C the decay of INCT I increases
and by 128 °C there is no longer any remaining. At 113.7 °C INCT II appears and grows
steadily until reaching its maximum content at 126.6 °C, at which point it immediately
begins to decrease. At the same temperature LABA begins to decrease dramatically and
continues to do so until the end of the heating programme. At 138 °C the reaction crystal
emerges and grows rapidly until 145 °C when it plateaus.
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Figure 4-61. Plot of relative quantity as a function of time for each of the identified species
present in a mixture of INCT and LABA [Data points for INCT form I between 130 °C and 140 °C
have been removed as refinements were incorrect in this range].
The first period of decline of INCT I is a result of either a conversion to a currently
unreported polymorph, co-crystallisation or reaction with LABA. The appearance of the
first new species (phase 1) at 90.5 °C corresponds closely to this decline. However, as
phase 1 remains unidentified and the data for LABA at the same temperature is
ambiguous, exactly which event is occurring remains uncertain. The steeper gradient of
the second period of decline of INCT I is a direct result of the further conversion of some
of the material to INCT II, and the maximum intensities of reflections for phase 1 and
INCT II occur at 128.7 °C and 126.6 °C respectively. Both then begin to decline. The
decrease in LABA begins at the same temperature at which the second unidentified
species (phase 2) appears, suggesting phase 1 is a new polymorph of LABA. Emergence
of the reaction crystal does not occur until all of the known forms of INCT have
disappeared and at the same temperature there is an increase in the rate of decline of
LABA.
The complex nature of the data make it very difficult to ascertain exactly which forms of
the two raw materials directly preclude the reaction crystal. However, it is clear that both
forms of INCT melt prior to its first appearance. It appears that INCT in the reaction
crystal results from either a solid state reaction from phase 1 or growth from the melt.
LABA is simpler, and appears to undergo a solid state reaction from phase 2, since the
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disappearance of this structure occurs over the same temperature range as the
appearance of the reaction crystal.
The rapid decline of LABA following completion of reaction crystallisation may be
attributed to melting, albeit at a lower temperature than expected due to destabilisation
by the other species present. A more likely explanation, however, is that decomposition
occurs: in all DSC traces of this system significant degradation was observed above 150
°C.
4.3.4. Co-crystallisation by milling
4.3.4.1. INCT-HBA
DSC analysis of the powder produced by ball milling an equimolar mixture of INCT and
HBA at 20 Hz for 15 minutes can be seen in Figure 4-62. There is one clear endothermic
event with an onset at 183.3 °C, after which the material begins to degrade. This
endotherm occurs at the same temperature as the endotherm in the DSC trace for the
printed crystals (181.6 °C), and so the same conclusions can be drawn as those in
Section 4.3.2.1.1: it appears that a co-crystal has formed.
Figure 4-62. DSC data for INCT, HBA, crystals printed from an equimolar ethanolic solution of
both and a mixture of the two following ball milling.
PXRD analysis (Figure 4-63) resulted in a pattern very similar to that of the previously
reported co-crystal,232 albeit with an overall shift in reflection positions to lower angles.
The intensity ratios are very similar, as are the relative peak positions. The similarity of
the two patterns suggests that the structures of the two samples are the same. The shift
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in angles of diffraction can be attributed to the difference in temperature of the two
samples. Data for the milled sample were collected at room temperature whereas data
for VAKTOR were collected at −120 °C.
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Figure 4-63. PXRD patterns collected for a ball milled mixture of INCT and HBA and predicted from single crystal data obtained from the CSD (VAKTOR).
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The FTIR spectrum recorded for the milled sample (Figure 4-64) is almost identical to
the spectrum recorded for the printed crystals, which again supports the conclusion that
a co-crystal has formed upon milling.
Figure 4-64. FTIR spectra for a ball milled mixture of INCT and HBA and for crystals printed
from an equimolar ethanolic solution of the two.
4.3.4.2. INCT-HPAA
The results obtained after milling mixtures of INCT and HPAA in a 2:1 molar ratio are
similar to those of INCT and HBA, in as much as they strongly resemble the findings with
crystals grown by solvent evaporation and those printed and discussed in Sections 4.3.1
and 4.3.2.2 respectively. The DSC data (Figure 4-65) exhibit a single endotherm with
onset at 126.3 °C, the same temperature as the printed crystals (125.9 °C). The
implications of this are discussed in Section 4.3.2.2.1. The formation of a co-crystal is
strongly suggested by this observation.
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Figure 4-65. DSC data for INCT, HPAA, and crystals printed from a 2:1 molar ratio solution of
the two in EtOH:H2O (7:3 v/v), and a 2:1 molar ratio mixture of the two following ball milling.
Comparison of the powder diffraction data with the pattern simulated from the single
crystal data shows the two to be very similar. Like the INCT-HBA milled sample the
intensity ratios of the two are very similar as are the angles of diffraction, with the milled
reflections all appearing at slightly lower angles as a consequence of thermal expansion
of the unit cell.
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Figure 4-66. PXRD patterns collected for a ball milled mixture of INCT and HPAA and that predicted from single crystal data collected for a crystal grown from
solution (see Section 4.3.1).
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FTIR spectra for both the printed crystals and the milled sample (Figure 4-67) are almost
identical, suggesting that the same co-crystal is grown via both methods.
Figure 4-67. FTIR spectra for a ball milled 2:1 molar mixture of INCT and HBA and for crystals
printed from a 2:1 molar solution of the two in EtOH:H2O (7:3).
The combination of DSC, PXRD, and FTIR data for the milled sample of INCT and HPAA
and their comparison to similar data for a single crystal grown by evaporation and
crystals formed by thermal inkjet printing strongly suggest the three methods all result in
the formation of the same co-crystal, described in detail in Section 4.3.1.
4.3.4.3. INCT-DHPAA
As with the two ball milled samples discussed in the previous paragraphs the DSC data
(Figure 4-68) for a milled sample of INCT and DHPAA displayed one endotherm at a
similar temperature to the one observed for the crystals formed by inkjet printing (122.6
°C and 118.6 °C respectively), although a little too high to be confident that the two are
a result of the same event. In fact, the enthalpy associated with melt of the printed
crystals is 111.7 J g−1 and that of the milled sample is 163.0 J g−1, suggesting that the
two events are different. The onset of the endotherm for the milled sample is more than
8 °C higher than the observed III transition in INCT (114.3 °C) and its magnitude is
much larger than that of the III transition which occurs with an associated enthalpy of
19.1 J g−1. The melt of DHPAA occurs at 128.3 °C and has an enthalpy of 198.3 J g−1.
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The difference in onset temperatures between this and the milled sample is not so large
that they can be affirmed as different events, but the difference in enthalpies confirms
that they are. The DSC data suggest milling may have formed a different co-crystal to
those formed by thermal and printing methods.
Figure 4-68. DSC data for INCT, DHPAA, crystals printed from an equimolar solution of both in
EtOH:H2O (9:1) and a mixture of the two following ball milling.
The PXRD data (Figure 4-69) are less clear. The pattern collected for the milled sample
has many reflections at similar angles to the co-crystal grown by solvent evaporation, as
well as the two raw materials. However, the intensity ratio of the reflections suggests that
the milled material has a different structure to all three. The Bragg angles of the two main
reflections (20.5°, 24.2°) do not correspond to those of any of the other materials, and
the reflection at 16.2° is only present in the milled material, not in any of the other
substances. From these data it appears that ball milling has caused co-crystallisation of
INCT and DHPAA to a second structure. The higher onset of the endotherm in the DSC
trace suggests this is a more stable form of the co-crystal than those formed by inkjet
printing and solvent evaporation. However, the separate formation of new polymorphs of
the raw materials cannot be ruled out.
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Figure 4-69. PXRD patterns collected for INCT and DHPAA.
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FTIR spectra can be seen in Figure 4-70. Aside from the disappearance of the weak
band at 1728 cm−1, probably relating to a carbonyl stretch, the spectra are identical. This
confirms the materials present have not undergone any chemical changes but does not
provide any additional data to confirm whether a co-crystal has formed.
Figure 4-70. FTIR spectra for a ball milled mixture of INCT and DHPAA and for crystals printed
from an equimolar solution of the two in EtOH:H2O (9:1).
4.3.4.4. INCT-LABA
The DSC trace for a milled mixture of INCT and LABA (Figure 4-71) has multiple events
of both endothermic and exothermic enthalpies. The trace most closely resembles that
of a mixture of the two materials after they have been ground separately. The calorimetric
data appear to follow the same pattern as the sample analysed by DSC-XRD, only with
higher peak resolution. Had all of the material reacted during milling then it is likely that
the thermogram would contain only one endotherm at ca. 140 °C, as the reaction crystal
melted. As was observed in Section 4.3.3.4, DSC suggests the milling of the two results
in few or no new intermolecular interactions.
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Figure 4-71. DSC data for crystals printed from an equimolar ethanolic solution of INCT and
LABA, and from mixtures of the two after being ground separately or ball milling [Data points for
the milled mixture between 102 °C and 108 °C have been removed as the data contained an
artefact in this range].
The diffraction pattern for the milled sample of INCT and LABA (Figure 4-72) further
clarifies the identity of the material. The pattern contains reflections which correspond to
both of the raw materials and the crystals formed by printing, but it is unclear whether
there are any from the other crystal formed by reaction and subsequent solvent
evaporation. Although the intensities are different the peak positions of the milled mixture
are all the same as those of the physical mixture and so it seems the most likely outcome
is no co-crystallisation.
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Figure 4-72. PXRD patterns collected for the INCT and LABA system products of each method.
258
Finally, FTIR spectra recorded for the milled sample and the physical mixture that
underwent no grinding (Figure 4-73) are almost identical. Again this suggests that no
changes in structure have occurred and confirms that no chemical changes have
occurred. As with the spectra for the INCT-DHPAA system, the only noticeable difference
is the appearance of a weak band at 1707 cm−1, relating to C=O stretching.
Figure 4-73. FTIR spectra for a ball milled mixture of INCT and LABA and for an equimolar
physical mixture of the two.
4.4. Discussion
Four co-formers (HBA, HPAA, DHPAA and LABA) were selected and their ability to form
co-crystals with INCT investigated using four synthesis methods (solvent evaporation,
thermal inkjet printing, heat co-crystallisation and ball milling). It is possible to synthesize
co-crystals of INCT and three of the four chosen co-formers, not only by the traditional
method of solvent evaporation, but for HBA, HPAA and DHPAA, by the three much faster
methods. In each case a co-crystal was grown by solvent evaporation and analysed by
single crystal XRD. These analyses defined crystal structures that were then used to
generate predicted powder patterns for comparison with data collected for samples
produced by the other three methods. The single crystal data were also used to carry
out Rietveld refinements on PXRD patterns collected for samples produced by heat
induced co-crystallisation using the combined DSC-XRD method described in Chapter
2.








HBA    
HPAA    
DHPAA   Unknown 
LABA    
INCT-HBA was the only system studied that had previously been reported to form a co-
crystal (VAKTOR). In this work a second, as yet unreported, co-crystal structure with the
monoclinic space group P21/c was grown by solution evaporation. DSC and PXRD
analyses confirmed that thermal inkjet printing resulted in crystals with the structure of
the previously reported co-crystal, rather than the new form produced in this work.
Rietveld refinement of DSC-XRD diffraction data has shown in great detail the process
by which heating a mixture of INCT and HBA results in their transition to VAKTOR.
Initially, INCT I and HBA form the newly discovered co-crystal before the evolution of
INCT becomes dominated by its conversion to INCT II. Following this, the new co-crystal
converts to VAKTOR, and INCT II and HBA combine to form the known co-crystal. This
system was also successfully co-crystallised via ball milling, as shown by DSC and
PXRD, and supported by FTIR.
Solvent evaporation has been employed to grow single co-crystals of INCT-HPAA in a
2:1 molar ratio with the triclinic space group P-1. All other methods employed were
successful in their attempts to grow the same co-crystals. Diffraction patterns collected
for samples produced by thermal inkjet printing and ball milling very closely matched that
predicted from single crystal diffraction data. Rietveld refinements of DSC-XRD data
have shown heat induced co-crystallisation to occur by what appears to be a localised
melt re-crystallisation mechanism for both materials with no other phases present. The
melt of the co-crystal in this experiment was shown to be the same as that of the printed
and ball milled samples, adding support to the conclusion that each method resulted in
the same co-crystals.
Solvent evaporation experiments on INCT and DHPAA were unsuccessful, however co-
crystals have previously been grown from a solution of these materials by other
researchers, although the results are yet to be reported. These crystals were formed in
a 1:1 molar ratio in the triclinic space group P-1. Thermal inkjet printing has produced
co-crystals with the same structure as those formed by solvent evaporation as
demonstrated by the similarity of the PXRD patterns of both. Applying heat to a mixture
of the two materials does appear to have resulted in co-crystallisation, but to a different
crystal structure to that of the solvent-grown and printed crystals. The same can be said
for the ball milled material. DSC traces for these two events exhibit a similar endothermic
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event at a slightly higher temperature than that of the printed crystals but their diffraction
patterns are distinct. Suggesting the occurrence of at least three polymorphs of this co-
crystal.
INCT and LABA reacted when in solution and results of the other methods are
inconclusive but appear to have been unsuccessful. It seems that the two materials are
incapable of co-crystallisation.
The results of the inkjet printing experiments were in line with those seen by Buanz and
co-workers81 who highlighted the necessity for multiple print passes to prepare sufficient
quantity for analysis, whilst also commenting on the low intensity to noise ratio resulting
from the small crystallite size, an effect observed here. Thermally driven co-
crystallisation has been shown to occur in all systems in which co-crystallisation was
possible, whilst in agreement with Yamashita’s86 work no crystallisation exotherms were
observed although it is expected that their suggestion of altering the heating rate would
reveal one in the two cases of confirmed co-crystallisation.
4.5. Conclusion
For all but one of the systems thermal inkjet printing produced co-crystals of the same
structure as those grown by solvent evaporation, which is unsurprising as the process is
very similar but on a much smaller scale. This method was very quick but resulted in very
small crystals and small sample sizes and so the quality of the diffraction data was not
as good as the other methods. Ball milling was by far the fastest and easiest method
employed and also produced co-crystals for all three systems in which it is deemed
possible.
Full characterisation of a co-crystal can most easily be carried out by single crystal
analysis and so solvent evaporation remains best method for this. However, initial
screening for the co-crystallisation potential of a system need not take so long. Thermal
inkjet printing is a cheaper and quicker alternative and ball milling provides an extremely
fast, cheap and environmentally friendly alternative but DSC-XRD analysis stands out
as the best method for fast screening and detailed analysis of the mechanism by which
two materials co-crystallise. Although the requirement of a synchrotron does mean it is
more expensive than all of the other methods, this would be an easy service for
synchrotron facilities to offer researchers, reducing the cost and in many cases resulting
in higher quality data.
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5. Physical Vapour Deposition of APIs
5.1. Introduction
As described in Chapter 1, amorphous materials have the structure of a liquid but the
physical properties of a solid. Upon cooling, at the Tm, a liquid will either crystallise (if
possible) or, if cooled sufficiently quickly to avoid crystallisation, become a metastable
supercooled liquid. In this state the response of the specific volume or enthalpy to further
cooling is the same as would be expected from a liquid above Tm2 and the system will
remain in equilibrium. If the supercooled liquid is cooled further the molecular movements
will continue to slow until eventually equilibrium cannot be maintained and the rate of
volume/enthalpy change becomes slower than the predicted liquid behaviour. This is the
Tg, and is the point at which the supercooled liquid becomes a glass.112,118
There are a number of methods currently employed in the vitrification of pharmaceuticals,
some of the most common being spray-drying, freeze drying, quench cooling, melt
extrusion, milling, and compaction.2,250 Glasses prepared by different methods exhibit
different stabilities,251 and quench cooling has been shown to produce some of the most
stable amorphous materials.4
Quench cooling applies the theory of rapid cooling very simply. The API in question is
heated to just above its melting point and held there until any crystalline character has
dissipated, whilst taking care not to let the sample degrade, before then quenching the
melt at a temperature below the Tg. Liquid nitrogen (LN2) is commonly used as the
quenching medium, although this is compound dependent (some are easier to vitrify than
others). So long as the rate of cooling is rapid enough that crystallisation does not occur,
the quenched sample will pass from the liquid phase through the supercooled liquid
phase and transition to a glass at the Tg.252 The benefits of quench cooling lie in its
simplicity: all that is required is a heat source and a quenching source. However, some
materials decompose upon melting or cannot be cooled quickly enough to avoid
crystallisation.2
PVD is an atomistic or molecular deposition process. This term refers to the mechanism
by which the deposition occurs, i.e. as individual atoms or molecules. Deposition in this
report refers solely to molecular deposition. The amorphous drug is produced by placing
a solid sample in a vacuum. The solid is then vaporised via either melting and boiling or
sublimation. Following vaporisation, the material is deposited onto a substrate. As
molecules arrive at the substrate from the vapour phase they join a fluid layer that is
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several molecules thick.118 At low deposition rates, molecular mobility in the surface layer
is sufficiently high that molecules will orientate themselves so that they are close to
equilibrium. They will then lose the ability for translational motion when subsequent
layers are deposited. There is a direct relationship between the temperature of the
substrate, the rate at which material is deposited, and the stability of the resulting film.119
The role of the substrate is to remove the thermal energy of the molecules as they are
deposited, fixing them with reference to their position in space and their orientation on
the substrate or previous layer of molecules. The rate at which a vaporised molecule
travels towards the substrate will affect the time allowed to remove the thermal energy
before it is locked into place by the next layer.
Figure 5-1. A schematic of the PVD apparatus.
Physical vapour deposition (PVD) has long been recognised as a feasible technique for
producing amorphous materials.121 However, until recently, these glasses were
considered to be high energy unstable materials that, as a result of this instability, would
relax and become crystalline far more rapidly than amorphous forms of the same species
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prepared via other, more conventional, methods.121–124 The reason for this perceived
instability stems from early studies into the properties of PVD samples, which were
deposited at low temperatures (in the region of −233 °C and above)124 without
considering the rate of molecular deposition. As a result of the findings of these studies
there has been little research into PVD for pharmaceuticals. If amorphous forms of a
drug are to be used clinically, they need to be stable at room temperature but highly
soluble, with a rapid rate of dissolution. Early reports suggested samples prepared via
PVD would dissolve quickly but also revert to crystallinity very quickly, therefore losing
the advantageous properties of an amorphous material.121–124,253
Considering the nature of amorphous materials it makes sense that if low temperature
deposition occurs at a fast rate the molecules will not have time to reorient themselves
into a more stable, lower energy, position relative to their surroundings before they are
trapped by subsequent molecules. This will lead to a bulk material with a few small
regions of short range order that is very unstable and relaxes quickly. Conversely,
deposition at the same rate onto a higher temperature substrate means that the
molecules in the mobile surface layer have more thermal energy and so will be able to
adjust their position more rapidly and settle into a more stable position before being
trapped by the next layer of material deposited. This should result in a bulk with larger
regions of short range order. Both methods will deliver amorphous products but with
different relaxation and dissolution characteristics. The former will both relax and
dissolve more rapidly than the latter, but both will dissolve more rapidly than the
crystalline form of the same substance; hence, the second option is more favourable
when considering drugs, as the resultant material is more stable and will retain its
amorphous character for longer upon storage.
It seems that the rate of deposition has a greater effect on the stability of the resulting
material127 than the substrate temperature. For any substance it is hypothesised that
there must be a combination of deposition rate and temperature at which the most stable
amorphous configuration will form, and from this point any decrease in temperature will
require a decrease in deposition rate to hold that equilibrium. If the rate is too low the
material will crystallise and if it is too high the product will have a higher energy and lower
stability.
Recently, it has been reported that vapour deposition can be utilised to prepare glasses
that are of lower energy and higher stability than those prepared via quenching of the
melt.119,129 This has been achieved by depositing on to low temperature substrates at a
low rate, and it is predicted that glasses prepared this way will be more stable than those
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aged for a period of more than 1000 years. These have been termed “ultrastable
glasses”.118,120,127
Swallen et al.129 have shown that deposition of a material onto a substrate 50 °C below
its glass transition temperature (Tg−50) results in glasses with higher kinetic and 
thermodynamic stabilities than those of the same substance vitrified via melt quenching.
The criterion for determining greater kinetic stability was a higher onset temperature for
the Tg, since this demonstrated that the molecules require more energy to alter their
glassy configurations. The thermodynamic stability was assessed by calculating the
fictive temperature (Tf) and comparing that of the two methods of vitrification. The Tf is
the temperature at which the supercooled liquid would have last been in structural
equilibrium (i.e. structural rearrangements occur at a high enough rate that the
enthalpy/volume reduces linearly with temperature) when the physical temperature
dropped below it. Therefore, the lower the Tf of a material the higher its stability. Swallen
also made the observation that a slower deposition rate results in a more stable glass.129
Kearns et al.119 looked at the influence of substrate temperature on stability and found
that the most stable indomethacin (IMC) glasses were obtained when deposited at 0.85
Tg and at a rate of 15 ± 3 nm s-1. No other compounds were studied, however, meaning
no general trends could be established.119 In 2010 another study led by Kearns used
nanocalorimetry to analyse the heat capacities of IMC glass formed at 0.84 Tg by PVD,
and showed that they are lower than those deposited at Tg, and therefore the former are
more stable.126 Kearns further investigated the effect of deposition rate on the stability of
the glass produced at constant substrate temperature, and found that the slower the rate
the higher the stability was.127
It has been reported that tris(naphthylbenzene) vapour deposited at 0.85 Tg shows
translational movements at least 100 times slower than those of the supercooled
liquid.254 This is supported by the work of Dawson et al.118 who have also shown, via
wide angle X-ray scattering, that in samples deposited at 0.2 nm s-1 and 0.84 Tg there is
a different local molecular packing arrangement to those of the melt quenched glass and
the supercooled liquid. These authors also reported that, when annealed slightly above
or slightly below the Tg, there is a phase transition resulting in the local packing reverting
to that of the supercooled liquid.118
This chapter will describe in detail studies to use PVD to prepare amorphous forms of a
range of active ingredients. The PVD vacuum chamber and its component parts will be
described, together with the extensive modifications required to render it suitable for
working with pharmaceutical materials. Following this, data will be presented for a
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number of pharmaceuticals that have been deposited using this apparatus with the aim
of metastable polymorph discovery according to Ostwald’s rule of stages (see Chapter
1).
5.2. The Physical Vapour Deposition Apparatus
5.2.1. Vacuum Chamber
Prior to the work reported here the apparatus described was developed by Jacob
Shephard for the preparation of amorphous solid water (ASW).125 The vacuum chamber
used (Figure 5-2) is a bespoke, stainless steel cabinet, with an aluminium door housing
a small glass window. It is manufactured by Kurt J. Lesker, and is the largest single part
of the apparatus. The internal dimensions of the chamber are 24 x 12 x 12 inches and it
has nine recesses, each leading to either a KF40 or an LF100 flange. These are standard
sizes and were used so that standard market components could easily be added to the
chamber. The volume of the chamber, including the attached components, is estimated
to be 0.080 m3 with an internal surface area of 1 m2.
Figure 5-2. The deposition apparatus.
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5.2.2. Diffusion Pump
The chamber is evacuated using a Diffstak 63 diffusion pump (BOC Edwards, Crawley)
(Error! Reference source not found.) with a water cooled body. Additionally, the pump i
s equipped with a liquid nitrogen (LN2) cooling baffle to reduce backstreaming (the
process of the oil vapour not condensing quickly enough and travelling backwards
through the system, thus contaminating the internal surface of the chamber). The
diffusion pump is a high vacuum pump and was used to consistently achieve chamber
pressures of 1.5 x 10-5 mbar and lower.
5.2.3. Deposition Stage and Plate
As the chamber was originally intended for the preparation of ASW at −193 °C, the 
deposition stage was designed to operate at this temperature. It consists of a 6 mm thick,
203 mm diameter copper plate. Embedded within the upper side of the stage is a coil of
¼ inch diameter copper tubing through which nitrogen vapour, at −193 °C, can flow via 
the bespoke stainless steel feedthrough (Kurt J. Lesker) from which it is also suspended.
Attached to the underside of the deposition stage, by six bolts, is a copper deposition
plate of the same dimensions as the stage (Figure 5-3). This allows for removal of the
plate following deposition and easy retrieval of the deposited material (Figure 5-4). The
upper face of the plate has seven protruding cylindrical copper contacts to allow for visual
inspection of the connection between it and the stage.
Figure 5-3. The deposition stage and plate within the vacuum chamber.
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Figure 5-4. (a) The deposition plate being removed from the deposition stage and (b) deposited
IMC being removed from the lower face of the deposition plate with a spatula.
The temperature of the deposition stage can be monitored by a K-type thermocouple
fixed to the upper side of the stage with a bolt and thermal paste, a temperature controller
(331, Lakeshore Cryotronics) and the Labview computer software (National
Instruments). Nitrogen flow was achieved by connecting one side of the feedthrough to
a 5 L Dewar with 2 m of insulated rubber tubing and the other side to a rotary vane
pump (Sogevac SV16, Oerlikon Leybold Vacuum) by 5 m of rubber tubing. A copper
coil submerged in a water bath was placed between the feedthrough and the rotary vane
pump to increase the temperature of the nitrogen vapour and so protect the pump (Figure
5-5). It is possible to control the flow of the nitrogen vapour through the system, and thus
the temperature of the stage, by adjusting a valve positioned between the water bath
and the pump.
Figure 5-5. A schematic illustrating the apparatus used for cooling the deposition stage with
liquid nitrogen.
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5.2.4. Sample Dosing Apparatus
The original sample heating set up (Figure 5-6) was designed to vaporise both water and
a solid, separately, within the evacuated chamber. It was originally used by Jacob
Shephard in the study of two-component liquids, namely water and fullerene, as it
allowed the deposition of a layer of fullerene between two layers of amorphous solid
water. A flange was fitted with a stainless steel tube, offset from the centre of the plate,
to which a bespoke water feeding set up could be attached outside the chamber. Next
to this, offset from the centre by an equal distance, is an electrical feedthrough to which
a tungsten basket filament (6.3 V, 43 A, 271 W, 1800 °C) (EVB8B3025W+, Kurt J.
Lesker) can be fitted within the chamber. Initial experiments involved placing powdered
solid IMC (ca. 0.3 g when filled) in an alumina crucible (13 mm diameter) designed to fit
within the coil of the filament whilst maintaining as much thermal contact as possible.
The water dosing apparatus connects to the stainless steel tube outside the chamber via
a clamp and O-ring, and consists of a needle valve and bespoke 3 chambered ground
glass flask. The feedthrough plate is located within a recess in the centre of the bottom
face of the chamber, directly beneath the centre of the deposition stage. The seal is
created by a gasket and O-ring (not pictured).
Figure 5-6. Photograph of the water/electrical feedthrough baseplate.
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5.3. Alterations and Additions to the Vacuum Chamber
5.3.1. Quartz Crystal Microbalance
When carrying out physical vapour deposition it is advantageous to employ a system for
monitoring the rate at which the material is being deposited onto the substrate. This rate
will affect the physical form and properties of the final product, as it dictates the time
each molecule will have to realign itself into a more stable position before being locked
into position by the next layer.118 Kearns et al.127 have shown that lowering the deposition
rate by two orders of magnitude, in two substances, lowered their respective fictive
temperatures by at least 10 K.
A quartz crystal microbalance (QCM, 710-SH Sensor Head, Allectra) was installed to
permit the deposition rate to be monitored. The QCM consists of a thin quartz disc with
gold plated electrodes and a sensor head (Figure 5-7) which is used to apply an
alternating electrical potential across the crystal. Quartz is a piezoelectric material and
therefore the application of an electrical potential will cause mechanical stress within it.
An oscillating electrical field applied across the crystal will result in an oscillating
mechanical response (a wave). The impedance experienced by the propagating acoustic
wave is measured using an impedance analyser (N2PK Vector Network Analyser (VNA),
makarov.ca) in conjunction with a graphical user interface (GUI) (myVNA, makarov.ca).
This information is interrogated using another piece of software (QTZ, Institute of
Physical Chemistry, Clausthal University of Technology) allowing determination of a
number of parameters, including the frequency shift experienced by the crystal when
material is deposited onto its surface. The amplitude of the oscillation will reach a
maximum when the thickness of the crystal is a multiple of a half wavelength of the
acoustic wave, at this point the conductance also reaches a peak.255 The frequency of
the oscillation is directly influenced by any material in contact with it, be that gas, liquid
or solid. A change in the mass, Δm, of the material accumulated on the crystal will result
in a change in the frequency, Δf, at which the crystal oscillates (Figure 5-8).256 This
change in frequency can then be used to calculate the mass of the material adsorbed
using the Sauerbrey equation:256–258
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Where f0 is the resonant frequency of the crystal, q is the shear modulus of the quartz
crystal, and q is the density of the quartz. Subsequently, the rate at which the material
is being deposited can be calculated by plotting the mass adsorbed against time and
taking the differential of the curve. The QTZ software has the option of plotting the
Sauerbrey thickness (thickness of the adsorbed layer) against time and, as is the
convention for deposition rate recording in the literature, has been used to calculate a
rate in nm s−1.
Figure 5-7. (a) Internal view of the two parts of the QCM sensor head showing the back of the
quartz crystal and the gold plated electrodes, and (b) the assembled QCM sensor head with a
quartz crystal in situ.
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Figure 5-8. A schematic showing the frequency shift experienced by the quartz crystal when
material is deposited onto it.
The QCM has been positioned in the centre of the deposition plate, directly above the
centre of the base plate feedthrough (Figure 5-9), because this is where the rate of
deposition will be highest and where the bulk of the material will be deposited.
Figure 5-9. The PVD assembly in experimental configuration, including the QCM.
5.3.2. Sample Dosing Apparatus
5.3.2.1. Alumina coated tungsten filament/crucible
Early experiments with indomethacin (IMC, Molekula) were carried out using the
feedthrough with the water dosing configuration previously developed and described in
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Section 5.2.4. However, a number of problems were encountered. A significant drawback
was the lack of reproducibility of the rate at which material could be deposited onto the
substrate, as can be seen from the three examples in Figure 5-10. Two of the depositions
were carried out by filling the crucible with IMC and applying an initial voltage of 70.0 mV
at the transformer (which translates to 7.0 A at the filament), which was later increased
to achieve a higher rate of deposition, yet despite the use of identical initial conditions
the increase in the thickness of the layer deposited onto the quartz crystal was very
different. The third (black squares) was carried out by applying 75.0 mV to the
transformer and increasing this incrementally to 113.0 mV, at which point deposition was
observed. This demonstrates a clear problem with poor reproducibility of deposition rate.
This is directly related to the temperature within the crucible.
Figure 5-10. Plots of Sauerbrey thickness versus time for three different depositions of IMC
using the original dosing configuration.
The chamber pressure in all of the initial depositions was relatively uniform, as can be
seen from the examples in Figure 5-11, which shows the pressure dropping to between
1.8 x 10−6 mbar and 2.6 x 10−6 mbar on all three occasions. This is representative of all
of the depositions carried out. This consistency of the base pressure of the chamber
indicates the temperature of the crucible is the cause of the poor reproducibility of the
deposition rate.
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Figure 5-11. Plots of chamber pressure versus time for three depositions of IMC, using the
original dosing configuration.
As the crucible and basket filament are separate items it is possible that the physical
contact between the two may not have been the same for each experiment. Between
each deposition the crucible was removed from the chamber and cleaned before refilling
it with sample and again placing it in the filament. The orientation of the crucible in
relation to the filament may not have been exactly the same each time, or the crucible
may not have been placed within the filament with the same amount of pressure. The
decision was made to replace the dosing apparatus with an alumina coated tungsten
filament/crucible (NC-11, Megatech) (Figure 5-12).
Figure 5-12. A photograph of the alumina coated tungsten filament.
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In addition to this alteration, it was necessary to replace the entire electrical feedthrough
assembly responsible for applying current to the filament. The original configuration was
unable to accommodate the new coated filament and, as stated previously, was capable
of depositing both water and a solid sample simultaneously. The water dosing apparatus
was not necessary for this study and therefore a new baseplate was built without this
feature. Figure 5-13 shows the new baseplate and copper feedthroughs (261-1000WC-
BP, Allectra). Whereas the original baseplate required a bespoke water cooled brass
plate to be manufactured and fitted, the new feedthroughs were designed, by the
manufacturer, with an integrated water cooling feature. This should reduce any effects
caused by radiated heat. Another advantage of the new arrangement is that the coated
filament sits more centrally between the two copper feedthroughs and therefore deposits
more centrally on the deposition plate. This is more important with the addition of the
QCM to the centre of the face of the deposition plate.
Figure 5-13. A photograph of the new baseplate and water-cooled copper feedthrough
assembly.
Deposition rates of IMC from the coated tungsten filament were more reproducible than
with the original sample dosing configuration, as can be seen in Figure 5-14. However,
the reproducibility was still unacceptable. The major drawback of this and the previous
set up was that the temperature of the crucible could not be monitored directly. Initially
the heating apparatus was designed to sublime fullerene, which requires much higher
temperatures at the crucible than any pharmaceutical material would. Consequently, a
much lower current was required across the filament to achieve sublimation of IMC and
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so a relatively small change in the voltage applied had a large effect on the behaviour of
the sample. As a current was applied to the filament, its temperature increased, causing
a rise in its resistance and thus the current, and so the voltage, to drop. Over time this
caused a decrease in temperature at the sample. This change in voltage was observed
at the transformer for all deposition experiments carried out with both sample dosing
configurations. Therefore, apparatus allowing more precise control of voltage was
required to implement a reproducible process.
Figure 5-14. Sauerbrey thickness as a function of time when supplying 0.100 ± 0.005 V to an
alumina coated tungsten filament containing IMC [* denotes time at which voltage was supplied
to the filament].
A further problem observed for the coated filament was that following each experiment
very little material was present on the deposition plate. This is a consequence of two
factors: the small size of the crucible, and its conical shape, resulting in a much broader
cone of sublimation than the cylindrical crucible used with the initial heat source. As a
result, less material was directed towards the deposition plate, and much of it collected
on the chamber walls. This was observed when cleaning the chamber following each
experiment. For these reasons a third heat source was installed.
5.3.2.2. Low Temperature Evaporator (LTE)
To solve the problems outlined above the filament/crucible was replaced by a
proportional integral differential (PID) controlled (2208e, Eurotherm) low temperature
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evaporator (LTE10, Kurt J. Lesker) (Figure 5-15). This allows direct control of the crucible
temperature between 50 and 600 °C, to a tolerance of ± 0.1 °C. Samples were loaded
into an aluminium oxide crucible (EVCEF-10AO, Kurt J. Lesker) which was then placed
within the heating coil. The temperature at the base of the crucible was monitored by
external contact with a K-type thermocouple connected to the PID controller. The crucible
used with this heat source was cylindrical and much larger than either of the two previous
sample vessels, and so had the advantage of a more directed cone of deposition. Thus,
less material was lost to the vacuum pumps. This addition was the final alteration made
to the sample heat source.
Figure 5-15. The LTE heat source showing full assembly (left) and heating coil with stainless
steel housing removed (right).
The initial objective of the work in this chapter was to produce high stability amorphous
APIs via physical vapour deposition and to assess the stability of these materials upon
storage using a number of different techniques. However, development of the vacuum
chamber took significantly longer than anticipated and so, rather than attempt to produce
high stability amorphous materials the work herein demonstrates the utility of the
technique for preparing novel amorphous pharmaceuticals.
5.4. Materials and Methods
IMC and griseofulvin (GF) were purchased from Molekula and used as received. Benzoic
acid (BA) was purchased from Sigma-Aldrich, while famotidine (FMT) and finasteride
(FST) were purchased from Alfa Aesar and used as received. Urea was purchased from
Fluka. Due to their large particle size BA and urea were gently ground in a pestle and
mortar before loading into the PVD crucible.
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5.4.1. Physical vapour deposition
Vapour-deposited samples of all APIs were prepared in a Kurt J. Lesker vacuum
chamber, the components of which have been described in Sections 5.2.1 and 5.3. The
crystalline powder sample was placed in the crucible in the LTE within the vacuum
chamber (Figure 5-2), which was then evacuated to a base pressure of no more than 5
x 10−6 mbar. The sample was then heated and vaporised and the vapour deposited onto
a copper substrate held at either 20 °C or −189 °C. The deposition plate was removed 
from the stage and the deposited material scraped from it using a spatula. Material
deposited at −189 °C was removed from the chamber and deposition plate under LN2 to
avoid any phase transitions resulting from a rise in temperature, and to avoid the
adsorption of atmospheric water. Cold-deposited materials were also stored under LN2.
5.4.2. PXRD
Room temperature powder X-ray diffraction patterns were recorded using a Rigaku
Miniflex 600 instrument operating at 40 kV and 15 mA (Cu Kα radiation, λ = 1.5418 Å)
with powder samples mounted onto aluminium plates. Diffracted intensity from the
sample holder did not interfere with characterisation.
Cold (−186 °C) powder X-ray diffraction was conducted on a Stoe Stadi-P diffractometer 
(Ge 111 monochromated Cu Kα, 40 kV, 30 mA). Samples were transferred under LN2 to
bespoke brass sample holders with Kapton windows before mounting on the goniometer.
Data were collected using a Mythen 1K linear detector, and the temperature of the
sample was controlled by an Oxford Instruments CryojetHT.
5.4.3. DSC
Conventional DSC measurements were carried out on a TA Instruments Q2000
calorimeter. Calibrations for cell constant and enthalpy were performed with indium (Tm
= 156.6 °C, ΔHf = 28.71 J g−1) according to the manufacturer’s instructions. The cell was
purged with dry nitrogen at a flow rate of 50 mL min−1 throughout experiments. TA
Instruments Tzero aluminium pans and lids and a heating rate of 10 °C min−1 were used
for all experiments unless stated otherwise. Data were analysed using the TA
Instruments Universal Analysis software, and transformation temperatures are reported
as extrapolated onsets unless stated otherwise.
Low-temperature DSC measurements were conducted on a Perkin Elmer DSC 8000.
Samples were transferred into stainless steel pans with threaded lids under LN2 before
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transferring to the precooled (−180 °C) furnace. A heating rate of 10 °C min−1 and a
helium flow rate of 40 mL min−1 was used for all samples.
5.5. Results and Discussion
PVD was attempted on a number of materials with varying success. Some relevant data
are presented in Table 5-1. Due to the relatively high vapour pressure of BA it sublimed
while lowering the chamber pressure and, as there was no way to cool the sample,
deposition was impossible. In contrast, IMC, GF and FMT all appeared to melt and boil
in the chamber rather than sublime. Whilst this led to some sputtering effects for all three,
in the case of IMC it was still possible to collect sample from the deposition stage. GF
was abandoned in preference of a subliming sample, and upon removing the crucible
from the chamber following deposition of FMT the remaining material was observed to
have browned and degraded, and so this compound too was abandoned. Urea is
reported to have a vapour pressure higher than the base pressure reached when
evacuating the chamber (ca. 3.5 x 10−6 mbar), but nevertheless deposition was
successful and no evidence of sublimation prior to heating of the sample was observed.
This suggests that the literature vapour pressure might be incorrect. No data could be
found relating to the vapour pressure of FST, however deposition was successful onto
the substrate at ambient temperature.
Table 5-1. APIs submitted to PVD, with some relevant physical properties.
Property IMC GF BA FMT FST Urea
Tmelting / °C 158.95259 220260 122.38259 163.38259 258.7261 133.85259













25 °C / mbar




1.09 x 10−3 
[264] - -
2.33 x 10−5 
[265]
Deposition
success Y N N N Y Y
*values are predicted due to lack of experimental data. No vapour pressure data could be found
for FMT or FST.
5.5.1. Indomethacin
IMC was deposited at ambient temperature. Figure 5-16 (a) shows a DSC trace typical
of the IMC samples prepared via PVD.
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Figure 5-16. (a) A DSC thermogram of amorphous IMC prepared by PVD. Both the Tg and
endotherm of crystallisation are present. (b) PXRD patterns of an empty sample holder (red)
and IMC prepared by PVD in the same sample holder (black). (c) DSC thermograms of the
melting endotherms for three samples of γ-IMC. The enthalpy of fusion is shown for each.
There is an obvious Tg at 23.8 °C confirming the presence of amorphous material. The
temperature at which this transition occurs is much lower than the value of ca. 42-50 °C
generally reported in the literature for the Tg of IMC.110,266–268 This indicates that the glass
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formed by PVD is less kinetically stable than glasses formed via other techniques, as it
requires much less energy to enable the molecules to find equilibrium.129
The X-ray pattern of the deposited material (Figure 5-16 (b)) contains no Bragg
reflections and so confirms the presence of amorphous material. These data prove the
utility of the apparatus for the preparation of amorphous pharmaceutical materials.
5.5.2. Finasteride
FST was submitted to ambient PVD using the LTE heat source described in Section
5.3.2.2. The chamber pressure was maintained between 1.5 x 10−5 mbar and 6.2 x 10−6
mbar (Figure 5-17). Initial experiments were conducted to establish the temperature
required to induce deposition, as monitored by the QCM. For all experiments,
irrespective of the dosing configuration, there was a spike in chamber pressure observed
when first supplying power to the heat source. It is unclear what caused this but there is
a similar event in the QCM data, which indicates that it may be the sample outgassing
(releasing trapped/adsorbed gas) or an artefact resulting from the chamber not being
earthed. Following this there is a steady increase in Sauerbrey thickness of the material
adsorbed to the quartz crystal, resulting from vaporisation and deposition of the sample.
Initially, the temperature was set to 70 °C. The deposition rate was monitored and as the
heat source reached the target temperature it was increased by 5 °C. This was repeated
up to 175 °C and is visible as steps in the deposition data in Figure 5-17. The range of
temperatures applied to the sample resulted in deposition rates up to ca. 10 nm s−1.
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Figure 5-17. Chamber pressure and deposition rate for a sample of finasteride deposited onto a
substrate at ambient temperature.
Following deposition the sample was removed from the copper plate at ambient
temperature and pressure and characterised by PXRD. Insufficient material was
retrieved from the substrate for additional DSC analysis. The resulting diffraction pattern
(Figure 5-18) is absent of Bragg reflections, and displays no evidence of any crystal
structure. Thus PVD is a useful technique for vitrifying FST. A literature search revealed
only one other instance of amorphous FST, a patent application which refers to recovery
of the material from solution.269 This work appears to be the first instance of dry
vitrification of FST.
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Figure 5-18. The PXRD pattern for a sample of FST deposited onto a substrate at room
temperature.
A second sample of FST was prepared by PVD. The crucible was heated to 170 °C as
quickly as possible, which resulted in a deposition rate of 55 nm s−s (Figure 5-19), a
fivefold increase in the maximum rate observed for the previous deposition at 175 °C. It
was noticed in subsequent experiments that the heat source thermocouple was
intermittently outputting an error message. The temperature controller was programmed
to cut power in this instance, which may be the explanation for the difference in
deposition rates. Eventually the thermocouple was replaced.
Figure 5-19. Chamber pressure and deposition rate data for a sample of FST submitted to PVD
onto a substrate at ambient temperature. The sample was heated at 170 °C, achieving a
deposition rate of 55 nm s−1.
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Towards the end of the deposition, at around 11200 s, the chamber pressure began to
fluctuate and increased to ca. 2.8 x 10−4 mbar. It is unclear whether this was caused by
a leak in the system or a problem with the diffusion pump. It does not appear to have
been caused by the sample as deposition had almost completely stopped by 12000 s
and the pressure remained high until 12930 s, at which point it rapidly dropped back
down to 1.0 x 10−5 mbar. This does not appear to have affected the material properties.
The sample was removed from the chamber as was the previous sample and submitted
to simultaneous DSC-XRD (Figure 5-20 (a and b)). Again the deposition process resulted
in the vitrification of the drug, as can be observed by the complete absence of reflections
in the contour plot. The pattern collected at 39.9 °C (Figure 5-20 (c)) shows only those
reflections resulting from the experimental set up that were observed in all datasets.
Upon heating there is a broad endotherm visible in the thermogram, which continues
until ca. 120 °C, just prior to the onset of the subsequent exotherm. This is a result of
water loss, which is commonly observed around 100 °C. This is confirmed by the lack of
changes in the diffraction data. Amorphous materials are known to be much more
hygroscopic than crystals2 and so it is unsurprising that water loss was observed in the
DSC trace for FST glass. The presence of water in an amorphous material is also known
to be a plasticiser leading to the eventual crystallisation of the substance.2 It is interesting
that the sample did not crystallise prior to analysis, suggesting that even in the presence
of a plasticiser such as water PVD FST is a relatively stable glass.
Immediately following the water loss the sample begins to crystallise as can be seen by
the appearance of a number of reflections in the diffraction data, which are accompanied
by an exotherm with a small shoulder on the low temperature side. The onsets of the two
peaks occur at 127.6 °C and 135.2 °C respectively, and it appears they are both a result
of the same process, as the diffraction data show the appearance of only one set of
Bragg reflections.
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Figure 5-20. (a and b) DSC-XRD data for a sample of FST after physical vapour deposition onto
a copper substrate at ca. 25 °C. (c) the PXRD pattern collected at 39.9 ºC for the same sample
[reflections marked * are a result of the experimental set up].
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Rietveld refinement of the pattern recorded at 237.2 °C (Figure 5-21 and Table 5-2)
shows that the glass has crystallised to FST polymorph II, with no other species present,
confirming the exotherm to be a result of crystallisation to a single species. The
multiplicity of the exotherm suggests the crystallisation occurs in two steps.
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Figure 5-21. Rietveld refinement data for FST at 237.2 °C following preparation via PVD. The tick marks show the positions of allowed reflections.
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Table 5-2. Refinement parameters for a vapour-deposited sample of FST following heat induced
crystallisation. The starting model was taken from the CSD (WOLXOK03).
Property Finasteride
Form II
T / °C 237.2
Space group P21
a / Å 16.8042(11)
b / Å 7.9090(4)
c / Å 18.086(2)
α / ° 90
β / ° 105.926(6)
γ / ° 90
Cell volume / Å3 2311.5(3)
Rwp 0.0727
Rwp-bkd 0.1625
Material from the same deposition experiment was subjected to a number of further DSC
analyses under different conditions (Figure 5-22). The aim of initial experiments was to
establish whether the broad endotherm was water loss and if this had an effect on the
subsequent crystallisation. Annealing at 80 °C and 100 °C before cooling the sample and
reheating successfully removed the endotherm, confirming the event was caused by
evaporation of water.
Figure 5-22. DSC thermograms showing crystallisation of a sample of vapour deposited FST
after aging and annealing. For all samples the annealing time was 5 minutes and the heating
rate 10 °C min−1.
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Due to the proximity of the endotherm to the crystallisation exotherms it was not possible
to accurately measure the enthalpy of crystallisation (ΔHc). However, the data in Figure
5-22 are all normalised to units of W g−1 and so the peak shapes, sizes and positions are
directly comparable. The ΔHc for all samples except that annealed at 100 °C are very
similar and all crystallisation occurs at the same temperature. It appears that the
crystallisation from amorphous to form II occurs via a two-step process, although it is
unclear what these two steps may be.
Dawson et al118 used WAXS to probe the structure of amorphous IMC prepared by PVD
and compared it to that of the supercooled liquid of the same compound. Diffraction
patterns collected for the supercooled liquid and the glass prepared by quenching the
melt (Figure 5-23 (a)) show very subtle differences in intensity, indicating the average
local packing changes only slightly with temperature. The initial pattern recorded for the
PVD IMC (Figure 5-23 (b)) displays a broad, high intensity reflection at low angles that
is not present in the other disordered phases. These data suggest the existence of two
glass structures. One is essentially the same as that of the melt and is accessed by
supercooling it, the other is accessible by PVD. Annealing of the deposited sample for
relatively long periods (in excess of 13 hours) above Tg resulted in its reversion to the
packing of the quench cooled glass, whereas little change was observed in the structure
of the supercooled liquid as a function of temperature. It was initially thought that this
may be the reason for the doublet nature of the exotherm of crystallisation for FST.
However closer inspection of the diffraction data shows no change in the profile of the
amorphous pattern as a function of temperature, only the appearance of Bragg
reflections as the material crystallises. In fact, the profile of the pattern recorded at 39.9
°C for the deposited material closely matches the pattern recorded for the melt. The two-
step nature of the crystallisation is not observable in the diffraction data and it appears
in this instance that DSC is more sensitive to the changes occurring.
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Figure 5-23. WAXS patterns for IMC (a) in the supercooled liquid state, and the melt quenched
glass state, and (b) vapour deposited onto a substrate at −8 °C and annealed at 46 °C (4 °C 
above Tg) for 500 min. Permission to reproduce these images has been granted by Dawson et
al.118
The evolution of FST from amorphous to polymorph II is depicted in Figure 5-24. The
initial crystallisation occurs very rapidly and is complete by 148 °C, which shows good
agreement with the exothermic peak in the DSC data at 142.7 °C. Following
crystallisation the amount of crystalline material in the beam continues to grow but at a
much slower rate; this is probably due to more material being lifted into the beam from
the bottom of the sample pan as it expands. It is unlikely that there would be additional
crystallisation occurring with further heating, since nucleation from the crystalline
material already present would result in rapid crystallisation of any amorphous material
in contact with it in the first stage of crystallisation. Finally the sample melted, and by 259
°C there was no crystalline material left; this coincides with the peak of the large
endotherm in the DSC trace (258.9 °C).
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Figure 5-24. A plot of integrated area under the diffraction pattern of FST form II as a function of
temperature for a sample prepared by PVD.
5.5.3. Urea
5.5.3.1. Determination of temperature required for deposition
Urea was deposited onto a substrate held at −189 °C. As with FST, initial experiments 
were run to establish the temperature range in which an acceptable rate of deposition
would occur. The chamber pressure (Figure 5-25) remained relatively constant at 4 x
10−6 mbar throughout the experiment except for three large spikes at 7880 s, 8560 s and
11140 s. This behaviour was observed in all experiments and coincides with the
application of more power to the heat source. These spikes are an artefact and probably
a result of the chamber not being earthed properly. Initially the heat source was set to 50
°C, but overshot this and settled at 67 °C. At this temperature the rate of deposition was
around 2.4 nm s−1 and the QCM was still responsive so the set point was increased. The
final temperature was 80 °C, which resulted in a deposition rate of over 15 nm s−1.
Following this the QCM became saturated with adsorbed material and no more useful
readings could be obtained. This was deemed an acceptable deposition rate to produce
a large enough sample for analysis and so further experiments were carried out heating
at 80 °C.
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Figure 5-25 Chamber pressure and deposition rate data for a sample of urea deposited at −189 
°C. The sample was heated gradually from ambient to 80 °C [Sauerbrey thickness data
between 9600 s and 11000 s have been removed as the QCM timed out in this range].
Following deposition the sample was analysed by PXRD (Figure 5-26). The procedure
for carrying out this analysis involved working under LN2 and using a bespoke sample
holder with Kapton windows. For this reason all diffraction patterns of samples deposited
at −189 °C display a broad high intensity reflection at 5.6° 2θ. The first pattern was
collected at −185 °C. Due to the complex nature of the sample transfer under LN2 it was
very difficult to ensure the material was not allowed contact with atmospheric air.
Consequently there are a number of reflections in the pattern that have been assigned
to hexagonal ice. It is apparent from the nature of the broad high intensity background
that most of the urea in the sample was amorphous, however there are three unassigned
reflections (*). This suggests the presence of some crystalline urea.
A second pattern was recorded after heating the sample to −123 °C (Figure 5-26). The 
Kapton and hexagonal ice reflections remain unchanged, as does the background.
However, the three unidentified reflections from the first pattern are absent. This
indicates that the crystalline entity present in the lower temperature pattern is no longer
present. It seems unlikely that the species was less stable than the amorphous form but
it is unclear why it has disappeared.
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Figure 5-26. Diffraction patterns for a sample of deposited urea at −185 °C and following heating to −123 °C. 
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A final pattern was recorded for this sample of urea at −83 °C (Figure 5-27), at which 
temperature the material has fully crystallised to polymorph I. Some hexagonal ice
remains in the sample and the reflection for Kapton is also still present, but there are no
unassignable reflections. Other than the disappearance of the three unidentified
reflections it should be noted that there is a range of high intensity diffraction at low 2θ
values that gradually decreases in intensity as the sample is heated.
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Figure 5-27. Diffraction pattern collected for a deposited sample of urea after heating to -83 °C and predicted from single crystal data obtained from the CSD
(UREAXX12).270 Reflections marked * are attributed to hexagonal ice.
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These data show amorphous urea without additives can be prepared by PVD onto a
substrate at −189 °C and crystallises to form I between −123 °C and −83 °C. This 
appears to be the first time this has been achieved. The data also suggest the existence
of another polymorph at low temperatures, although there are not enough reproducible
data to confirm this. There are two other polymorphs of urea reported in the literature271
but they have only been shown to exist at high pressures.
5.5.3.2. DSC
A second urea formulation was prepared by PVD onto a cold substrate by heating the
sample to 80 °C under vacuum. Following collection from the substrate three samples of
the material were subjected to DSC analysis (Figure 5-28). All three traces have a
relatively small exotherm at −90 °C, a result of crystallisation of form I from the glass. 
Two of the three traces display a large exotherm at ca. −154 °C that is absent from the 
third. This absence is a consequence of the difficulty of the sample transfer under liquid
nitrogen. It seems that the temperature of the third sample increased during loading of
the DSC pan, allowing the exothermic event to occur before analysis. It is interesting that
the large exotherm is of a different magnitude in each of the two traces in which it is
present. This may also be a result of some increase in temperature during loading of the
pan. The temperature at which the exotherm occurs coincides with the range of
temperatures at which the unidentified reflections disappear from PXRD patterns of the
first sample, suggesting the two responses are caused by the same event. It is also
possible that whatever caused the decrease in intensity at low 2θ is responsible for the
exothermic events in the thermograms. This is discussed in section 5.5.3.3.
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Figure 5-28. DSC traces recorded for urea deposited onto a substrate at -189 °C. All samples
were deposited during the same experiment.
5.5.3.3. Low Temperature PXRD
Following the two initial experiments described in the previous paragraphs attempts were
made to deposit sufficient sample for both DSC and XRD analysis of material from the
same experiment. Data were collected for four depositions; the results were the same in
all cases, and thus data for one representative sample are given. Figure 5-29 shows
PXRD patterns recorded for the deposited urea as a function of temperature. As was
described in Section 5.5.3.1, the pattern collected at −185 °C displays reflections 
indicating the presence of hexagonal ice and a medium intensity broad reflection caused
by the Kapton window of the sample holder, but the urea is amorphous. However, there
are no unidentifiable reflections in this case. Again there is a region of high intensity at
low angles. From −183 °C to −103 °C the only observable change in the data is a 
reduction in the low angle intensity, and between −103 °C and −93 °C the glass 
crystallises to urea form I.
The DSC trace recorded for material from the same deposition (Figure 5-30) shows
crystallisation at −88 °C, but the large exotherm at −154 °C observed previously for 
deposited urea (Section 5.5.3.2) has been replaced by a much smaller (relative to the
exotherm of crystallisation) broad exothermic event that appears to also have an
accompanying change in heat capacity. A change in heat capacity would usually be
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associated with the glass transition of a sample, which may be the case here. However,
the intensity of the low angle reflection in the XRD data undergoes a gradual decrease
over the temperature range of the experiment and may be caused by the same event.
Recent work probing the formation of metal organic frameworks (MOFs) using in situ
synchrotron PXRD has ascribed an increase in low angle diffraction at the beginning of
the process to the formation of non-crystalline aggregates.272 These clusters of
molecules go on to form crystal nuclei. The result of this is a decrease and eventual
disappearance of the low angle scattering. This may be the explanation for the presence
and behaviour of the diffracted intensity at low angles in this work.
Figure 5-29. PXRD patterns recorded as a function of temperature for a sample of urea
deposited onto a copper substrate at −189 °C. 
298
Figure 5-30. A DSC thermogram for a sample of urea deposited onto a copper substrate at
−189 °C. 
Despite numerous attempts, DSC and PXRD data from the first two samples deposited
could not be replicated. The identity of the crystalline species present between −185 °C 
and −123 °C remains unknown. However, it has been shown that PVD is an effective 
method for the vitrification of urea, and that the transition from this glass to polymorph I
occurs at −90 °C. 
5.6. Discussion
The aim of this study was to vitrify a number of pharmaceutical materials that could either
not be made glassy by other methods or that could be made into transient, unstable
amorphous materials by other methods. Following which it was hoped that, upon heating,
these glasses may recrystallise to new metastable polymorphs according to Ostwald’s
rule of stages. Initial experiments with IMC were promising and produced amorphous
material but the mechanism by which the drug was vaporised (i.e. boiling rather than
sublimation) resulted in spluttering of the material onto the substrate and so the
deposited film was not uniform. Successful depositions of IMC in the literature were
carried out at pressures in the region of 10−8 mbar,127,128 around two orders of magnitude
lower than reported here. No mention of this sputtering was found in the literature and
although its effect on the properties of the prepared drug was not known it was decided
to deposit other materials, having proven the ability of the experimental set up to vitrify a
model glass former.
Studies of FST were successful in vitrification without sputtering, indicating the
vaporisation process occurred via sublimation rather than boiling. Samples were
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submitted to detailed analysis via simultaneous DSC-XRD, and the glass was shown to
be reproducibly stable, upon heating, to 120 °C, at which point it crystallised to form II.
There is no literature with which to compare these results.
Urea was also successfully vitrified but onto a substrate cooled with a flow of liquid
nitrogen. These data are particularly promising as only one mention of amorphous urea
has been found in the literature. Lu attempted to prepare amorphous matrices from
physical mixtures of urea and tolbutamide by quench cooling the melt. Urea crystallised
immediately following quenching when present with tolbutamide in an equal mass ratio,
but mixtures with less than 40 % w/w urea remained amorphous. Furthermore, attempts
at vitrifying pure urea by quench cooling were unsuccessful, even when quenching with
LN2 (−196 °C).273
A Scopus search using the terms amorphous and pharmaceuticals on 22 August 2017
returned 27871 results, whereas a search for amorphous, physical vapour deposition
and pharmaceuticals returned 107, 25 of which had a common author. In the past 5 years
the average number of publications per year is less than 13. It is clear that the topic is
little known to the pharmaceutical scientific community. Furthermore, much of the work
was carried out on indomethacin (adding indomethacin to the vapour deposition search
returned 58 documents), widely used as a model pharmaceutical glass former,
suggestive of a difficulty in vitrifying other materials by this method. Although a number
of others have been shown to form stable glasses by PVD.132
The literature undoubtedly shows PVD to be a technique capable of producing extremely
stable glasses.118,120,127–129,132,274–276 However, work in this thesis has proven it to be a
very technically challenging process that requires a very delicate balance of parameters
to achieve the best results. Furthermore, it seems unlikely to be easily scaled up for the
purpose of the production of large quantities of material without considerable expense.
5.7. Conclusions
Physical vapour deposition has been shown to be an effective method for the vitrification
of pharmaceutical materials. Indomethacin, a material known to form a glass via
PVD,118,119,127,129 was used as a model material to demonstrate the ability of the technique
to produce glasses. Subsequently, FST (a drug with just one instance of glass formation
in the literature) and urea (with no history of glass formation) were vitrified by the same
method. Simultaneous DSC-XRD has shown vapour deposited FST to crystallise to form
II at 120.1 °C. Examination of the crystallisation exotherm reveals that the glass is stable
at ambient temperature over a period of three weeks. Deposition of urea at −189 °C 
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resulted in its glass formation for, to the best of my knowledge, the first time. Upon
heating, crystallisation to form I occurs at −90 °C. PXRD suggests there may be another 




Solubility and dissolution are major barriers to the successful development of new solid
state medicines and can considerably affect the bioavailability of an active
pharmaceutical ingredient (API). The vitrification of drugs or formulation as metastable
polymorphs and co-crystals are all approaches which have the potential to overcome this
problem. However, for many APIs methods of vitrification are frequently incapable of
producing glasses of adequate stability, and methods of screening possible co-crystals
are slow, expensive, and often many must be employed to be confident that any
polymorphs likely to appear in future manufacturing processes have been discovered.
A major aim of this work was to develop a novel method for the analysis of phase
transitions in pharmaceutical materials by combining high energy synchrotron X-ray
diffraction with differential scanning calorimetry (DSC-XRD) and thus collect in situ
structural and calorimetric data on temperature driven phase transitions. Initial work was
designed to prove the utility of the hyphenated technique by examining two
enantiotropically polymorphic systems (Chapter 2), and subsequently it was used to
examine phase transitions in materials exhibiting multiple polymorphs (Chapter 3).
Building on this, Chapter 3 moved on to examine the effect of the addition of sugar based
excipients on the crystallisation behaviour of paracetamol glass upon heating, with
particular emphasis on the stabilisation of metastable polymorphs II and III.
The aims of the experiments discussed in Chapter 4 were to create new co-crystals
between isonicotinamide, a common pharmaceutically acceptable co-former, and four
antioxidant compounds, whilst also assessing the ability of four different techniques
(solvent evaporation, thermal inkjet printing, heating, and milling) to prepare co-crystals.
Again DSC-XRD was employed for the study of the processes by which temperature
driven co-crystallisation progresses.
Finally, physical vapour deposition, a novel technique in the field of pharmaceuticals,
was investigated for the preparation of amorphous materials, with particular emphasis
on drugs considered to be poor glass formers, such as griseofulvin, or that had not been
vitrified without excipients before, such as finasteride, and urea. Additionally it was hoped
that preparation of these glasses may lead to the discovery of new polymorphs of the
materials according to Ostwald’s rule of stages.
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6.1. Chapter 2
The data presented in Chapter 2 have evidenced the simplicity of the set-up required to
modify a DSC for use in conjunction with synchrotron X-ray diffraction techniques. With
the application of high intensity synchrotron radiation it is possible to collect diffraction
patterns on a sample mounted in a conventional DSC pan in seconds simply by drilling
two holes in the DSC cell. This allows the simultaneous probing of both energetic and
structural changes occurring in the sample as it is heated. Rietveld refinement of the
pattern collected for a sample of sulfathiazole procured as phase pure form III identified
two phases, form III and unexpectedly the metastable form IV. As expected, increasing
the temperature of the sample caused expansion of the unit cell in all three dimensions
for both polymorphs. At 154 °C forms III and IV simultaneously underwent an
endothermic solid-solid conversion to polymorph I, which is stable at high temperatures.
A sample of glutaric acid (GA) explored by DSC-XRD was shown to be the ambient
temperature stable β polymorph at room temperature. When heated, β-GA transformed
to the high temperature stable α polymorph at 72 °C via a solid-solid pathway. Of
particular importance is the potential of the technique to provide information on otherwise
hidden phases, as exhibited in the data recorded for sulfathiazole. Direct solid-solid
phase transitions were observed and batch Rietveld refinements were carried out on the
hundreds of patterns collected for each sample, allowing the assessment of changes in
the unit cell parameters and phase quantification as a function of temperature.
6.2. Chapter 3
The use of DSC-XRD to study phase transitions has revealed that many are more
complex than previously thought. The mechanism of many solid-solid phase transitions
has been shown to progress via a rapid transitional melt phase within small regions of
the sample, with some melting and recrystallising before others melt, resulting in the
continuous presence of crystalline material in the sample.
Dihydrocarbamazepine form II was shown to convert to form I on heating, by a solid-
solid phase transition. Carbamazepine (CBZ) form IV transformed to form I at 182 °C by
the same mechanism, and from a third sample of CBZ, consisting of forms II and III, form
II underwent a solid-solid conversion to form I at 119 °C and form III appeared to
simultaneously melt-recrystallise and sublime, presumably recrystallising207 out of the
path of the incident beam due to the pan being open.
Monitoring the lattice constants as a function of temperature and comparing these data
with the hydrogen bonding patterns throughout has allowed establishment of a
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directional order of stability in three dimensions. Dimensions dominated by stronger
intermolecular bonding patterns (e.g. H-bonds) show smaller expansion per unit
temperature rise than those with weaker interactions (e.g. π interactions). Expansion
rates were shown to be similar in polymorphs of different materials.
Pure paracetamol glass, prepared via quench-cooling the melt at ambient temperature
in a DSC pan, crystallises to a mixture of forms II and III upon heating. Form III
crystallisation occurs much more rapidly than form II and goes on to transform to form II
at ca. 125 °C, whilst form II melts at 158 °C. Adding 10 % w/w HPMC to the material prior
to the melting and subsequent vitrification process had the effect of either stabilising form
II or destabilising form III so that only form III crystallised from the glass. This remained
until ca. 135 °C, at which point it converted to form II which then melted just below 160
°C. Vitrification of PCM with 10 % w/w lactose was incomplete and some form II
crystallised during cooling. However, even in the presence of form II crystals, lactose
was successful in stabilising form III, which crystallised from the glass and remained
stable until 130 °C, when it transformed to form II before melting at the expected
temperature. As with lactose, vitrification of trehalose was incomplete and some form II
crystallised from the melt. Upon heating form II grew from the amorphous material and
converted to form I at 116 °C; the form I produced then melted at 170 °C. No form III was
observed, and it seems trehalose has the effect of destabilising polymorph III and
promoting the III conversion.
6.3. Chapter 4
Three of the co-formers examined in Chapter 4: 4-hydroxybenzoic (HBA) acid, 4-
hydroxyphenylacetic acid (HPAA) and 3,4-dihydroxyphenylacetic acid (DHPAA), were
found to form co-crystals with isonicotinamide (ICNT), and all four methods explored
(solvent evaporation, thermal inkjet printing, heating, and milling) were found capable of
producing co-crystals. L-ascorbic acid reacted with INCT in solution and data from inkjet
printing, heating and milling were inconclusive. For the other three co-formers, co-
crystals were formed by solvent evaporation and analysed by single crystal XRD. These
data were used to solve the structures of the new co-crystals.
The INCT-HBA co-crystal was found to crystallise in the P21/c space group when grown
from solution, and is different to the previously reported structure (CSD reference:
VAKTOR).232 Separate DSC and PXRD analyses showed the crystals grown by thermal
inkjet printing to be the same as the known co-crystal, rather than that reported here.
The rapid evaporation of solvent during printing, being much faster than the slow
evaporation from the single crystal growth experiments, may have been the reason for
304
the growth of two different polymorphs of the same co-crystal. Rietveld refinement of
DSC-XRD diffraction data showed that on heating a mixture of INCT I and HBA in a 1:1
molar ratio, some material converts to the new form of the co-crystal and some INCT
converts to the enantiotropically related INCT polymorph II via a solid-solid transition.
Subsequently, the new metastable polymorph of the co-crystal converts to VAKTOR by
a solid-solid pathway. At the same time, some of the remaining INCT II and HBA co-
crystallise to VAKTOR, whilst some of the INCT II melts. Crystals produced by ball milling
were also of the same structure as VAKTOR.
For INCT mixed with HPAA in a 2:1 molar ratio all four co-crystallisation techniques
produced crystals in the prepared ratio with the triclinic space group P-1. This is
demonstrated with room temperature PXRD data, and in the case of thermal co-
crystallisation, Rietveld refinements from DSC-XRD. The refinements revealed that 13.2
% of the physical mixture of the two materials had in fact co-crystallised prior to heating
in the DSC. Combined DSC-XRD also demonstrated that the co-crystallisation of the
remaining INCT and HPAA occurred by a localised melt-recrystallisation pathway of both
materials until the HPAA is exhausted, after which the remaining INCT melts, followed
closely by the co-crystal at ca. 120 °C, more than 30 °C below the melting point of ICNT
form II, the stable polymorph above this temperature.
A co-crystal of INCT and DHPAA was grown by solvent evaporation prior to this work,248
with a 1:1 molar ratio and crystallising in the triclinic space group P-1. Thermal inkjet
printing produced crystals of the same structure, as evidenced by PXRD. Heating a
mixture of the two raw materials appears to have formed a second co-crystal however,
again confirmed by comparison of diffraction data. Unfortunately structural determination
of this product could not be carried out due to the lack of single crystal diffraction data
for this species. A ball milled sample of the two materials in the same ratio produced
crystals that, when analysed by DSC, exhibited a similar endothermic event as the
crystals produced by heating, but their diffraction patterns proved them to be different
structures.
Thermal inkjet printing produced co-crystals of the same structure as those grown by
solvent evaporation for two of the three systems that were successfully co-crystallised.
This method proved to be very rapid, but produced very small crystals and sample sizes,
meaning that the diffraction data suffered from a low intensity to noise ratio and low peak
resolution. Ball milling was the quickest, easiest and cheapest method and also
successfully produced co-crystals in the three systems. Since these methods do not
generally allow the formation of single crystals, solvent evaporation experiments are
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required to solve the structure of new polymorphic forms. However, for scale up purposes
the ball milling approach in particular has great potential. A wealth of information on the
mechanism and energetics of the co-crystallisation process could be obtained by DSC-
XRD, making it too an incredibly valuable tool for the screening of co-crystals.
6.4. Chapter 5
In Chapter 5 the development of a vacuum chamber for the physical vapour deposition
of amorphous pharmaceutical materials was explored, and a number of materials were
successfully vitrified. Initially indomethacin, a good glass former, was used as a model
drug to prove the utility of the method for the task and was successfully converted to a
stable glass. Following this, deposition was attempted unsuccessfully with a number of
other materials (benzoic acid, griseofulvin and famotidine). Problems stemmed from the
materials’ vapour pressure being too high, such that sublimation occurred whilst reducing
the pressure, or the process caused the APIs to melt and boil (rather than sublime) and
sputtering of the sample resulted in non-uniform films on the deposition plate.
Finally finasteride and urea glasses were successfully deposited, at ambient temperature
and −189 °C respectively. Amorphous finasteride remained stable up to 120 °C, at which 
point it crystallised to form II. This marks the first time that crystallisation from amorphous
finasteride has been studied/observed. This is also the first report of the vitrification of
pure urea, to the best of the authors’ knowledge. The urea glass remained stable up to
−90 °C, at which point it crystallised to form I. Tantalisingly, PXRD data hints at the 
existence of an additional polymorph to be found below −150 °C, but owing to time 
constraints and equipment malfunction it was not possible to explore this in detail.
6.5. Future Work
DSC-XRD is a powerful too that may be used to carry out detailed examination of solid-
state phase transitions at different heating rates. Many of the transitions reported here
involved multiple overlapping events in both the DSC and XRD data. Reducing the
heating rate may allow the separation of these events and interpretation of the underlying
processes in these transitions. Isothermal measurements may also be used to collect
additional information on the mechanisms by which these conversions occur. These
experiments would be informative both for the materials discussed in this work, but also
for many polymorphic pharmaceutical materials.
The DSC-XRD technique may also be used to further interrogate co-crystallising systems
in conjunction with single crystal techniques. Once structures have been solved from
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single crystal XRD, they may be used to monitor the evolution of different phases during
heat induced co-crystallisation processes.
The work carried out in Chapter 5 on physical vapour deposition proceeded slowly due
to large amount of time it took to develop the vacuum chamber and the associated
equipment to allow the collection of pharmaceutical glasses. Now the system is
optimised, it would be interesting to carry out more work on the vitrification of materials
such as felbinac, lidocaine, naproxen and tolbutamide, all of which are known to be poor
glass formers. It can also be further explored to make ultrastable glasses from them.
The potential for the chamber as a polymorph discovery tool, by applying Ostwald’s rule
of stages and vitrifying materials at low temperatures then analysing phase changes as
they are heated should also be further explored. In this work, there was the glimpse of a
possible new phase of urea below −150 °C, but owing to time constraints this could not 
be thoroughly investigated. This field of work seems to be an avenue of research with
potentially far reaching benefits for the pharmaceutical industry. Preparing more samples
of amorphous urea and analysing them by low temperature PXRD would be a good
starting point. Further work may be conducted on any number of materials, starting with
a survey of the Cambridge Structural Database to identify those pharmaceutical
materials that have not been found to exhibit polymorphism to date. It has long been
believed that all compounds are capable of polymorphism, and all that is required to
discover polymorphs is time and effort.277
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3. Comparison of the PXRD patterns for crystals printed from a 1:1 molar ratio mixture of INCT
and DHPAA and the known polymorphs of the two raw materials (INCT: EHOWIH, DHPAA:
NELTON).
